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Introduction 
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The impact of BPH on health care
Benign prostatic hyperplasia (BPH) is a common disease of men beyond middle age.
BPH leads to morphological and functional changes in the urinary tract1, manifested
clinically by lower urinary tract symptoms (LUTS).
The relation between age and prostate volume has been quantified by autopsy studies2.
After puberty, the prostate measures about 15 ml in volume, but during life it may
increase in volume up to 100 ml or even more. No men younger than 30 years had
BPH, and the prevalence of BPH rose with age, peaking at 88% in men over 80 years.
BPH is usually a slowly progressive condition. Longitudinal population-based studies
have shown an average increase in prostate volume of 1 to 2 ml per year3. In a random-
ly selected cohort of 350 men a prostate volume increase of 1.4% per year4 was found.
Analyses of prostate growth in 164 men (mean age 63±6 years) during 4 years have
shown that mean prostate volumes (55±26 ml) changed by -9 to + 30 ml5.
As the prevalence of BPH and LUTS increases with age, the absolute number of
patients affected, is rising worldwide due to ageing populations6. Today life expectancy
even approaches 80 years in most developed countries7. 
Surgical treatment for BPH is one of the most frequent operations performed in the
modern western world. The lifetime probability of surgical treatment of men for BPH
is estimated to be 30%8-10. 
In the Netherlands, in 1999 the transurethral resection of the prostate (TURP) was the sec-
ond most performed surgery on men above 50 years of age. The TURP took up 5.2% of all
operations performed compared to 5.5% for the most performed surgery, the aortocoronary
bypass. In the Netherlands, in 1999 about 10,000 TURPs were performed. The total number
of days of hospitalisation for the TURP was about 64,000 in 1999 in the Netherlands
(Prismant). Taking into account about 450 Euro per day for hospitalisation, and about 270
Euro per TURP, the total cost of performing TURPs in 1999 in the Netherlands was about 32
million Euro.
The chance of undergoing surgical treatment increases with age. Keeping in mind the
ageing population, the proportion of men with LUTS caused by BPH will increase con-
siderably in the near future and thus diagnostics and treatment of BPH will make
increasing demands on health care facilities. Besides, the probability of treatment for
BPH is likely to increase as more men may seek newly available medical therapy for
their symptoms in order to avoid surgical management.
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Natural history of BPH
The prostate gland is separated into three zones: the transition zone, the central zone
and the peripheral zone11. Carcinoma occurs mainly in the peripheral zone. The transi-
tion zone, which surrounds the urethra, commonly gives rise to BPH. The prostate
gland is androgen dependent and testosterone is necessary for the development,
growth, differentiation and function of the gland12. In the normal prostate, cell forma-
tion is balanced by programmed cell death. BPH develops when excessive cell division
is promoted or the rate of cell death is reduced3. As BPH progresses, the normal pro-
static tissue changes into hyperplastic tissue and compresses the prostatic urethra,
resulting in progressive obstruction of urinary flow during voiding. The detrusor mus-
cle responds to this obstruction by smooth muscle hypertrophy. Possible consequences
are increased voiding pressure, increased bladder stiffness (decreased bladder compli-
ance) and/or troublesome involuntary bladder contractions (detrusor instability), some-
times with urinary incontinence. Detrusor instability may even occur as a result of
obstruction-induced changes to the bladder nervous system3.
BPH is nowadays rarely a life-threatening disease. The worsening of symptoms is usu-
ally slow3, but a serious outcome such as urinary retention is  rather common. In 2,000
community-men, an incidence of acute urinary retention of 7 per 1000 persons per year
was found13. Kidney stones have been detected with similar frequency, but
hydronephrosis, acute renal failure and urethral strictures were much less common13.
Besides, patients may present with symptoms related to complications secondary to
BPH, such as urinary tract infection, hematuria, bladder stones, and renal
insufficiency14. 
Risk factors for the development of BPH
The aetiology of BPH is undoubtedly multifactorial, but still poorly understood7. The
only clearly defined risk factors for the development of BPH are age2,15 and the pres-
ence of androgens secreted by functioning testes3,7. Men who are castrated before
puberty do not develop BPH16.
Different studies on the risk of family history and BPH show a 1.3 to 4.4 fold increase
in risk for men with one or more first-degree relatives with BPH compared to men
without such family members17-19. The increase in risk was greatest amongst men with
3
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relatives diagnosed with BPH before the age of 60 years17. A shortcoming of these
studies is, however, the self-reported family history of disease7.
Clinical BPH might be more common in black races than in white races, and in their
turn more common than in Asian races, but further studies are needed to confirm this7.
Until now, no firm evidence on the impact of lifestyle factors as determinants of the
risk of developing BPH has come forth20,21. The hormonal influences on the prostate
lead to the idea that mechanisms, which can alter the concentration of sex-hormones
or the interaction with their environment, may contribute to the aetiology of BPH.
Alcohol consumption may decrease testosterone production, and increases testos-
terone clearance in humans7. Reduced age-adjusted relative risks for alcohol consump-
tion and obesity have been reported, although confidence intervals were wide22. Taking
BPH surgery as the outcome, a decreased risk of alcohol consumption and BPH could
be demonstrated23,24. However, the association could be due in part to the poorer surgi-
cal risk of heavier drinkers7. 
Androgen and oestrogen levels seem to increase as an effect of smoking cigarettes due
to their nicotine content. There is, however, little evidence of an increased risk of BPH
for smokers compared to non-smokers7.
A positive correlation between the incidence of hypertension and symptoms associated
with BPH has been reported25.
BPH has been reported to be less common in men who eat large amounts of vegeta-
bles. It has been suggested that certain vegetables protect against BPH because they
contain phyto-oestrogens, which have antiandrogenic effects on the prostate7.
In conclusion, age, the presence of functioning testes and positive family history of
BPH are the only proven risk factors for the development of BPH. More research is
necessary to give recommendations concerning life-style factors for the prevention of
BPH.
Definitions associated with BPH
Historically, hyperplasia of the prostate, prostate enlargement, bladder outlet obstruc-
tion and lower urinary tract symptoms were considered to be almost synonymous.
Today there is increasing awareness that some men have hyperplasia with or without
enlargement of the prostate, some have symptoms, and others bladder outlet obstruc-
tion with overlap of these conditions to varying degrees. Histological BPH does not
necessarily cause prostatic enlargement and men with enlargement do not necessarily
4
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have bladder outlet obstruction7.
Abrams26 pleaded for a more meaningful use of the term “BPH”, pointing out that BPH
is a histological diagnosis and should be reserved only for this purpose. When either
digital rectal examination or transrectal ultrasound has shown gland enlargement, the
preferred term is benign prostatic enlargement: “BPE”. Bosch et al.27 and Abrams28
favour a cut-off point of 30 ml for BPE. When urodynamic studies have demonstrated
bladder outlet obstruction (BOO) secondary to BPE, only then should the term benign
prostatic obstruction (“BPO”) be used. The use of the abbreviations BPH, BPE, BPO
and BOO and their definitions are generally accepted nowadays29. The still quite cur-
rent term BPH has to be discussed in terms of BPE, BOO and/or BPO30. Lower uri-
nary tract symptoms (LUTS) suggestive of BPH should be interpreted as LUTS
suggestive of BPH, BPE and/or BPO.
Symptoms associated with BPH and their bothersomeness
BPH is characterised by a spectrum of symptoms, nowadays often referred to as lower
urinary tract symptoms (LUTS)26. Previously, LUTS in elderly men were referred to as
“prostatism”. This term implies that the symptoms have a prostatic origin. However,
these symptoms are not gender-specific. Age-matched women have similar symptoms
and equal severity of symptoms31-33. Even in elderly men the symptoms may be not
from prostatic origin but caused by detrusor instability, bladder hypersensitivity and/or
possible bladder/urethral denervation with age14,28 and may occur in men with urinary
tract infection, carcinoma in situ, bladder stones or other disorders3,34.  Besides, symp-
toms can be elevated by life-style factors such as diet, fluid intake, alcohol intake, and
anticholinergic effects of commonly used non-prescription medications7. It is for these
reasons that the International Scientific Committee29 has recommended the term
lower urinary tract symptoms (LUTS) instead of “prostatism”. More investigation is
needed to establish whether LUTS in an elderly man is associated with BPH. 
Traditionally, “prostatism” symptoms (nowadays LUTS suggestive of BPH) have been
divided into obstructive and irritative symptoms. As there is only a poor association
between “obstructive symptoms” and bladder outlet obstruction (BOO), and because
detrusor function impairment also causes “obstructive symptoms”, the use of this
term is confusing and should be avoided. Voiding symptoms is a more accurate term28.
“Irritative symptoms” carries the connotation with inflammation that in most men is
not the case. Therefore, storage symptoms should be used as a more accurate term
5
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instead of “irritative symptoms”28. Typical voiding symptoms and typical storage symp-
toms associated with BPH are listed in Table 1.13.
In addition to the usual factors believed to lead to prostate-induced LUTS, age-related
changes can also give rise to symptoms usually interpreted as symptoms associated
with BPH14. Age-related changes are for example the decrease of bladder capacity35,
the decrease of detrusor contractility, the increase of the incidence of detrusor instabil-
ity14,36 and increase of the stiffness of the prostate gland37,38. Increase of bladder insta-
bility with age probably has a greater impact on symptoms than do changes in other
parameters such as impaired urinary stream during voiding.
Of the greatest consequences to the patient are the worry, bothersomeness, and
embarrassment from voiding and storage symptoms, all parameters that heavily influ-
ence the individual quality of life14. Storage symptoms appear to be more bothersome
than voiding symptoms39.
While BPH is relatively common among older men, perceptions about the bothersome-
ness of the symptoms might vary between individuals and with cultural differences40.
Consequently, most patients are actually treated not because there is an unequivocal
indication for treatment but rather because they consider that their LUTS are seriously
deteriorating their quality of life41. 
6
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Table 1.1 Lower urinary tract symptoms associated with BPH.
Voiding symptoms Storage symptoms
Weak urinary stream Frequency and repeated urination
Abdominal straining Nocturia
Hesitancy Urgency
Intermittency Incontinence
Incomplete bladder emptying Bladder pain
Terminal and postmicturitional dribble
Dysuria
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Diagnostics in BPH
Patronised by the World Health Organisation (WHO), the International Scientific
Committee of the International Consultation on BPH attained an increased, but not yet
total agreement as to the extent of pre-treatment investigation necessary in men with
LUTS suggestive of BPH29. This Committee defines four classes of diagnostic tests in
men with LUTS suggestive of BPH:
Highly recommended tests are tests that should be done on every patient.
Recommended tests are tests of proven value in the evaluation of most patients and
their use is strongly encouraged during initial evaluation.
Optional tests are tests of proven value in the evaluation of selected patients; their
use is left to the clinical judgement of the physician.
Not recommended tests are tests of no proven value in the evaluation of most
patients. However, such tests may be helpful in selected patients who do not fulfil the
criteria for the standard (usual) patients.
Highly recommended tests: 
Medical history: 
Adequate medical history should be focusing on the nature and the duration of genito-
urinary tract symptoms, previous surgical procedures, general health issues, current
medication and the patient’s fitness for possible surgical procedures.
Physical examination: 
Physical examination should include investigation of the suprapubic area for possible
bladder distension and neurological examination to exclude a neurogenic bladder. In
addition, digital rectal examination (DRE) should be performed to evaluate the prostate
gland with regard to size, consistency, shape, and abnormalities suggestive of prostate
cancer.
DRE also provides an estimation of prostate volume and is generally sufficient for selecting
the most appropriate treatment when size is a determining factor14. However, the correlation
between estimated prostate volume by DRE and true prostate volume is low42,43. Prostate
volume tends to be underestimated by DRE44.
Urinalysis: 
The urine should be analysed to determine possible pathology, such as urinary tract
infection or hematuria.
7
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Quantification of symptoms: 
Symptom prevalence from the patient’s perspective should be objectively documented
using the seven questions of the International Prostate Symptom Score (I-PSS) and the
question concerning the quality of life (QoL), developed by the Measurement
Committee of the American Urological Association45. The seven questions, covering
incomplete emptying, frequency, intermittency, urgency, weak urinary stream, hesitan-
cy and nocturia, can be answered on a scale of 0 to 5 (ranging from “not at all” to
“almost always”). The I-PSS is the sum of the seven scores and, therefore, ranges from
0 to 35. Because the symptoms in an individual can vary on a day-to-day basis, symp-
tom questions have been worded by asking the respondent to integrate his impression
of the frequency or severity of those symptoms during a one-month period. Men with
an I-PSS of 7 or under more commonly rate the urinary condition as not at all as
opposed to a little bothersome. These men might be considered the mild symptom
group. Men with an I-PSS of 8 to 19 generally gave intermediate ratings of bother, and
can be defined as the group with moderate symptoms. Men with an I-PSS of 20 or
above are generally bothered some or a lot by the symptoms, and could be considered
the group with severe symptoms45. The quality of life question (“If you were to spend
the rest of your life with your urinary condition just the way it is now, how would you
feel about that?”) may be answered (QoL score) on a scale of 0 (“delighted”) to 6 (“ter-
rible”). 
There is variation in the extent to which patients with similar symptom scores are
bothered by their symptoms30. Many patients wish first to be reassured that they do
not have cancer. They are then largely concerned with the relief of symptoms and
improvement in quality of life. There are indexes to measure the bothersomeness of
symptoms. The AUA Measurement Committee developed and validated a Symptom
Problem Index (SPI) with 7 bother questions, each corresponding to a symptom ques-
tion of the AUA Symptom Index46. They also developed and validated a BPH Impact
Index (BII) which measures how much the urinary problems affect various domains of
health.
The assessment of lower urinary tract symptoms (LUTS) is an essential component of the
evaluation of men with BPH in clinical practice and research. Symptom evaluation is neces-
sary for the assessment of outcome in individuals and the evaluation of the effectiveness of
treatments in randomised controlled trials47-49. 
The experience of illness from a patient’s perspective, which tends to be dominated by symp-
toms, worry, and functional limitation, is not so easy to measure. To some clinicians, measure-
ments of these phenomena with questionnaires are inherently subjective and ‘soft’50.
However, a number of instruments have been developed and used to quantify the severity of
LUTS among men with BPH45,49. The resulting measurements, such as validated question-
8
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naires, can result in ‘objective’ measurements of inherently ‘subjective’ patient characteris-
tics50.
Several questionnaires that are self-completed by patients have been developed to assess
LUTS, of which some have been shown to be valid and reliable in a number of settings45,51-55.
The indices are reproducible, internally consistent, and sensitive to changes in symptoms.
The specificity is lower because of the nonspecificity of LUTS32,33, and the indices are not
designed as screening instruments56. 
Studies have revealed regional and international differences in symptoms and bothersome-
ness57-60, and symptom prevalence varies spontaneously over time61. Comparisons between
studies have in the past been compromised by the difficulties of defining each of these various
aspects and by the use of a wide range of validated and unvalidated questionnaires62.
Recognising the limitations of previously published indices, a measurement committee
appointed by the American Urological Association (AUA), developed and validated the AUA
Symptom Index45. The primary purpose of the AUA Symptom Index was evaluative. The
Index was to be used as an outcome measure in a study of different treatment strategies for
BPH. However, implicit in the development and validation of the AUA Symptom Index was a
discriminative purpose: to distinguish between men more or less bothered by their urinary
condition. The AUA Symptom Index was not developed to distinguish between men with uri-
nary symptoms due to different pathophysiologic processes, to discriminate between men
with or without physiologic evidence of bladder outlet obstruction, or to serve as a general
measure of urinary symptom severity amongst patients (including women) with various caus-
es of lower urinary dysfunction50.
The validity and test-retest reliability of the AUA Index has been proven45. In a study by
Plante et al.63 in which 64 patients completed two AUA symptom questionnaires during the
same office visit, one self-administered and the other by physician interview, mean total AUA
Symptom Scores by physician-versus patient-administered questionnaires were similar, irre-
spective of the order of administration. The index could discriminate between BPH and con-
trol subjects and was sensitive to change. 
The questionnaire developed by the AUA, with an additional question regarding the impact of
BPH on quality of life, was subsequently adopted by the WHO and is known as the
International Prostate Symptom Score (I-PSS)53. 
Increasingly, researchers are including the I-PSS in their studies62. Because these question-
naires contain identical symptom questions, and because the I-PSS has been translated into a
wide variety of languages, this will permit more direct comparisons. However, comparisons
between studies in different countries are often difficult because of the finding of different
levels of symptoms in different societies, probably because of cultural factors49.
The I-PSS is considered to be easy for patients to complete49. Barry et al.45 reported no read-
ing difficulties, but MacDiarmid et al.64 found 15% of 202 patients were unable to read it or
9
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unable to understand it. The authors cautioned that this might introduce bias into studies.
Five percent of men in their twenties, and 15% of men in their forties have moderate-to-
severe LUTS (IPSS ≥ 8)65. Population-based studies all over the world have shown percent
prevalence of moderate-to-severe urinary symptoms of about 25%, 33% to 40% for 50-59, 60-
69 and 70-79 years, respectively66-70. In a community-based study of more than 1,100 men
aged 40 years and older in Spain71, one-quarter were found to have moderate-to-severe symp-
toms (I-PSS score ≥ 8), which increased in prevalence with increasing age. In a community-
based study of 514 men aged 50 years and over, 23% of Korean men reported
moderate-to-severe symptoms72. The proportions of those severely symptomatic approxi-
mately doubled with each decade of age. Reports on longitudinal changes in LUTS-severity in
the Olmsted County cohort revealed an average increase in I-PSS of approximately 0.2 points
per year of follow-up73.
It is generally found that men in the community tend to tolerate LUTS, with only a proportion
seeking medical attention74-76. This finding has been confirmed by a study in Spain of 2,000
community-based men aged 50 years or older77, in which 38% had sought medical advice for
their LUTS. Younger men with moderate symptoms reported a worse quality of life than older
men71.
Relationships between the severity of LUTS and either bothersomeness or impact on quality
of life have been investigated in many studies and in many countries, but a consistent pattern
has not emerged49. Subjective symptoms (LUTS), bothersomeness, and negative impact on
the quality of life are the main reasons for the patient to seek treatment for BPH. From the
patients’ perspective, symptoms and the effect of these symptoms on their state of mind and
daily activities are the principal causes of morbidity50. Therefore, the improvement of this
subjective discomfort ought to be an important treatment goal and criterion of evaluation.
Because surgery is intended to reduce bladder outlet obstruction, it seems inappropriate to
submit symptomatic patients who have no obstruction to such treatment. Currently, however,
the decision for surgery is usually based on the severity of the symptoms and the impact on
quality of life1. The management of BPH, although based on the best available evidence,
should be individualised to patients’ circumstances and personal choices. There is a clear
trend to make the patient an active part of this decision process78. Nevertheless, the opinion
of the treating physician still seems to take an overwhelming impact on the patients’ choice79.
Recommended tests:
Renal function assessment: 
Renal function should be investigated for instance by serum creatinine.
Serum prostate specific antigen (PSA): 
Serum PSA measurement is recommended in the initial evaluation of patients with an
10
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anticipated life expectancy of over 10 years, and in whom the diagnosis of prostate can-
cer once established would change the treatment plan.
PSA levels are influenced by the amount of benign prostatic enlargement tissue. As a conse-
quence, development of BPH increases the PSA serum level.
A high percentage of patients with BPH has an elevated level of PSA80 that is variable over
time81,82. The significant overlap between PSA values in BPH and prostate cancer compli-
cates the distinction between these two diseases. The general consensus is that prostate can-
cer and BPH cannot reliably be distinguished by PSA alone. Prostate biopsy remains the
cornerstone if DRE is unconclusive14.
Flow rate recording: 
Flowmetry is a method of objectively assessing the voiding process. It is non-invasive,
simple, and relatively inexpensive. Uroflowmetry measures a number of parameters of
micturition, of which the most important is the maximum urinary free flow rate
(Qmax.free)
3. Because of the great intra-individual variability81,83-85 and the volume
dependency86-88 of the Qmax.free, if possible, at least two flow rates, both with a volume
ideally of >150 ml voided volume, should be obtained.
From the beginning of the 20th century it has been obvious that bladder outlet obstruction,
due to an enlarged prostate, affects the urine flow rate. Many methods have been used to
measure the flow rate, but it was not until the end of the 1950’s that reliable electronic equip-
ment was developed, by von Garrelts89. Uroflowmetry should be performed with the patient
in a normal voiding position, in private, and when the patient feels the urge to void14.
Uroflowmetry is commonly used to identify patients with abnormal voiding physiology and to
monitor changes in voiding dynamics over time in watchful waiting programmes and follow-
up of therapies90. Uroflowmetry confirms that obstruction is or is not likely14. 
Several authors have studied free urinary flow rates in asymptomatic populations and have
demonstrated the diminishing of flow variables with advancing age86-88. The maximum flow
rate decreases with age, ranging from more than 25 ml/s in young men to less than 10 ml/s in
80-year-old men88. A decrease of maximum free flow rate from a median of 18.5 ml/s at the
age of 50 to 6.5 ml/s at the age of 80 was found in 93 community men, who had no subjective
voiding problems87. In the latter study, 62% of the men had a maximum free flow rate less
than 15 ml/s and 29% had a maximum free flow rate less than 10 ml/s, but 30% voided less
than 150 ml. 
Uroflow studies are not without problems, such as within-person variability in maximum flow
rate over repeated tests. A mean variation has been described of 0.1±3.2 ml/s for maximum
flow rate with a variation range from -15 to +14 ml/s81. There is evidence that repeated
uroflow studies result in increasing maximum flow rate85. Several causes contribute to the
described variability, such as patients’ learning effect, variability related to circadian
11
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rhythm81,84, abdominal straining91, artefacts from weight or stationary system used to meas-
ure flow92 and dependence of flow rate on voided volume86-88. Interestingly, the variability of
uroflow studies is higher in the BPH population than in healthy men, suggesting that this
variability is related to the disease rather than to the test itself30. The exclusion of low voided
volumes, below 150 ml29 is recommended.
Another reason for controversy of the usefulness of peak flow rates in clinical practice and
urological research is that uroflowmetry cannot distinguish between obstruction and impaired
detrusor function as the cause of a low flow rate93-95. Uroflowmetry fails to detect patients
with a high-flow/high-pressure BOO or patients with a low-flow/low-pressure without BOO14.
The prognostic value of maximum flow rate versus the diagnosis of BOO is known to be in
the range of 90, 67 and 30% for maximum flow rate values of less than 10 ml/s, 10-15 ml/s and
greater than 15 ml/s, respectively90.
Home uroflowmetry has been proposed as an alternative way to minimise the learning curve
effect and to provide a more ‘normal’ environment for the patient92,96,97. Dedicated portable
systems have been developed over the years; they are generally easy to operate and can
store several flow tracings that can be downloaded and analysed98 at a later date.
Residual urine: 
The measurement of residual urine volume adds important information to the assess-
ment of the severity of BPH99. Because of the marked intra-individual variability of
residual urine volume, the International Scientific Committee recommends to repeat
the test to improve precision, if the first residual urine volume is significant.
Voiding diaries (Frequency-Volume charts): 
The International Scientific Committee recommends a voiding diary filled out over sev-
eral 24-hour periods when nocturia is the dominant symptom. The reason for this re-
commendation was that voiding diaries would help to identify patients with nocturnal
polyuria or excessive fluid intake, which are supposed to be common in the ageing male.
In the evaluation of patients with lower urinary tract symptoms, the frequency-volume chart
is an important and inexpensive investigative tool100. This chart gives information about fre-
quencies and voided volumes during daytime and at night. It can also provide information
about fluid intake if this is registered, although the value of this is sometimes disputed101. It is
known that the usual history taking is liable to subjective interpretation by both patient and
physician and that there is a discrepancy between patient questionnaires and frequency-vol-
ume charts102. Frequency-volume charts give a more objective indication of the patients’
voiding pattern. It has been demonstrated that recordings on frequency-volume charts are
valid by comparing self-reported voided volumes with collected 24 h voided output in 18
patients103. 
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The frequency-volume chart offers physicians a useful instrument, for example to evaluate
therapeutic results. At the same time it encourages patients to participate in management of
their own problem and increases a more objective awareness of their voiding and drinking
habits. However, frequency-volume charts in LUTS are not suitable as a differential tool101,104.
Although frequency-volume charts are widely used by urologists, little research has been
done to examine how many data are sufficient to gain insight into the patients’ voiding pat-
tern. In many clinics patients report 24 h voiding patterns for 2 to 7 days. If the requirement
could be reduced to 24 h, this would be of interest for both patient and physician. It has been
demonstrated that in patients with interstitial cystitis105 and in women with objective urinary
motor urge incontinence106, the use of one 24 h frequency-volume chart was sufficient to gain
insight into the voiding patterns of such a patient.
Optional diagnostic tests:
Pressure-flow studies: 
The only reliable method for directly diagnosing bladder outlet obstruction is simulta-
neous measurement of the driving pressure and the resulting flow rate: pressure-flow
studies. If outflow resistance is increased, driving pressure will increase and flow rate
will decrease107. Pressure-flow measurements involve introducing a small catheter to
measure pressure within the bladder (and to fill the bladder). Detrusor pressure meas-
urement during filling the bladder (filling cystometry) provides information about blad-
der capacity, compliance, and detrusor stability. Detrusor pressure measurement with
simultaneous flow rate measurement (pressure-flow study) provides information about
the strength of the detrusor muscle and the resistance of the urethra to urine flow. 
The rationale for using pressure-flow studies in the evaluation of patients with LUTS
(possibly due to BPE) derives from the lack of correlation between symptoms of the
lower urinary tract and the presence of an enlarged prostate or BOO. The relationships
among symptoms, urodynamics, pathology and pathophysiology of BPH are complex98. 
Pressure-flow studies are widely accepted as the method to separate men with a low
urinary flow rate due to an impaired detrusor contractility from those with infravesical
obstruction. They are recommended in all patients if invasive treatment is being con-
sidered, particularly in patients with maximum flow rates <10 ml/s and whenever the
patient’s history does not agree with clinical findings.
As the classical surgical treatments of LUTS intend to relieve BOO and relieve the patient of
bothersome symptoms, a careful distinction between the presence and absence of BOO
seems important. For this purpose urodynamic examination has been advocated as part of the
routine evaluation before surgery108-110. 
Originally, prostatectomy has been performed for complications of infravesical obstruction.
Today, 70% is performed because of lower urinary tract symptoms which might be due to
13
CHAPTER 1 INTRODUCTION
hoofdstuk 01  24-07-2001  13:45  Pagina 13
obstructive BPH, but also might be a consequence of detrusor weakness or other age-related
functional changes in the lower urinary tract110. The value of pressure-flow studies included
in the preoperative evaluation has been studied and different studies have found an increase
in success rate if the decision to treat has been based on objective demonstration of obstruc-
tion110-113. Although the prediction of relief of BOO is good, the findings were found to be only
slightly better than free uroflowmetry in predicting the improvement of symptoms and both-
er113,114. A valuable use of pressure-flow studies could be in younger patients in whom BOO
is less likely14.
Pressure-flow studies have been performed for many decades, and even though the method
has gained increasing attention, the technique of examination has changed little115. In 1997 a
subcommittee of the International Continence Society (ICS)116 published a manuscript about
the standardisation of terminology of lower urinary tract function. The paper deals with stan-
dardisation of pressure-flow studies, and evaluation of urethral resistance, BOO and detrusor
contractility. It also standardises the electronic format in which the information obtained from
pressure-flow studies is stored.
The interpretation of results, however, has been altered notably since the early works by von
Garrelts89. Several methods to analyse and interpret the pressure-flow data have been devel-
oped. Some of these are simple, easily interpreted nomograms intended to distinguish
obstruction from non-obstruction, while others are complicated computer-based manipula-
tions of data intended to allow grading of obstruction115. The oldest of the nomograms, by
Abrams and Griffiths111, simply divides the area of a pressure-flow plot into regions of
obstruction, non-obstruction and equivocal. However, there is still controversy among urolo-
gists about where on the nomogram to place the borders delineating obstruction, equivocal
zone, and no obstruction. Controversy among the experts about what constitutes obstruction
is one of the problems with having pressure-flow studies as the basis for treatment30.
In 168 patients90 and 105 patients117 the test-retest variability of pressure-flow studies has
been investigated. Overall, 16% and 12% of patients changed diagnostic category according to
the provisional International Continence Society (ICS) or the Abrams-Griffiths nomogram
after the second or the third test. The observed differences in maximum urine flow rate and
detrusor pressure at maximum flow rate values were statistically significant, but of little clini-
cal relevance and showed the presence of a systematic change towards a less obstructed void-
ing with repeated measures over a short term. The presence of detrusor instability did not
affect the test-retest variability117.
Artificial filling cystometry has been the standard method of investigating lower urinary tract
function. However, various factors impose restrictions on the reliability of the data. These
include non-physiological rates of bladder filling, short duration of the test, urethral catheteri-
sation, the clinical setting, and the degree of immobility imposed by the investigation118. A
method aimed at obtaining natural measurements in a more comfortable environment has
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been ambulatory monitoring with portable data storage devices119,120. 
A promising development to diagnose bladder outlet obstruction noninvasively, is the use of
the variable outflow resistance catheter121. This catheter is used to measure isovolumetric
bladder pressure noninvasively. It has been shown that the combination of this pressure and a
separately measured maximum flow rate may be used to diagnose bladder outlet obstruction.
Transrectal ultrasonography (TRUS):
Ultrasonographic imaging of the prostate is mainly used to exclude the presence of a
malignant process or other pathology in the prostate41,99 or when more precise estima-
tions of prostate size and shape are required122.
TRUS is indicated when DRE findings and/or PSA values suggest the presence of prostate
cancer, and it also serves to guide the automatic prostate biopsy needle3. TRUS is non-inva-
sive, easy to use, and has good reproducibility123. Because the development of BPH is reflect-
ed by a change in shape from the usual triangular-shaped appearance to a more rounded
appearance on ultrasound, the shape of the prostate on ultrasound might assist in the diagno-
sis of BPH99.
TRUS provides the most accurate method for determining the prostate size124 and is far more
precise for determining prostate volume than DRE122 is. Apart from diagnostic applications,
determination of prostate volume may have a rôle in treatment recommendations in patients
with LUTS, because prostate volume may predict the outcome of treatment30,99. TRUS can
guide and evaluate treatment of patients with LUTS99.
Prostate volume appeared to be poorly correlated to LUTS and urodynamic parame-
ters112,125,126. Although there is a weak correlation between prostate volume and symptoms
for a large population of patients, this does not imply correlation for the individual patient30. 
Imaging of the upper urinary tract: 
Ultrasonography of the upper urinary tract or intravenous urography is recommended
for patients in whom there is suspicion of upper urinary tract pathology.
Endoscopy: 
Endoscopy of the lower urinary tract is only recommended when success or failure of
treatment alternatives depend on the anatomical configuration of the prostate.
Not recommended tests:
Tests, which do not provide useful information in the assessment of patients with
LUTS suggestive of BPH, are:
Retrograde urethrography.
Urethral pressure profilometry.
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Voiding cystourethrography.
Electromyography of the external urinary sphincter.
Filling cystometry. 
Aims of the dissertation and justification of the studies
As men age and the availability and variety of treatments for BPH increase, more and
more men receive treatment. BPH is creating an increasing demand on the health care
system21, so total expenses for the management of BPH are expected to increase dra-
matically127. Because appropriate treatment should attack the actual cause of the prob-
lem, accurate diagnosis of BPH and patient classification should result in
improvements in treatment for this disease99.
Today, treatment of BPH is no longer reserved for preventing possible severe compli-
cations,  but is now also used to relieve bothersomeness and to improve quality of life.
This has resulted in a more heterogeneous group of patients presenting with LUTS to
the urologist. Detrusor instability or hypocontractility, instead of BPO128 hampers an
increasing number of these patients. The distinction between these disorders cannot
be made accurately by means of conventional diagnostic tools, such as uroflowmetry
and prostatic volume measurement129,130. Pressure-flow studies represent the gold
standard to establish the presence of obstruction131. The inclusion of pressure-flow
data in the pre-treatment evaluation and patient selection for interventional therapies
improve the overall clinical results110,112,113. Therefore it is important that the patients
are defined according to their symptom status (LUTS), their prostate status (BPE) and
their voiding characteristics (BOO) 28. The correlation between symptoms and objec-
tive measures of outlet obstruction is important41. Relationships between reported
LUTS and clinical measures such as prostate size, uroflowmetry and urodynamic stud-
ies have been found to be weak among men attending urology clinics7,112,125,126. In gen-
eral community populations however, correlations between urological measures have
been found to be somewhat stronger than the correlations seen in urology clinic
patients69,131,133. The selection process that leads to referral to a specialist is complex
and may vary from one primary care practice to the next.
The aims of this thesis are:
1. To evaluate different diagnostic methods and their associations in well-
defined groups of men with LUTS suggestive of BPH;
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2. To estimate the prevalence and bothersomeness of LUTS and their impact
on well-being, and
3. To quantify the diagnostic value and overlap of the different diagnostic
investigation methods and combination of methods.
What makes our population and data different from those in other studies? 
In our studies we investigated a well-defined group of 565 men with LUTS suggestive
of BPH, who visited the outpatient department Urology of the University Medical
Center in Utrecht from October 1993 until January 2000. The highly recommended and
the recommended tests were performed, conforming to the recommendations of the
International Consensus Committee on BPH of 199353. Men were included if they
were over the age of 50 years, without any of the other specified exclusion criteria of
the Committee (prostate cancer, neurological disease, previous prostate surgery, or
taking medication active on the urinary tract), they voided >150 ml during uroflowme-
try studies, residual urine was estimated and prostate size was determined by trans-
rectal ultrasound. The International Prostate Symptom Score and Quality of life score
were collected. We added to these questions also the Symptom Problem Index (SPI)
and the BPH Impact Index (BII)46. If the men could be included, they were evaluated
urodynamically by filling cystometry and by pressure-flow studies. 
The reported lack of associations between LUTS and clinical measures in BPH in the
literature may be due to the way the men were included in the studies. Our group is
different from those used in the reported studies because our men all met the inclusion
criteria of the Committee and because we included only men who were able to void a
volume of at least 150 ml during free uroflowmetry. The number of patients who had to
be excluded for this reason strongly depends on the efforts made to obtain a reliable
flow registration. In our urology department, the number of excluded patients for this
reason could be reduced to 5%. Men who needed a catheter due to severe retention
were excluded anyhow. Excluding men with a voided volume of less than 150 ml and/or
with severe retention will lead to an exclusion of those men with (starting) decompen-
sation of the bladder with changes of bladder properties. With our strict selection, we
hoped to reduce aetiology to the patients’ complaints to a minimum of variables. We
judge our included men to be a reasonable representative sample of the population with
LUTS who attend a urologic clinic, and for whom there is suspicion of BPH. 
Apart from this strict selection of men we tried to estimate parameters as reliably as
possible. Free uroflowmetries were performed with the patient private and when the
patient feels the urge to void. It was always checked whether the patient had produced
a voiding as he would do at home. If not, the flowmetry was repeated. In all patients
residual urine was estimated during one of the visits to the outpatient department by
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transabdominal ultrasonography. If residual volume was significant, this test was
repeated. The urodynamic investigation always started with uroflowmetry and deter-
mination of the residual volume by catheterisation. Some men were not able to arrive
with a full bladder and sometimes were not able to produce a flow curve. At the end of
the urodynamic investigation the bladder of these patients was refilled and after
removal of the catheters uroflowmetry was performed. If these patients were known to
have significant residual volume, catheterisation was performed once more.
In our urodynamic investigation room, measures are taken to guarantee the privacy of
the patients. Telephone calls are not allowed, personnel are not allowed to enter the
room during the investigation, and buzzers are forbidden. The number of investigators
is restricted to a minimum. During voiding the investigators withdraw to a room with a
second display showing the actual pressure and flow curves. It is always verified
whether the patient has voided as he would do at home. If not, the study is not suitable
for analysis and a new attempt is made to obtain a reliable measurement. Patients who
met all inclusion criteria, but were not able to produce a reliable pressure-flow study,
were exceptional. We have computerised systems to abstract data from the curves dur-
ing the filling cystometry, pressure-flow studies and free uroflowmetry. Nevertheless,
it is always checked whether these data are correct by visual inspection of the curves
and if necessary, data were adjusted.
As transrectal ultrasound is more precise for determining prostate volume than digital
rectal examination122, all patients underwent transrectal ultrasound investigation.
Reliability of data from voiding diaries and their relation to symptoms
In 1997 the International Scientific Committee29 recommended frequency-volume
charts in the initial diagnostic evaluation of men with LUTS suggestive of BPH when
nocturia is the dominant symptom. 
As data from frequency-volume charts are reflections of the (dys)functions of the lower
urinary tract, it is logical to attach more importance to the frequency-volume charts in
the diagnostic work-up of men with LUTS suggestive of BPH, than only to identify
patients with nocturnal polyuria or excessive fluid intake. Because hardly any study
has been performed concerning the diagnostic contribution of frequency-volume charts
in men with LUTS suggestive of BPH and the relations of data from these charts with
other diagnostic findings, we studied in a sub-population of 160 men frequency-volume
charts comprehensively.
In chapter 2 the reliability of frequency-volume charts in men with LUTS sug-
gestive of BPH is studied. In chapter 3 the relations between reported data on
these frequency-volume charts and symptoms and quality of life were investi-
gated. 
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Symptoms, bothersomeness, age, prostate volume and urodynamics
The relationships between reported LUTS and clinical measures such as prostate size,
uroflowmetry and urodynamic studies have been found to be weak in men attending
urology clinics7,125,126. We hoped to reduce aetiology to the patients’ complaints to a
minimum of parameters and thus to increase possible associations between LUTS and
clinical measures.
In chapter 4 associations of symptoms and quality of life with age, prostate
volume and urodynamic parameters were estimated.
Up to now, decision making in the treatment of LUTS suggestive of BPH was mainly
based on symptoms and the degree of bladder outlet obstruction53. However, nowadays
the opinion prevails more and more that the degree of bother reported by the patient is
not the same as the presence and frequency of their symptoms39,96,134,135.
Nevertheless, bothersomeness of symptoms and their negative impact on the quality
of life are the main reasons for the patient to seek treatment for BPH96,135,136. 
In chapter 5 the prevalence and bothersomeness of symptoms were analysed.
Additionally, the impact of each symptom and its specific bother on various
domains of health and overall quality of life were studied.
Bladder outlet obstruction
Urodynamics offer an objective tool for the assessment of bladder outlet obstruction
(BOO) in BPH. Different methods of analysing pressure-flow plots, to quantify bladder
outlet resistance and to classify whether or not a patient is obstructed, have been
developed in the past116. These different approaches are based on similar theoretical
principles, but are different in detail and objectives. In chapter 6 the extent of
(dis)agreement among different methods of analysing pressure-flow plots to
define bladder outlet obstruction was quantified.
Prostate volume, urethral resistance, bladder outlet obstruction, and filling cystometric
estimated parameters
In recent years it has become clear that the interrelationships between BPH, prostatic
enlargement, LUTS and bladder outlet obstruction are not simple107. Prostatic obstruc-
tion, impaired detrusor contractility, decreased bladder compliance, reduced bladder
capacity, residual volume and/or detrusor instability all play a rôle in the genesis of
symptoms as well as in the severity of BPH. These pathophysiological elements are all
common in the elderly man and may be present alone or in all possible combinations,
each giving rise to specific complaints. When evaluating these characteristics in men
with BPH, it is not fair to compare men with recent onset of BPH with those who have
severe and prolonged obstruction. In the latter group, the long term effects of obstruc-
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tion may result in detrusor decompensation or other changes. In chapter 7 the char-
acteristics of our well-defined group of men with LUTS suggestive of BPH are
described. Further, the interactions between prostate volume and different
urodynamic parameters were investigated.
Pressure-flow studies have been widely adopted in the evaluation of patients suspected
of having obstruction, as well as in scientific studies, but the method suffers from a lack
of validation from urodynamic studies in the normal population108,137. However, to
decide what is pathological, it seems mandatory to agree on what can be considered
normal in elderly men. Objective parameters obtained from urodynamic tests on which
functional diagnoses are based should be related to normal standardised reference val-
ues.
In chapter 8 the characteristics of healthy elderly volunteers without and of
volunteers with LUTS suggestive of BPH were established. Additionally, we
compared these characteristics with those in our patient group.
Data from frequency-volume charts versus urodynamic data
The International Scientific Committee on BPH29 classified filling cystometry as a not
recommended test. The dominant reason for this classification was that findings during
filling cystometry may not be representative of bladder behaviour during natural blad-
der filling at home. If this statement is true, one would expect a lack of associations
between data obtained during filling cystometry and those obtained from frequency-
volume charts. The relations between data on frequency-volume charts and
properties during the bladder-filling phase at urodynamic evaluations were
studied in chapter 9.
In chapter 10 associations of data from frequency-volume charts with bladder-
emptying properties were studied. Additionally, the impact of the amount of
fluid intake on voiding frequency was investigated.
Bladder outlet obstruction number (BOON) 
Different studies have found an increase in success rate if the decision to treat has
been based on objective demonstration of obstruction110-113. However, pressure-flow
studies are often considered too invasive, time-consuming and expensive to be routine-
ly utilized138,139. The method is invasive which by its nature may obstruct or irritate
the detrusor or urethra118, and can cause discomfort to the patient. Our experience,
however, agrees more with the findings of Kortmann et al. 140 that urodynamic investi-
gation was associated with low objective and subjective morbidity. World wide, this
means that some men will undergo urodynamics while other men, with equal medical
history and diagnostics, will not, depending on the consent of the investigator. Because
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we investigated associations of bladder outlet obstruction with diverse other non-inva-
sively obtained parameters (Chapters 4,7,8,10), we wondered whether it was possible
to classify men as obstructed, equivocal or unobstructed using a combination of non-
invasively estimated parameters. In that way urodynamic investigations may be
restricted to a selected group of men. In chapter 11 possible combinations of non-
invasive obtained parameters to discriminate men who are obstructed from
those who are not, are developed and validated.
Finally, in chapter 12 the results are discussed and general conclusions are for-
mulated. 
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Abstract
Objectives: The aims of this study were to analyse the data from frequency-volume
charts and to study the reliability of these charts in men with lower urinary tract symp-
toms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Methods: Men with LUTS suggestive of BPH were consecutively included in the
study if they met the criteria of the International Consensus Committee on BPH, void-
ed more than 150 ml during uroflowmetry, residual volume and prostate size were esti-
mated and frequency-volume charts were completed correctly. From the
frequency-volume charts, voiding habits and fluid intake were evaluated.
Results: 160 patients could be included. Another 28 patients who met all other criteria
did not complete the frequency-volume charts correctly. Agreement exists between
reported voided volumes in the literature and those found by us. We found a significant
correlation (p<0.001) between nocturia and score on symptom question 7, and
between diuria and score on symptom question 2 of the AUA symptom index. The dif-
ference between results obtained from frequency-volume charts completed during 24 h
and those obtained from charts completed during three or more 24-hour periods was
negligible with respect to the variation of data at an individual level.
Conclusions: Frequency-volume charts are reliable in the investigation of patients
with LUTS suggestive of BPH. Reporting on frequency-volume charts during just 24 h
is sufficient to gain insight into their voiding habits during normal daily life.
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Introduction
Frequency-volume charts are important in the investigation of people with voiding dis-
orders and give the urologist information about frequency in the daytime and at night
together with the voided volumes1. Hansen and Klarskov2 reported that recordings on
frequency-volume charts are valid. McCormack et al.3 assessed the agreement
between patient questionnaire and frequency-volume charts. They reported a poor
agreement between patient questionnaire- and chart-determined urinary frequency,
suggesting that a frequency-volume chart show a more valid indication of urinary
habits, than the patient questionnaire itself. Other authors4-9 also found the frequency-
volume chart to be a basic tool in lower urinary tract symptoms (LUTS), although not
suitable for young children or as a differential tool. Most of these studies6-10 focus on
frequency and incontinence, whereas the composition of the patient groups was quite
diverse concerning age, sex and symptoms. 
Voiding dysfunction in the elderly is a common problem with far-reaching implications.
In the past, extensive scientific and clinical considerations have led to an international
consensus11 about the diagnostic work-up of men presenting with LUTS suggestive of
benign prostatic hyperplasia (BPH). Nevertheless, hardly any study has been per-
formed concerning the diagnostic contribution of frequency-volume charts in these
men and the relation of data from these charts with other diagnostic findings. The
American Urological Association (AUA) symptom index and quality of life question12
are accepted as mandatory tools in the clinical evaluation of these patients11. The AUA
symptom index consists of seven questions concerning voiding habits. As from fre-
quency-volume charts a lot of information is available concerning voiding habits, it
seems logical to investigate whether data on frequency-volume charts can contribute
to the diagnosis in BPH.
As a first step in such an extensive investigation, this paper deals with the analysis of
data from frequency-volume charts and with the reliability of these data in a well-
defined group of men with LUTS suggestive of BPH. Moreover, it is examined whether
reporting during 24 h is as sufficient as reporting during three or more periods of 24 h
to gain insight into the voiding habits of these patients. 
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Materials and Methods
In men with LUTS consecutively presenting to our outpatient department of urology, basic
standard evaluation (history, quantification of symptoms by the seven questions and quality of
life question proposed by the AUA12, physical examination and digital rectal examination, uri-
nalysis and renal function assessment) and recommended tests (uroflowmetry and residual
urine estimation) conforming to the recommendations13 of the International Consensus
Committee on BPH were performed. We introduced an additional question 8 to the AUA
symptom index concerning frequency of voiding in the daytime. Patients could score on ques-
tion 8: score 0: 1-3 times, score 1: 4-5 times, score 2: 6-7 times, score 3: 8-9 times, and score
4: 10 times or more. Patients were requested to report on frequency-volume charts for 3 peri-
ods of 24 h during normal daily activity. Patients with LUTS were included if they were over
the age of 50 years without any of the specified exclusion criteria of the International
Consensus Committee on BPH13, if they voided a sufficient volume (>150 ml) during one or
more free uroflowmetry studies, residual volume was estimated reliably, prostate size was
determined by transrectal ultrasound and if frequency-volume charts were available showing
voiding and drinking habits during at least one 24 hour period.
From the frequency-volume charts, the minimum voided volume (Vmin), the maximum voided
volume (Vmax), mean diuria (Ndiuria) and mean voided volume in the daytime (Vmean,day), mean
nocturia (Nnocturia) and mean voided volume at night (Vmean,night) were estimated. Nighttime
was defined as the period between 23:00 h and 07:00 h. Voiding volumes on the frequency-
volume charts when the patient did not indicate a desire to void were excluded from these
analyses, but were included for estimation of mean total urine production in the daytime
(Vtotal,day) and of mean total urine production at night (Vtotal,night). Mean fluid intake in the day-
time (Vintake,day) and mean fluid intake at night (Vintake,night) were calculated as well.
Calculations were repeated after changing the definition of nighttime to the period between
24:00 h and 06:00 h.
Ninety-one men reported on their voiding and drinking habits for three or more nights and
109 men reported on three or more daytime periods. Data from all nights were compared to
those of the first night and data from all daytime periods to those of the first daytime period. 
Symptom question 7 (“over the past month, how many times did you most typically get up to
urinate from the time you went to bed at night until the time you got up in the morning?”)
allows the patient to score between 0 and 5. In order to be able to compare nocturia from fre-
quency-volume charts with symptom question 7 scores, a nocturia score (Snoct) was defined:
Snoct=5 for mean nocturia>4, Snoct=4 for 3<mean nocturia≤ 4, Snoct=3 for 2<mean noc-
turia≤ 3, Snoct=2 for 1<mean nocturia≤ 2, Snoct=1 for 0<mean nocturia≤ 1 and Snoct=0
for mean nocturia=0. In the same way, in order to compare diuria from frequency-volume
charts with the score of question 8, a diuria score, Sdiuria, was introduced: Sdiuria=4 for
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mean diuria>9, Sdiuria=3 for 7<mean diuria≤ 9, Sdiuria=2 for 5<mean diuria≤ 7, Sdiuria=1
for 3<mean diuria≤ 5, and Sdiuria=0 for mean diuria≤ 3.
The 24-hour day was divided in five time periods: 23:00 h-07:00 h, 07:00 h-11:00 h, 11:00 h-
15:00 h, 15:00 h-19:00 h, and finally 19:00 h-23:00 h. For each patient we estimated the period
during which the lowest volume was voided and the period during which the largest volume
was voided.
Since a normal distribution of some measured parameters is not to be expected, we present
means and standard deviations together with the ranges of the parameters. Statistical analy-
ses were done with the distribution free Kendall and Gibbons rank correlation method14. The
significance level was set at p<0.05.
Results
From 188 men who met all other inclusion criteria, 28 (15%) did not complete the fre-
quency-volume charts correctly during at least 24 h (they reported accumulated vol-
umes, they reported only during parts of days, or they were not willing to complete the
charts). The included 160 men (age 64.9±8.3 years, range 50-89) had an average
symptom score of 16.9±6.5 (range 3-32) and a quality of life score of 3.8±1.5 (range 1-
6). Mean prostate size was 44±21 cm3 (range 13-155). Mean maximum flow at free
uroflowmetry was 12.9±5.4 ml/s (range 3.5-33) and mean residual volume was 51±78
ml (range 0-400).
Figure 2.1A shows the number of men in relation to the number of days they reported
on their voiding habits, figure 2.1B shows the number of men in relation to the number
of nights they reported on their voiding habits.
Mean Nnocturia was 2.1±1.4 (range 0-7), mean Vmean,night was 222±101 ml (range 55-
660), mean Ndiuria was 6.7±2.7 (range 1-15), and Vmean,day was 188±77 ml (range 65-
565). Mean voided volume during 24 h was 195±74 ml (range 65-495). Mean lowest
voided volume (Vmin) was 95±58 ml (range 10-350), and mean largest voided volume
(Vmax) was 351±142 ml (range 100-850).
In figure 2.2A, the relation between symptom question 7 (nocturia) and Snoct, calculat-
ed from the frequency-volume charts is given (correlation coefficient 0.44, p<0.001).
In figure 2.2B, the relation between question 8 (diuria) and Sdiuria, calculated from the
frequency-volume charts, is given (correlation coefficient 0.44, p<0.001). In figure
2.2C, the relation between diuria calculated from the frequency-volume chart and the
score on question 2 (“over the past month, how often you have had to urinate again
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less than 2 h after you finished urinating?”) of the AUA symptom index is plotted (cor-
relation coefficient 0.38, p<0.001).
In figure 2.3A, the number of patients is given in relation to the time period during
which the maximum volume (Vmax) is voided. In figure 2.3B, the number of patients is
given in relation to the time period during which the minimum volume (Vmin) is voided. 
Ninety-one patients (57%) reported on their voiding and drinking habits for three or
more nights. In table 2.1, data from all nights were compared to those of the first night.
One hundred and nine patients (68%) reported on three or more daytime periods. In
table 2.2, data from all daytime reports were compared to those of the first daytime
report.
36
CHAPTER 2
Figure 2.1 A. Number of patients in relation to the number of daytime periods, B. number of
patients in relation to the number of nights they completed the frequency-volume charts.
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Figure 2.2 A. Scores for nocturia (Snoct) with standard deviation (SD) as calculated from the
frequency-volume charts versus score on question 7 from the AUA symptom index. B. Scores
for diuria (Sdiuria) with SD as calculated from the charts versus score on question 8. C. Mean
number of diurnal voidings versus score on question 2 of the AUA symptom index.
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Figure 2.3 A. Number of patients versus time period in which maximum volume is voided. B.
Number of patients versus time period in which minimum volume is voided.
Table 2.1 Data (mean±SD) from three or more nights (91 patients) compared to those of
the first night.
≥ 3 Nights First night Correlation Significance Regression 
coefficient coefficient
Nocturia 2.09±1.22 2.05±1.36 0.79 <0.001 0.96
Vmean,night (ml) 208±110 204±152 0.67 <0.001 0.95
Vtotal,night (ml) 433±236 437±359 0.59 <0.001 0.84
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Figure 2.4 compares the mean voided volume during three or more daytime periods
with the mean voided volume during the first daytime period.
Figure 2.5A shows the percentage of patients in whom the proportional difference
between mean voided volume V1 during one daytime period and the mean voided vol-
ume V3 during 3 or more daytime periods is lower than the cut-off point, or mathemati-
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Table 2.2:Data (mean±SD) from three or more daytime periods (109 patients) compared to
those of the first daytime period.
≥ 3 Days First day Correlation Significance Regression 
coefficient coefficient
Diuria 6.74±2.56 6.65±2.76 0.74 <0.001 0.98
Vmean,day (ml) 185±73 190±79 0.75 <0.001 0.99
Vtotal,day (ml) 1250±459 1261±525 0.65 <0.001 0.98
Figure 2.4 Mean voided volume during the first daytime period versus mean voided volume
during three or more daytime periods.
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cally formulated: figure 2.5A shows the percentage of men in whom absolute value of
[{V1-V3}/V3] * 100%<cut-off point. Figure 2.5B-D shows these percentages for diuria,
mean voided volume at night and nocturia, respectively.
Table 2.3 illustrates the effects by changing the definition of nighttime from 23:00 h-
07:00 h to 24:00 h-06:00 h.
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Figure 2.5 Percentage of patients in whom the proportional difference of the value of a parame-
ter calculated from one 24-hour period with respect to that calculated from three or more 24-
hour periods is less than the cut-off point. A. Mean voided volume in the daytime. B. Diuria. C.
Mean voided volume at night. D. Nocturia.
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Discussion
The inclusion criteria we used are recommended by the International Consensus
Committee on BPH13. We consider it not reasonable to change any of these criteria
because of the extensive scientific and clinical considerations, which led to the recom-
mendations of the Committee. Nevertheless, we realise that our inclusion criteria,
especially the condition that free flowmetry was performed with a voided volume of
more than 150 ml, will lead to an exclusion of those men with (starting) decompensa-
tion of the bladder. Thus it is reasonable to assume that we selected men in whom
obstruction is developing or who are in the early phase of obstruction, i.e. in whom
bladders are still able to compensate for impaired outflow condition.
According to Abrams15 frequency-volume charts are essential in the investigation of
the function of the male and female lower urinary tract and they are completed with
enthusiasm and accuracy.
From a study in which patients during three consecutive days recorded their fluid
intake and voided volume beside collecting 24-hour urinary output, Hansen and
Klarskov2 concluded that recordings on frequency-volume charts are valid and useful in
the investigation of patients with voiding symptoms. The mean voided volume in their
18 patients (16 men and 2 women, median age 63 years, range 20-80) was 179 ml (ver-
sus 195 ml in our group). The mean lowest voided volume was 73 ml (in our group: 95
ml) and the mean largest volume was 421 ml (in our group: 351 ml). In 95 older people
(age 72±5.3 years) Asplund and Åberg10 found a mean voided volume at night of
256±113 ml (versus 222±101 ml in our group) and a mean voided volume in the day-
time of 188±86 ml (versus 188±77 ml in our group). McCormack et al.3 assessed the
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Table 2.3 Mean values calculated from frequency-volume charts after defining the period
of nighttime by the period between 23:00 h and 07:00 h and after defining this period by
the period between 24:00 h and 06:00 h.
23:00 h–07:00 h 24:00 h– 06:00 h
Nnocturia 2.1±1.4 1.5±1.0
Vmean,night (ml) 222±101 231±102
Ndiuria 6.7±2.7 7.3±2.8
Vmean,day (ml) 188±77 190±75
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agreement between patient questionnaire and frequency-volume charts in 88 patients.
They found a mean diurnal voided volume of 176±64 ml and a mean voided volume at
night of 233±130 ml. They reported a poor agreement between patient questionnaire-
and chart-determined urinary frequency, suggesting that the frequency-volume chart
shows a more valid indication of urinary habits than the patient questionnaire. Other
authors4-9 also found the frequency-volume chart to be a basic tool in LUTS, although
not suitable for young children or as a differential diagnostic tool.
Despite the fact that the compositions of the reported groups are quite different from
the composition of our group and we excluded voidings when patients did not indicate a
desire to void, agreement exists between the reported volumes and ours. Agreement
also exists (fig. 2.2A-C) between patient questionnaire scores concerning frequency,
nocturia and diuria, and the data calculated from the frequency-volume charts.
The mean lowest voided volume was 95 ml and the mean largest voided volume was
351 ml in our group, demonstrating the well-known large variation at an individual
level. However, a large variation at an individual level and as a consequence a large
variability in voiding parameters does not mean that the frequency-volume charts are
completed unreliably. In a patient reporting ten voidings with a volume of 200 ml each
the variability in voiding volume is 0 ml, but one may have serious doubts about the
reliability of these data. Variability is not caused by measurement errors but by the
nature of the parameter: No one has a unique functional capacity! As a consequence,
studying variability or calculation of the average within-subject variation is not appro-
priate to judge the reliability of data on frequency-voiding charts. To judge reliability,
we calculated average voided volumes and the minimum and maximum voided volumes
and compared their means and standard deviations to data published in validated stud-
ies. Moreover, we compared nocturia and diuria calculated from frequency-volume
charts with scores on the I-PSS questionnaire. Keeping in mind the large variation at
an individual level, we conclude from the agreement between our data and those
reported in validated studies and from the agreement between data and scores on ques-
tionnaires that our 160 men completed their records reliably. 
We excluded volumes when patients did not indicate a desire to void. These voidings
may be prophylactic, for instance before going out, and are likely to have no relation to
LUTS.
Of our consecutively included patients, 15% were not able or were not willing to com-
plete the frequency-volume charts correctly at all. Despite the fact that all included 160
men were requested to complete charts during three 24-hour periods, 32% reported
only during one or two daytime periods (fig. 2.1A) and 43% only during one or two
nights (fig. 2.1B). Some of these men may start reporting in the morning of the first
day and may finish before going to bed on the second or third day. 
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At a group level, the number of voidings and volumes and their variability are hardly
influenced by the number of 24-hour periods (tables 2.1, 2.2). By including the mea-
surements of the first day in the mean of three or more days as well, the agreements
are influenced in a positive way. However, we just wanted to establish whether report-
ing during one day is as sufficient as reporting during three or more days. Figure 2.5A-
D illustrates the reproducibility of some parameters on an individual level. From figure
2.5A, it appears that in more than 80% of the men, the mean voided volume during the
first daytime period did not differ more than 20% from the mean voided volume calcu-
lated from three or more daytime periods. Compared to the difference between the
mean lowest voided volume (95 ml) and the mean largest voided volume (351 ml), this
difference of 20% is negligible. This fact and the data of the figure 2.5B-D strongly sug-
gest that reporting on frequency-volume charts during 24 h is sufficient to get an
impression of the voiding habits during normal daily life. It may even be better to
report for only one 24-hour period, as the less the patient is asked to do so, the more
eager he will be to perform the task accurately. We want to emphasise that these con-
clusions are formulated for our well-defined group of men with LUTS suggestive of
BPH.
Because most patients were treated for their symptoms shortly after the examinations,
it was not possible to repeat the reporting after some period in order to study the vari-
ability as a function of time.
Asplund and Åberg10 reported that the time going to bed at night and getting up in the
morning varied considerably among elderly. Therefore, we decided to use the 8-hour
period between 23:00 h and 07:00 h instead of true nocturia. Shortening of this time
period to 24:00 h-06:00 h only results in a proportional reduction of mean nocturia and
a proportional increase of mean diuria (table 2.3).
The average number of nightly voidings made 24% of the 24-hour frequency. The aver-
age urine volume at night was 27% of the total 24-hour urine production. In our group,
16 patients (10%) had a 24-hour urine production of more than 2.5 litres; however,
their fluid intake was also more than 2.5 litres. Of all men, only 4 (2.5%) had more than
half of their diuresis during nighttime. According to Abrams15, this shows that nocturia
is unlikely to be due to nightly polyuria in our group of men.
Figure 2.2A shows agreement between scores for nocturia and scores between 0 and 3
on symptom question 7. Keeping in mind the rather high standard deviation, a flatten-
ing of the curve towards symptom score 4 and 5 is observed. If we change the defini-
tion of nighttime to the period of 24:00 h-06:00 h this flattening would even be more
pronounced. We assume that as the number of times at which a patient has to get up to
urinate increases, he may increasingly overstate this number on the AUA symptom
index. Patients may simply be bothered by a nocturia frequency of more than 2 or 3. In
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figure 2.2B and 2.2C such a flattening is not observed. Agreement also exists between
frequency calculated from the patient questionnaire and diuria calculated from frequen-
cy-volume charts. Despite the fact that the correlation coefficients in figure 2.2A-C are
highly significant, we have to keep in mind the rather high standard deviation of the
data in the figures. Information from a questionnaire may be rather unprecise as
regards the number of voidings in the daytime and at night.
The largest volume is voided in most cases at night or in the morning (fig. 2.3A), possi-
bly due to a delay in sensation of a full bladder during sleep. The smallest volume is
voided in most cases in the morning or early afternoon (fig. 2.3B).
Conclusions
Frequency-volume charts completed by patients with LUTS suggestive of BPH are
reliable. Reporting correctly on frequency-volume charts during just 24 h is sufficient
to gain insight into the voiding habits of patients during normal daily life.
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Abstract
Objective: The aim is to study the relations between reported data on frequency-vol-
ume charts and the American Urological Association (AUA) symptom scores and quali-
ty of life score.
Methods: Men with lower urinary tract symptoms suggestive of benign prostatic
hyperplasia (BPH), were consecutively included in the study if they met the criteria of
the International Consensus Committee on BPH, they voided >150 ml during
uroflowmetry, residual volume and prostate size were estimated and frequency-volume
charts were completed correctly. From the frequency-volume charts, voiding habits
and fluid intake in the daytime and at night were evaluated.
Results: In the included 160 men no correlation was found between total urine produc-
tion at night or in the daytime and symptom index or quality of life score. Nocturia was
correlated with symptom index, but surprisingly not with quality of life score. Small
voided volumes at night and in daytime are attended by high symptom index and high
quality of life score (= low quality of life). Diuria has a high impact on symptom index
and quality of life score. Men who completed frequency-volume charts during 3 or
more daytime periods (68%) had a significantly higher symptom index than those who
completed only 1 or 2 daytime periods (32%). 
Conclusions: High diuria, and small voided volumes at night and in daytime contribute
significantly to high symptoms and low quality of life. Nocturia correlated with AUA
symptom index but surprisingly not with quality of life score.
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Introduction
The American Urological Association (AUA) symptom index and quality of life ques-
tion1 are accepted by the World Health Organisation as mandatory tools in the clinical
evaluation of men with lower urinary tract symptoms (LUTS) suggestive of benign pro-
static hyperplasia (BPH)2. The AUA symptom index consists of seven questions con-
cerning voiding habits: incomplete emptying (question 1), frequency (question 2),
intermittency (question 3), urgency (question 4), weak urinary stream (question 5),
hesitancy (question 6), and nocturia (question 7). Symptom index (0-35) is calculated
by summing the scores (0-5) on the seven questions. A survey of Gee et al. 3 revealed
that 99% of respondents of a random sample of 514 American urologists were aware of
and used the AUA symptom index. Even 21% of these respondents had altered their
diagnosis and management strategies because of its existence. Many attempts have
been made to explain symptoms from prostate size, urinary flow rate, residual urine
and pressure-flow studies. However, symptom index hardly correlates with prostate
size4-6, urinary flow rate5,6, residual volume5,6, and obstruction grade4,5,7,8. Quality of
life increases with increasing maximal flow rate during free flowmetry and with
decreasing residual volumes5. However, quality of life does not correlate with prostate
volume and obstruction grade5. 
Frequency-volume charts are an important tool in the investigation of men with void-
ing disorders and give the urologist information about frequency in daytime and at
night together with the voided volumes9. The reliability of the data on frequency-vol-
ume charts completed by a well-defined group of men with LUTS suggestive of BPH
was discussed in a previous paper10. It was concluded that frequency-volume charts
completed during one period of 24 h are reliable and sufficient to gain insight into the
voiding habits of these men.
The relations between reported data on the frequency-volume chart, symptom scores,
and quality of life score in men with LUTS suggestive of BPH hardly have been stu-
died. Our aim is to study these relations in a well-defined group of men with LUTS sug-
gestive of BPH.
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Materials and Methods
Methods, definitions and units conform to the standards proposed by the International
Continence Society (ICS) except when specifically noted.
In men with LUTS consecutively presenting to our outpatient department of urology, basic
standard evaluation (history, quantification of symptoms by the seven questions, calculation of
the symptom index and quantification of quality of life as proposed by the AUA1, physical
examination and digital rectal examination, urinalysis and renal function assessment) and re-
commended tests (uroflowmetry and residual urine estimation) conforming to the recommen-
dations2 of the International Consensus Committee on BPH were performed. Men with
LUTS were included if they were older than 50 years without any of the specified exclusion
criteria of the International Consensus Committee on BPH11, they voided a sufficient volume
(>150 ml) during one or more free uroflowmetry studies, residual volume was estimated reli-
ably, prostate size was determined by transrectal ultrasound and frequency-volume charts
were available showing voiding and drinking habits during at least one normal 24-hour period.
From the frequency-volume charts, the minimum voided volume (Vmin), the maximum voided
volume (Vmax), mean diuria (Ndiuria) and mean voided volume in the daytime (Vmean,day), mean
nocturia (Nnocturia) and mean voided volume at night (Vmean,night) were estimated. Nighttime
was defined as the period between 23:00 h and 07:00 h. Voided volumes on the frequency-vol-
ume charts when the patient did not indicate a desire to void were excluded from these analy-
ses, but were included for estimation of mean total urine production in daytime (Vtotal,day) and
of mean total urine production at night (Vtotal,night). Mean fluid intake in daytime (Vintake,day)
and mean fluid intake at night (Vintake,night) were calculated as well. Parameters and correlation
coefficients were recalculated after changing the definition of nighttime into the period
between 24:00 h and 06:00 h.
Statistical analyses were done with Kendall and Gibbons distribution free rank correlation
method12 and Student’s t-test. The Kolmogorov-Smirnov goodness of fit test13 was used to
examine whether a distribution of a parameter resembled the normal distribution.
Significance (two-tailed) was set at p<0.05.
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Results
The included 160 men (age 64.9±8.3 years, range 50-89) had an average symptom
score of 16.9±6.5 (range 3-32) and quality of life score of 3.8±1.5 (range 1-6). Mean
prostate size was 44±21 cm3 (range 13-155). Mean maximum flow at free uroflowme-
try was 12.9±5.4 ml/s (range 3.5-33) and mean residual volume was 51±78 ml (range
0-400). The distributions of the scores on the seven questions, of the symptom index
and of the quality of life score are given in figure 3.1. Only the distribution of the symp-
tom index appeared to be normal (Kolmogorov-Smirnov test).
Table 3.1A shows the symptom index and quality of life of the 160 men in relation to
the number of daytime periods and table 3.1B in relation to the number of nights they
completed the frequency-volume charts correctly.
The mean AUA symptom index in men who completed the charts during 3 or more
daytime periods (68%) was significantly higher than in those who completed the charts
during only 1 or 2 daytime periods. 
51
CHAPTER 3 VOIDING DATA VERSUS SYMPTOMS AND QUALITY OF LIFE IN PROSTATIC HYPERPLASIA
Figure 3.1 Distributions of symptom scores, symptom index and quality of life score.
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In table 3.2 correlation coefficients are listed between scores and data calculated from
the frequency-volume charts. 
A significant correlation was found between minimum voided volume (Vmin) and the
score on question 2 (frequency): correlation coefficient -0.22 (p<0.01), resulting in a
correlation coefficient between symptom index and Vmin of -0.17 (p<0.01). However,
no significant correlation existed between Vmin and quality of life score (table 3.2).
Eighty men had a residual volume equal or higher than 10% of the mean voided volume
in daytime. The score on symptom question 1 (incomplete emptying) was 2.54±1.73 in
these men. In the others the score was 2.25±1.74. This difference is not significant
(p=0.15).
Of the 160 men, 25 (15.6%) noted sometimes voidings at night without desire to void.
By taking into account these voidings, average nocturia in this group of 25 men
increased from 1.6 to 2.3. Recalculations of the correlation coefficients between scores
and nocturia (including voidings without desire to void) for all 160 men, resulted in
minor differences with respect to the values listed in table 3.2.
Fifty-six men (35.0%) sometimes voided in daytime without desire to void. In this
group diuria increased from 5.5 to 7.4 by including these voidings in the calculations.
Taking into account these voidings did not result in significant changes in the correla-
tion coefficients between scores and diuria listed in table 3.2.
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Table 3.1 AUA symptom index and quality of life score in relation to the number of daytime
(A) and nighttime (B) periods the patients reported.
A.
1 or 2 daytime periods 3 or more daytime periods p
(51 men) (109 men)
Symptom index 15.4±6.3 17.6±6.5 0.045
Quality of life score 3.6±1.5 3.9±1.5 0.24
B.
1 or 2 nighttime periods 3 or more nighttime periods p
(69 men) (91 men)
Symptom index 16.6±6.8 17.1±6.3 0.63
Quality of life score 3.7±1.4 3.9±1.5 0.38
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In table 3.3 the correlation coefficients are listed between the scores on the different
questions and the quality of life score.
In table 3.4 the relation between nocturia and quality of life score is given. This relation
is hardly affected by taking into account the voidings without desire to void.
In table 3.5 urinary symptoms are listed in decreasing order of score, and listed in
decreasing order of correlation with quality of life.
Changing the definition of nighttime into the period between 24:00 h and 06:00 h
resulted in minimal changes in the correlation coefficients listed in table 3.2 for diuria,
mean voided volume in daytime and total urine production in daytime. For nocturia,
mean voided volume at night and total urine production at night, the correlation coeffi-
cients slightly decreased.
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Table 3.4 Relation between nocturia and quality of life score.
Number of men Quality of life score ± SD
0≤ nocturia<1 17 4.2±1.3
1≤ nocturia<2 54 3.6±1.6
2≤ nocturia<3 50 3.6±1.5
3≤ nocturia<4 22 4.1±1.2
4≤ nocturia 17 4.4±1.3
Table 3.5 Urinary symptoms listed in decreasing order of score, and listed in decreasing
order of correlation with quality of life.
Decreasing order of score Decreasing order of correlation with quality of life
Weak urinary stream Frequency
Frequency Incomplete emptying
Incomplete emptying Urgency
Urgency Intermittency
Intermittency Weak urinary stream
Nocturia Hesitancy
Hesitancy Nocturia
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Discussion
The inclusion criteria and the reliability of the frequency-volume charts are discussed
in a previous paper10. It was concluded that reporting correctly on frequency-volume
charts during 24 h is sufficient to gain insight into the voiding habits of patients during
normal daily life.
The distributions of the scores on the seven symptom questions and the score for qual-
ity of life do not resemble normal curves. Only the distribution of the symptom index is
normal (fig. 3.1). Kendall and Gibbons rank correlation method is a distribution-free
test and thus suited for our purposes.
As reported in our previous paper10 there is an overstatement of score on question 7
(nocturia) compared to the reported nocturia on the frequency-volume charts.
Although this overstatement suggests that nocturia is experienced as uncomfortable,
surprisingly no relation was found between nocturia calculated from frequency-volume
charts, and quality of life score (table 3.4). From the seven questions, even question 7
(nocturia) has the lowest impact on quality of life (tables 3.3, 3.5). Saito et al.14 studied
frequency in elderly (age >65 years) and adults (age <65 years). They found no differ-
ence between the two groups in sleeping hours: 8.64±0.96 h for the elderly (n=85)
and 8.46±1.09 h for the adults (n=130), Nevertheless, some elderly patients may have
very short sleeping times and may void because they wake up and not because they are
waken up by the desire to void. These patients may include these voidings in their
score on question 7 (nocturia). In our group 15.6% of the men noted some voidings at
nighttime without desire to void on their micturition dairy. Including these voidings in
the analysis did not change the reported overstatement on question 7 (nocturia) com-
pared to the reported nocturia on the frequency-volume chart.
A reasonable number of men scored 5 (“unhappy”) for quality of life. If all patients with
quality of life score 5 are excluded and Kendall and Gibbons correlation method is
applied to the remaining patients, again no correlation was found between nocturia and
quality of life. Thus the high incidence of score 5 for quality of life does not mask a cor-
relation between nocturia and quality of life. In contrast with nocturia, decreasing void-
ed volumes at night result significantly in a decreasing quality of life (table 3.2).
There is a fair correlation between mean diuria and score on symptom question 2 (fre-
quency). Patients do not overstate diuria10. Nevertheless, diuria has an important
impact on AUA symptom index and quality of life (table 3.2), which may be due to the
interference of diuria with social life. This assumption seems to be justified by the cor-
relation of frequency (symptom question 2) and urgency (symptom question 4) with
quality of life score (tables 3.3, 3.5): frequency and urgency have a high impact on qual-
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ity of life. Correlations of symptom scores and quality of life with nocturia or diuria
were hardly affected by including voidings without desire at night or during daytime.
The feeling of incomplete emptying (symptom question 1) is associated with a
decrease in quality of life as well. High diuria and small voided volumes correlate sig-
nificantly with score on symptom question 1 (table 3.2). Nevertheless, the score on
question 1 is hardly influenced by the presence or absence of residual volume. Possibly
frequent voiding of small volumes may be interpreted by the patient as caused by
inability to empty the bladder completely. Anyhow a significant correlation exists
between score on question 1 (incomplete emptying) and question 2 (frequency) (table
3.3) and a significant negative correlation between minimum voided volume and score
on question 2 (table 3.2). As expected, scores on symptom questions 3 (intermittency),
5 (weak urinary stream) and 6 (hesitancy) are hardly affected by data from frequency-
volume charts.
Total urine productions at night and in daytime have no influence on AUA symptom
index and quality of life. Changing the definition of nighttime into the period between
24:00 h and 06:00 h appears to have no implications for our conclusions. 
Some source of bias may arise from voidings without desire to void, as the next desired
voiding will be delayed by the voiding without desire. This will affect frequency and
urgency. However, in our opinion these voidings are part of a patient’s habits. We
assume that these voidings are prophylactic and will not contribute to symptoms and
quality of life. Therefore we considered it not reasonable to include these voidings in
the calculations of voided volumes.
The ICS “benign prostatic hyperplasia” study group reported on the bothersomeness
of urinary symptoms in BPH15. They found a higher order for the score on nocturia
than for the score on frequency. We included only men who were able to void at least
150 ml during uroflowmetry. In this way men may be excluded with a high score on
nocturia. Nevertheless, the ICS study group also reported a higher bothersomeness for
frequency (times/day) than for nocturia. In their men the high prevalence of a weak uri-
nary stream also did not have an impact on bothersomeness.
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Conclusions 
Diuria has a much higher impact on symptom index and quality of life than nocturia
has. High diuria, and small mean voided volumes at night and at daytime contribute sig-
nificantly to high symptom scores and high quality of life score (= low quality of life).
Total urine productions during nighttime and during daytime do not influence symptom
index and quality of life score.
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Abstract
Objectives: To investigate the associations of symptoms and quality of life with age,
prostate volume, and urodynamic parameters in a large group of strictly selected men
with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Methods: The 565 consecutive men met all the criteria of the International Consensus
Committee on benign prostatic hyperplasia, and voided more than 150 ml during
uroflowmetry. The residual volumes and prostate sizes were estimated. The
International Prostate Symptom Score (I-PSS) and quality of life score were collected,
and urodynamic evaluations performed.
Results: The prostate volume and obstruction grade were not, but low detrusor con-
tractility and low bladder capacity were significantly associated with symptoms. Except
for nocturia, older men presented with lower voiding scores on the I-PSS. The pres-
ence of a residual urine volume hardly influenced patients’ symptoms and quality of
life. Men with an unstable bladder scored higher on frequency, urgency, and nocturia on
the I-PSS but the symptom index or quality of life score were not affected by the pres-
ence of an unstable bladder. Because of the high variability and subjective interpreta-
tion of symptoms and the opposite implication from the urodynamic evaluation on
symptoms, associations were still weak.
Conclusions: Except for nocturia, older men had higher voiding scores on the I-PSS.
Prostate volume and obstruction grade were not, but low detrusor contractility and low
capacities were, associated with the symptom index. The presence of an unstable blad-
der and/or residual volume was hardly associated with the symptom index or quality of
life score. Although we used a large group of strictly selected men, the associations
were still weak.
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Introduction
The International Prostate Symptom Score (I-PSS) and quality of life question1 have
been adopted by the World Health Organisation International Consultation on Benign
Prostatic Hyperplasia (BPH) as an important part of the evaluation of men with lower
urinary tract symptoms (LUTS)2.
The I-PSS includes seven questions concerning incomplete emptying, frequency, inter-
mittency, urgency, weak urinary stream, hesitancy, and nocturia. Each question can be
answered on a scale of 0 to 5 (ranging from “not at all” to “almost always”). The symp-
tom index is the sum of the seven scores and, therefore, ranges from 0 to 35 points.
Additionally, one question concerning the patient’s quality of life with LUTS may be
answered on a scale of 0 (“delighted”) to 6 (“terrible”).
The symptom index and quality of life score measure the severity of LUTS suggestive
of BPH. The urodynamic examination objectively evaluates bladder and urethral behav-
iour in men with LUTS and allows quantification of the degree of urethral obstruction3.
Prostate volume estimation and free uroflowmetry are also important in the diagnosis
of LUTS due to BPH.
However, according to the results of various studies, symptoms do not appear to
correlate with prostate size4-6, urinary flow rate4, residual volume4, and obstruction
grade5,7-9. Barry et al.4 only found a weak significant correlation between prostate vol-
ume and nocturia. Ezz el Din et al.6 found weak associations between prostate volume
and urgency and weak stream. The lack of distinct correlations may be due to the
rather heterogeneous composition of the groups of men in whom the studies were per-
formed. On the other hand, other parameters, such as impaired detrusor contractility,
reduced bladder capacity, and the prevalence of detrusor instability, may play a role in
the severity of LUTS.
The present study was composed of a large group of men with LUTS in whom it is rea-
sonable to assume that the symptoms were primary due to BPH. Therefore, as recom-
mended by the International Consensus Committee on BPH10, patients with prior
failed invasive treatment for BPH, patients with a possibility of neurological disease,
and patients taking drugs affecting lower urinary tract functions were excluded. In
addition, we included only patients who were able to void more than 150 ml during free
flow recording. Thus patients with severe and prolonged obstruction and with (start-
ing) decompensation of the bladder were excluded. With these restrictions we hoped to
reduce the aetiology of the patients’ complaints to a minimum number of variables.
The aim of this study was to establish in this large group of strictly selected men with
LUTS suggestive of BPH, whether the associations of symptoms and quality of life
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with age, prostate volume, and urodynamically estimated degrees of obstruction, blad-
der contractility, residual volume, bladder capacities, and prevalence of detrusor insta-
bility are more pronounced. 
Materials and Methods
From October 1993 until January 2000, in consecutive men with LUTS who were self-
referred or referred by their primary care physician to the outpatient department of urology,
basic initial evaluations (history, physical examination, digital rectal examination, urinalysis
and renal function assessment) and recommended diagnostic tests (uroflowmetry and resid-
ual urine estimation) were performed, conforming to the recommendations of the
International Consensus Committee on BPH2.
Men were included if they were older than 50 years of age, without any of the specified exclu-
sion criteria of the International Consensus Committee on BPH10, and if they voided a suffi-
cient volume (>150 ml) during one or more free uroflowmetry studies, if the residual urine
was estimated reliably and if prostate size was determined by transrectal ultrasound. 
The I-PSS1 were collected for all patients. The symptom index was calculated by summing
the 7 scores. Every patient answered the question concerning quality of life1. According to
the clinical judgement of the urologist, if the results of the evaluation were suggestive of
LUTS due to BPH, the patients were also evaluated urodynamically.
Filling cystometric studies were performed with the patient supine and erect. Pressure-flow
studies were done twice with the patient erect. Bladder pressure was recorded with a 5F
catheter, and rectal pressure was measured with a 14F catheter connected to external pres-
sure transducers. The bladder was filled with saline at 37°C through a second 5F catheter at a
constant rate of 50 ml/min. In some men, an 8F double-lumen catheter was used for bladder
pressure measurement and bladder filling. Filling was stopped when the patient had a strong
desire to void. If two catheters were used, the first pressure-flow study was done with the
measuring and filling catheters in the bladder, and the second study was done after removal of
the filling catheter. The pressure-flow study with the lowest urethral resistance (usually dur-
ing voiding with only the measuring catheter in the bladder) was used for additional analysis.
In all patients, the residual urine volume was estimated during one of the visits at the outpa-
tient department by transabdominal ultrasound or catheterisation. If the residual volume was
significant, the test was repeated. From the pressure-flow studies, the obstruction grade (0,
no obstruction to 6, severe obstruction) and detrusor contractility grade (0, very weak to 5,
strong bladder), as proposed by Schäfer11, were estimated. Men with an obstruction grade of
3 or more were considered to have obstruction. An effective bladder capacity was defined as
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the maximum cystometric bladder capacity minus the residual volume.
Statistical analyses were performed with the distribution-free Kendall and Gibbons correla-
tion method and the Mann-Whitney U test. The Kolmogorov-Smirnov goodness of fit test was
used to analyse the normal distribution of variables12. The level of significance (two-tailed)
was set at p<0.05.
Results
We excluded about 5% of the patients because they did not void more than 150 ml dur-
ing the free flow recording. Results were obtained from the 565 included men. The
mean age of the men was 66±8 years (range 50-90). The mean prostate volume was
38±19 ml (range 10-155), and mean maximum free flow rate was 12±5 ml/s (range 3-
35). Except age and symptom index, no parameter was normally distributed
(Kolmogorov-Smirnov test).
Figure 4.1 shows the distributions of symptom scores, symptom index, and quality of
life score.
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Figure 4.1 Distributions of symptom scores, symptom index, and quality of life score.
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According to our definition, 301 men (53%, 66±7 years of age) had obstruction, and
264 men (47%, 66±8 years of age) had no obstruction. Of the 565 men 31 (5%) had a
prostate volume of less than 20 ml. Nevertheless, 8 (26%) of the 31 were obstructed.
Correlation coefficients are listed between scores on the symptom questions, symptom
index, and quality of life score, and between these variables and age, prostate size, and
urodynamic parameters in table 4.1. The correlation coefficient between the symptom
index and quality of life score was 0.44 ( p<0.001).
Of 565 men, 148 patients (26%, 68±7 years of age) had a residual volume more than
20% of cystometric capacity, 199 (35%, 65±8 years of age) had residual volume equal
or lower than 20% of cystometric capacity, and 218 (39%, 65±8 years of age) did not
have a residual volume. The scores on I-PSS question 1 (incomplete emptying) in
these three groups (score 2.4±1.8, 2.2±1.8, and 2.1±1.8, respectively) did not differ
significantly.
The presence of residual volume did result in a higher symptom index but this differ-
ence was not significant (p=0.065). The quality of life score was not affected by resi-
dual volume.
Of the 565 men, 259 (46%, 67±7 years of age) had an unstable bladder: 55 only in the
supine position, 106 only in the sitting position and 98 in both positions. In 306 men
(54%, 64±8 years of age), no instabilities were detected. No significant relation was
found between scores and the position in which instability occurred. Scores on frequen-
cy, urgency, and nocturia were significantly higher in the men with an unstable bladder
than in those with a stable bladder. However, the difference in symptom index was not
significant. The patients’ quality of life was not affected by the presence of instability
during filling cystometry.
Discussion
We excluded men with prior failed invasive treatment for BPH and men with possible
neurological diseases because their symptoms are likely not to be associated with
BPH. Men taking drugs affecting urinary tract functions were excluded because the
severity of their symptoms will depend on the medication. Conforming to the recom-
mendation of the International Consensus Committee on BPH10, we included men who
were able to void a volume more than 150 ml during free uroflowmetry. The number of
patients who had to be excluded for this reason strongly depends on the efforts made to
obtain a reliable flow registration. At our outpatient department, this number of
66
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patients could be reduced from about 20% in the early 1990s to about 5% during the
period of our study. This latter percentage agrees with the 8% reported by Ezz el Din6.
Excluding men with a voided volume of less than 150 ml leads to the exclusion of those
men with (starting) decompensation of the bladder with changes in bladder properties.
In a number of these men, a transurethral catheter had to be placed because of severe
retention. With our strict selection process, we hoped to reduce the aetiology of the
patients’ complaints to a minimum of variables. We believe the men we included in our
study to be a reasonable representative sample of the population who attend a urologic
clinic with LUTS, and for whom there is suspicion of BPH. Regardless, the mean and
variability of age, cystometric capacity, residual urine volume, and symptom index in
our group were comparable to those reported by Rosier and de la Rosette5 for a group
of 521 men with micturition complaints. In their group the average prostate volume
(44.1 cm3) was higher than in our group (38 cm3). We found 53% of the men in our
study to be obstructed, slightly lower than reported by the International Continence
Society on BPH study group (60%)13. These differences may be partly due to our con-
dition of a voided volume of more than 150 ml during free uroflowmetry. 
The value range of all the parameters was rather wide (fig. 4.1 and Results section).
Even though we only included men in whom it was reasonable to assume that their
symptoms are associated with BPH, the reported absence of a correlation among
prostate volume and symptom index and quality of life score4-6,9 and among Schäfer’s
obstruction grade and symptom index and quality of life score5,7-9 was reconfirmed in
our study. Only the scores for urgency (question 4) and nocturia (question 7) correlated
significantly but weakly with Schäfer’s grade. The replacement of the discrete Schäfer
grade by the continuous AG number14, did not have a significant impact on the results
listed in table 4.1. 
As in the study by Ezz el Din et al.6, we found a weak correlation between prostate vol-
ume and urgency. Impaired bladder outflow because of low detrusor contractility corre-
lated better with symptoms than obstruction grade (table 4.1). Low cystometric and
effective capacities resulted in higher scores for frequency, urgency and nocturia and
for symptom index and quality of life. These findings agree with the earlier reported
significant relation between frequent voiding of small volumes as estimated from fre-
quency-volume charts and symptom index and quality of life score15. We advice per-
forming urodynamic evaluations to be aware of a low bladder contractility and/or small
bladder capacity without outlet obstruction. It is generally accepted that patients with
low flow/low pressure BPH might not realise the same benefit from surgical treatment
as do other patients10. Surgery in unobstructed men will result in less benefit (symp-
tom index decrease from 19.6±9.4 to 10.1±6.8 and quality of life score decrease from
3.6±1.7 to 2.6±1.7) than in obstructed men (decreases from 19.1±6.6 to 5.4±4.3 and
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from 3.7±1.3 to 1.3±1.5, respectively)8. By performing urodynamic investigations,
patient can be informed preoperatively in an optimal manner.
Our study showed a negative correlation between age and symptom index and quality
of life score (p=0.049 and p=0.027, respectively). In most community-based studies,
age and symptom scores are correlated positively16-19. In our group, this association
was reversed. In our population, older patients tended to visit the outpatient depart-
ment with lower scores than younger ones.
The presence of residual volume resulted in a slight, but not significant, increase of
some symptom scores. Even in our group of 565 men this did not result in a significant
increase in the symptom index. The quality of life score was not affected by residual
volume. 
Of the 565 men, 46% had an unstable bladder during filling cystometries. This percent-
age is lower than the reported preoperative incidence of between 49% and 74% in 12
studies10. However, it is unclear whether the latter findings were from patients who
were already selected for operation.
In our study, the frequency, urgency, and nocturia scores were significantly higher in
patients with an unstable bladder than in those with a stable bladder. In patients with an
unstable bladder, these symptoms did not contribute to a significant higher symptom
index or higher quality of life score. The position in which the instabilities were detect-
ed did not affect the patients’ symptoms or quality of life. 
Despite the strict selection criteria, the correlations in table 4.1 are still weak. This
may be due to a number of factors. The parameters show a high variability and some
kind of saturation towards a higher score. Only 6 discrete values are possible as a score
on an I-PSS question. This has a negative impact on correlation calculations. The weak
association between the urodynamic parameters and symptom index (table 4.1) is also
due to the different and sometimes opposite impact of a urodynamic parameter on the
symptoms. For instance, a high contractility will result in a low score on question 5
(weak urinary stream) but a high score on question 4 (urgency) (table 4.1). Another
important issue is the still subjective nature of some questions. Patients do not have
quantitative information of whether their bladder is empty after voiding. No relation
was found between the score on question 1 (incomplete emptying) and the actual pres-
ence or absence of residual volume. Possibly, the frequent voiding of small volumes
may be interpreted by the patient as being caused by the inability to empty the bladder
completely, as illustrated by the high correlation between the score on incomplete
emptying and the score on frequency (table 4.1). Despite the strict selection of men,
strong associations of symptoms and quality of life with the results of urodynamic
investigations hardly exist. Symptoms and urodynamic evaluations show different
aspects of BPH.
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Conclusions
Older men scored significantly higher on the nocturia question but had significantly
lower scores for incomplete emptying, weak urinary stream, and hesitancy. They noted
less bother than younger patients did. Despite the strict selection of the men, prostate
volume and Schäfer’s obstruction grade did not correlate with the symptom index or
quality of life score. A weakly significant correlation was found between contractility
degree and symptom index. Low cystometric and effective bladder capacities resulted
in higher scores on the storage symptoms of frequency, urgency, and nocturia, but only
in a slightly higher symptom index and higher quality of life score. The presence of
residual volume and/or bladder instabilities was hardly associated with symptoms or
quality of life.
The lack of, or weak, association of the symptom index and quality of life score with the
urodynamic parameters was caused by the high variability and distribution and the
sometimes subjective interpretation of symptoms. Moreover, the urodynamic parame-
ters may have opposite implications than symptoms and vice versa, because symptoms
and the urodynamic parameters reveal different aspects of BPH.
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Abstract
Objective: We established the prevalence and bothersomeness of symptoms and their
impact on well-being in a large group of strictly selected men with lower urinary tract
symptoms suggestive of benign prostatic hyperplasia (BPH).
Methods: Included in our study were 475 consecutive men who met the criteria of the
International Consensus Committee on BPH and voided more than 150 ml during
uroflowmetry. International Prostate Symptom Scores and quality of life score were
determined. We included the 7 bothersomeness questions of the Symptom Problem
Index and the 4 of the BPH Impact Index of the American Urological Association
Measurement Committee. These questions refer to the degree of bothersomeness
caused by urinary problems and how they affect various health domains.
Results: The symptoms with the highest prevalence based on mean scores were weak
urinary stream, frequency, and urgency. Urgency, nocturia, and hesitancy were the
most bothersome symptoms. Patients were only discouraged from performing normal
daily activity when the symptom index exceeded 20. Incomplete emptying and frequen-
cy bothersomeness strongly correlated, and weak urinary stream and hesitancy bother-
someness weakly correlated with all health and quality of life domains.
Conclusions: Weak urinary stream, frequency, and urgency were the most prevalent
symptoms, while urgency, nocturia, and hesitancy were the most bothersome symp-
toms. In contrast to weak urinary stream and hesitancy, the bothersomeness of incom-
plete emptying and frequency was strongly associated with well-being.
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Introduction
The International Prostate Symptom Index and quality of life question were developed
and validated by the multidisciplinary measurement committee of the American
Urological Association (AUA)1. It was adopted by the World Health Organisation
International Consensus Committee (ICC) on benign prostatic hyperplasia (BPH) as
important aid for diagnosing of lower urinary tract symptoms (LUTS) suggestive of
BPH2.
To date decision making in regard to treatment has mainly been based on symptoms
and the degree of bladder outlet obstruction2. However, today the opinion is more
prevalent that the degree of bothersomeness reported by the patient is not the same as
the presence and frequency of their symptoms3-6. Symptom bothersomeness and nega-
tive impact on quality of life are the main reasons that patients seek treatment for
BPH5-7. 
Generally the most frequently reported symptoms have been associated with the void-
ing phase, such as hesitancy, intermittency, weak urinary stream and incomplete emp-
tying, and the most bothersome have been associated with the storage phase,
frequency, urgency and nocturia4. This relationship also applies to community men
with symptomatic BPH8,9 and even to those in whom prostatic obstruction has been
objectively identified10. 
Bothersomeness appeared to be much less sensitive to international differences than
symptom prevalence11. Barry12 assumed that bothersomeness was a common denomi-
nator that caused men to present to urologists. His assumption agreed with the finding
of Jacobsen et al.13 that men with greater bothersomeness than expected from symp-
tom frequency were more likely to seek medical care. Baseline bothersomeness has
been described as more predictive of outcome after prostatic surgery than symptom
score7,14.
The WHO International Guidelines for BPH treatment emphasised that therapy for
BPH must be initiated according to the degree of bothersomeness2. BPH management
should be individualised according to patient circumstances and personal choice.
Therefore, appropriate scores for quantifying the bothersomeness of LUTS are needed
to evaluate the need for and outcome of treatment for BPH from the patient perspec-
tive3,5. The AUA symptom index measures the occurrence of lower urinary tract symp-
toms. The AUA Measurement Committee developed and validated a symptom problem
index (SPI) with 7 bothersomeness questions, of which each corresponds to a symptom
question of the AUA symptom index1,15. The SPI indicates how bothersome patients
consider urinary symptoms. The Measurement Committee also developed and validat-
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ed the BPH impact index (BII) to measure how much the urinary problems affect vari-
ous domains of health15,16.  We combined the AUA symptom index and the quality of life
question with the SPI and BII into one questionnaire. We analysed symptom preva-
lence and bothersomeness in a large group of strictly selected men with LUTS sugges-
tive of BPH. In addition we investigated the impact of each symptom and its specific
bothersomeness on various domains of health and on overall quality of life.
Materials and Methods
In accordance with the recommendations of the ICC on BPH2 from October 1993 onward we
performed basic initial evaluations, including history, physical and digital rectal examinations,
urinalysis and renal function assessment and recommended diagnostic tests, including
uroflowmetry and post-void residual urine estimation, in consecutive men with LUTS who
presented to our outpatient department of urology.
Men were included in the study if they were over the age of 50 years and had no other speci-
fied exclusion criteria of the ICC on BPH17, such as prostate cancer, neurological disease, pre-
vious prostate surgery or medication that acts on the urinary tract. In addition, they voided a
sufficient volume (>150 ml) during one or more free uroflowmetry studies, residual urine
was estimated reliably and prostate size was determined by transrectal ultrasound. 
The International Prostate Symptom Scores (I-PSS)1 were determined in all patients, includ-
ing seven questions on the prevalence of incomplete emptying, frequency, intermittency,
urgency, weak urinary stream, hesitancy and nocturia. Each question may be answered on a
scale of 0-”not at all” to 5-”almost always”. The prostate symptom index is the sum of the
seven scores with a range of 0 to 35. In addition, each patient answered the validated2 ques-
tion on quality of life (QoL) with lower urinary tract symptoms on a scale of 0-”delighted” to
6-”terrible”1.
We included the 7 bothersomeness questions of the symptom problem index1,15, each of
which corresponds to a symptom question. Bothersomeness questions were separated from
symptom questions on the questionnaire and scored separately. Bothersomeness questions
refer to how troubled patients were by urinary symptoms during the last month, for example:
“Over the past month, how much has a sensation not emptying your bladder been a problem
for you?”. Each question may be answered on a scale of 0 to 4 as 0- no, 1- very small, 2- small,
3- medium and 4- big problem. The AUA symptom problem score is the sum of the seven
bothersomeness scores with a range of 0 to 28 points. We also included the BII15,16, consisting
of four questions on health-feeling with and social implications of LUTS on a scale with a
range of 0 to 13 points:
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B1. Over the past month, how much physical discomfort did any urinary problem cause you?
(Answers: “none” or “only a little” or “some” or “a lot”, range 0 to 3) 
B2. Over the past month, how much did you worry about your health because of any urinary
problems? (Answers: “none” or “only a little” or “some” or “a lot”, range 0 to 3)
B3. Overall, how bothersome has any trouble with urination been during the past month?
(Answers: “not at all bothersome” or “bothers me a little” or “bothers me some” or
“bothers me a lot”, range 0 to 3)
B4. Over the past month, how much of the time has any urinary problem kept you from doing
the kinds of things you would usually do? (Answers: “none of the time” or “a little of the
time” or “some of the time” or “most of the time” or “all of the time”, range 0 to 4)
Patients were excluded from analysis when they did not complete the symptom and bother-
someness questions consistently.
Statistical analysis was performed with the Kendall and Gibbons distribution-free correlation
method. The Kolmogorov-Smirnov goodness of fit test was used to analyse whether or not
the distribution of a variable was normal18. The level of significance (2-tailed) was set at
p<0.05.
The scores of all patients on a symptom question were plotted versus the corresponding
scores on the associated bothersomeness question. Quadratic curve estimation was applied
on the seven scatter plots. How the bothering due to each symptom was estimated is
explained under RESULTS. 
Results
Of the total population of 789 men older than 50 years old in whom basic initial evalua-
tions and recommended tests were performed 565 met all study inclusion criteria.
Patients were excluded from analysis for various reasons, but the dominant reason was
that they were on medication that acted on the lower urinary tract.
Of the 565 men who met all other inclusion criteria, 90 (16%) completed at least one
symptom-bothersomeness combination inconsistently. These excluded patients report-
ed bothersomeness due to the corresponding symptom, while answering “not at all” to
that symptom prevalence question.
Thus, our study included 475 men (66±8 years of age, range 50-89) with an average
symptom index of 17±7 (range 1-35), average symptom problem index of 13±7 (range
0-28), average BPH impact score of 5.6±3.2 (range 0-13), and average quality of life
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score of 3.6±1.5 (range 0-6). Mean prostate size was 39±20 ml (range 10-155). Mean
maximum flow on free uroflowmetry was 12±5 ml/s (range 3-34) and mean post-void
residual volume was 61±91 ml (range 0-630). 
Except for patient age and symptom index, no parameters were normally distributed.
In the literature it is not unusual to calculate the mean plus or minus standard devia-
tion, despite nonuniform distributions. Therefore, these values are provided.
Table 5.1 shows a correlation matrix relating each I-PSS symptom score and the I-PSS
Index with patient age, its bothersomeness score, SPI, the QoL score, score on each
BII question, and BII. Figure 5.1 shows the distributions of the scores per symptom.
For each symptom score we plotted the average score of the associated bothersome-
ness question. 
Figure 5.2 shows the results of quadratic curve estimations from the scatter-plots of
bothersomeness versus symptom scores per symptom based on all pairs of data. 
Symptom bothersomeness was quantified by the area under the curve in figure 5.2
(grey area) and expressed as a percent of the total area of the rectangle with the hori-
zontal and vertical axes as sides.
Table 5.2 lists the average symptom score and bothersomeness of urinary symptoms
based on the percent of area under the curve (figure 5.2).
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Table 5.2 Symptom scores and bothersomeness of urinary symptoms.
Symptom Mean score Bothersomeness % Area 
± SD order* under curve
Weak urinary stream 3.6±1.6 7 32.2
Frequency 2.8±1.5 5 40.9
Urgency 2.4±1.7 1 57.3
Incomplete emptying 2.3±1.8 4 41.7
Intermittency 2.3±1.7 6 37.2
Nocturia 2.2±1.3 2 47.1
Hesitancy 1.6±1.6 3 46.6
* Order 1- most to 7- least bothersome
hoofdstuk 05  19-12-2001  09:47  Pagina 78
CHAPTER 5 SYMPTOMS, BOTHERSOMENESS, AND WELL-BEING IN BPH
Ta
bl
e 
5.
1 
C
or
re
la
ti
on
 m
at
ri
x 
re
la
ti
ng
 e
ac
h 
I-
P
S
S
 s
ym
pt
om
 s
co
re
 w
it
h 
pa
ti
en
t 
ag
e,
 b
ot
he
rs
om
en
es
s,
 S
P
I 
an
d 
qu
al
it
y 
of
 li
fe
 s
co
re
, s
co
re
 o
n
ea
ch
 B
II
-q
ue
st
io
n 
an
d 
B
II
.
Q
ue
st
io
ns
 o
f t
he
 B
P
H
 Im
pa
ct
 In
de
x 
(N
o.
)
Sy
m
pt
om
 s
co
re
A
ge
B
ot
he
r-
Sy
m
pt
om
 
Q
ua
lit
y 
of
 
P
hy
si
ca
l
W
or
ry
 
O
ve
ra
ll 
bo
th
er
 
N
o 
no
rm
al
B
P
H
  
so
m
en
es
s 
P
ro
bl
em
 In
de
x 
L
ife
 s
co
re
 
di
sc
om
fo
rt
ab
ou
t 
w
ith
 u
ri
na
tio
n
ac
tiv
ity
 
Im
pa
ct
(S
P
I)
(Q
oL
)
(B
1)
he
al
th
 (B
2)
tr
ou
bl
e 
(B
3)
pa
rt
 o
f t
im
e 
(B
4)
(B
II
)
In
co
m
pl
et
e 
em
pt
yi
ng
-0
.1
0*
*
0.
62
**
0.
44
**
0.
33
**
0.
34
**
0.
25
**
0.
35
**
0.
25
**
0.
34
**
Fr
eq
ue
nc
y
-0
.0
1
0.
45
**
0.
36
**
0.
37
**
0.
33
**
0.
21
**
0.
37
**
0.
33
**
0.
34
**
In
te
rm
itt
en
cy
-0
.0
7*
0.
58
**
0.
38
**
0.
29
**
0.
23
**
0.
15
**
0.
25
**
0.
16
**
0.
22
**
U
rg
en
cy
0.
06
0.
64
**
0.
33
**
0.
31
**
0.
33
**
0.
19
**
0.
34
**
0.
35
**
0.
33
**
W
ea
k 
ur
in
ar
y 
st
re
am
-0
.1
9*
*
0.
32
**
0.
24
**
0.
27
**
0.
15
**
0.
10
**
0.
21
**
0.
07
0.
14
**
H
es
ita
nc
y
-0
.1
1*
*
0.
72
**
0.
45
**
0.
31
**
0.
32
**
0.
25
**
0.
26
**
0.
23
**
0.
30
**
N
oc
tu
ri
a
0.
10
**
0.
45
**
0.
26
**
0.
14
**
0.
19
**
0.
12
**
0.
23
**
0.
20
**
0.
21
**
I-
P
SS
-0
.0
7*
-
0.
57
**
0.
45
**
0.
41
**
0.
26
**
0.
44
**
0.
33
**
0.
42
**
*
C
or
re
la
tio
n 
si
gn
ifi
ca
nt
 a
t 0
.0
5
**
C
or
re
la
tio
n 
si
gn
ifi
ca
nt
 a
t 0
.0
1
79
hoofdstuk 05  19-12-2001  09:47  Pagina 79
80
CHAPTER 5
Figure 5.1 Distributions of symptom scores with average associated bothersomeness (bother
score) per symptom score.
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Figure 5.2 Results of quadratic curve estimations from scatter-plots of bothersomeness scores
versus symptom scores (=average bothersomeness score of corresponding symptom
score=top of bars in figure 5.1).
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Figure 5.3 shows the results of quadratic curve estimations from scatter-plots of symp-
tom index versus scores on the quality of life question and on the additional bother-
someness questions.
There was little or some physical discomfort due to urination problems in 66% of the
men, while 60% and 64% worried about health due to urination problems and about the
overall bothersomeness of urination problems, respectively. Urination problems did not
at all discourage 54% of the patients from performing normal daily activity, while only
5% discouraged most or all of the time.
Table 5.3 lists the correlations of age with SPI, quality of life, score on each BII ques-
tion and BII.
Table 5.4 shows correlation matrixes relating each symptom specific bothersomeness
score with age, SPI, quality of life score, score on each BII question, and BII. Table 5.5
lists symptom specific bothersomeness correlated with SPI, quality of life score and
BII.
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Table 5.3 Kendall and Gibbons correlation coefficients of patients age with SPI, quality of
life, BII questions, and BII.
Parameter Age
Symptom Problem Index (SPI) - 0.08*
Quality of Life (QoL) - 0.09**
BII-question (No.):
-Physical discomfort (B1) - 0.02
-Worry about health (B2) - 0.05
-Overall bothersomeness of urination problem (B3) - 0.06
-No normal daily activity part of the time (B4) 0.08*
BPH Impact Index (BII) -0.02
* Correlation significant at 0.05
**Correlation significant at 0.01
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Figure 5.3 Results of quadratic curve estimations from scatter-plots of symptom index versus
quality of life and BII (B1 to B4)(=average bothersomeness score of corresponding symptom
index).
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Discussion
The mean AUA symptom index, symptom problem score and BPH impact score were
similar to those noted by Barry et al.15 (17±7, 12±6 and 5.0±3.1, respectively).
The condition that men were included in the study only when they voided at least 150
ml urine during free uroflowmetry may have excluded those with severe and prolonged
obstruction. However, in a reasonable number of these excluded patients, bladder prop-
erties may have changed, resulting in a partially decompensated bladder. Our inclusion
criteria were based on the recommendations of the International Consensus
Committee on BPH2 and we did not consider it reasonable to change any of these re-
commendations. 
Figure 5.1 shows that the most common symptoms were not always the most bother-
some symptoms. For example, 41% of our patients reported a weak urinary stream
almost always with a mean bothersomeness of 2.1. Only 7% of respondents had hesi-
tancy almost always but that symptom had a mean bothersomeness of 3.3.
The symptoms with the highest prevalence based on average scores were weak uri-
nary stream, frequency and urgency (table 5.2). Hesitancy had the lowest prevalence.
Based on the area under the curve in figure 5.2 urgency, nocturia and hesitancy were
the most bothersome symptoms in our study (table 5.2). For all symptoms figure 5.2
shows a flattening of the bothersomeness curve toward a higher symptom score.
Recalculating the areas using a third degree equation resulted in a minimal difference
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Table 5.5 Symptom specific bothersomeness correlated with SPI, quality of life and BII.
Correlation order* SPI QoL-score BII
1 Incomplete emptying Frequency Frequency
2 Frequency Incomplete emptying Incomplete emptying
3 Intermittency Intermittency Nocturia
4 Weak urinary stream Nocturia Urgency
5 Hesitancy Urgency Intermittency
6 Nocturia Weak urinary stream Weak urinary stream
7 Urgency Hesitancy Hesitancy
* Order 1- most to 7- least correlated
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of less than 1% with the areas listed in table 5.2. Rank order was not affected.
Our results on the most bothersome symptoms agree with the conclusions of the ICS
“BPH” Study4. However, in that series rank order was based on decreasing order of
the proportion of patients reporting that the symptom was no problem. When we used
the category of “no problem” to create a rank order, similar to that of the ICS, urgency,
incomplete emptying and hesitancy were the most bothersome symptoms.
A limitation of the analytic approach was that the area under the bothersomeness curve
and, therefore, rank order may have been sensitive to the various response frames of
the questions. On the I-PSS nocturia has a different response frame from the other
questions, which may have changed the relationship of the ordered response categories
and bothersomeness ratings. Perhaps this possibility explains why nocturia changed
order so much when the ICS ratings of bothersomeness were used in our population.
Urinary problems had the highest impact on overall bothersomeness and the lowest
impact on patients not performing normal daily activity part of the time (fig. 5.3). Most
patients were not discouraged from normal daily activity until the symptom index was
at least about 20 (fig. 5.3). 
Tables 5.1 and 5.3 show that in our population generally older patients tended to pres-
ent with slightly fewer symptoms and less bothersomeness than younger patients.
The bothersomeness of incomplete emptying and frequency was strongly associated
with the symptom problem index, quality of life score, score on the BPH impact ques-
tions and BII (tables 5.4 and 5.5). In BPH the bothersomeness of incomplete emptying
and frequency had a high impact on well-being in contrast to that of weak urinary
stream and hesitancy. Also, the prevalence of the symptoms of incomplete emptying
and frequency had a strong impact on SPI, quality of life and BII (table 5.1).
Of our 475 patients 290 had post-void residual volume. The mean bothersomeness
score for incomplete emptying was 1.53±1.42. No post-void residual volume was evi-
dent in 185 men with a mean bothersomeness for incomplete emptying of 1.47±1.43.
This finding shows the lack of correlation of incomplete emptying bothersomeness
with actual incomplete emptying, suggesting that patients believed that the cause of
increased frequency was incomplete emptying.
The ICS “BPH” Study indicated that international differences are relevant when
reporting specific lower urinary tract symptoms11. Inevitably individual countries have
different cultural backgrounds and specific health care delivery systems. Therefore, the
results of studies of LUTS in specific countries may not be generally applicable in other
countries. An alternative would be to focus on bothersomeness, which appeared to be
much less sensitive to international differences11.
We emphasise that our conclusions were formulated for our group of strictly selected
men with LUTS suggestive of BPH.
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Conclusions
Based on mean scores, the symptoms with the highest prevalence were weak urinary
stream, frequency, and urgency. Hesitancy had the lowest prevalence. Urgency, noc-
turia, and hesitancy symptoms were the most bothersome in our study. 
Of the four BII questions that on overall bothersomeness scored highest. Patients were
only discouraged from normal activity when the symptom index exceeded 20. In con-
trast to weak urinary stream and hesitancy, the bothersomeness of incomplete empty-
ing and frequency were strongly associated with all domains of health and quality of
life.
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CHAPTER 6
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Abstract
Objectives: Different methods of analysing pressure-flow plots to quantify bladder
outlet resistance in men with lower urinary tract symptoms (LUTS) suggestive of
benign prostatic hyperplasia (BPH) were developed in the past. The aims of this study
were to quantify the degree of agreement between the diagnosis of obstruction by the
different methods, and to compare the applicability of the different methods in the eval-
uation of bladder outflow conditions, in a large group of these men.
Methods: In consecutive men with LUTS basic initial evaluations, recommended diag-
nostic tests and urodynamic investigations were performed. From pressure-flow stud-
ies, the group-specific resistance factor (URA), Schäfer’s obstruction grade and
Abrams-Griffiths (AG) number were estimated. Men with 21 cm H2O≤ URA≤ 29 cm
H2O and men with Schäfer’s grade equal 2 were classified as equivocal. In conformity
with the provisional ICS definition, men with 20≤ AG number≤ 40 were classified as
equivocal.
Results: In 78% of the 565 included men Schäfer’s classification agreed with URA
classification. In 82% ICS classification agreed with URA classification. Most agree-
ment (94%) existed between Schäfer’s classification and ICS classification. Men with
relatively low detrusor pressure at maximum flow and relatively low maximum flow
had a high prevalence among those in whom URA and Schäfer’s classifications and
among those in whom URA and ICS classifications differed.
Conclusions: Differences between URA, Schäfer’s and ICS classification were near
the points of intersection of the different boundaries, and a decision whether or not to
perform surgery is not likely to be influenced by this disagreement.  
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Introduction
The only reliable method for directly diagnosing bladder outlet obstruction (BOO) is
simultaneous measurement of the driving pressure and the resulting flow rate. If out-
flow resistance is increased, detrusor pressure will increase and flow rate will
decrease1. Urodynamics offers an objective tool for the assessment of BOO in benign
prostatic hyperplasia (BPH). Whether or not to perform surgery on patients with lower
urinary tract symptoms (LUTS) suggestive of BPH is partially based on the extent of
obstruction derived from pressure-flow relations. 
Different methods of analysing pressure-flow plots and to quantify bladder outlet
resistance in patients with BPH have been developed in the past2. These different
approaches are based on similar theoretical principles, but are different in detail and
objectives.
Urethral resistance factor (URA)
The concept of the passive urethral resistance relation (PURR) to quantify bladder out-
flow conditions from the complex pressure-flow relation in a few parameters3 is gener-
ally accepted. Urethral resistance can be quantified using a group-specific resistance
factor (URA) that is based empirically on the pressure-flow plots obtained in a large
number of voidings of adult patients. Every combination of pressure and corresponding
flow occurring during a micturition, can be represented in the figure by a point. The
value of the intercept on the pressure axis (at zero flow) for the curve on which the
point lies, represents the urethral resistance factor URA4. URA can be calculated for
any pair of pressure-flow values by solving the following equation for URA (pdet is
detrusor pressure (in cm H2O) and Q is the corresponding flow rate (in ml/s)):
URA = [(1 + 1.52.10-3 * Q2 * pdet)
1/2 -1] / (7.6.10-4 * Q2)
The units of URA are the same as those of pressure, i.e., cm H2O. In practice, URA is
calculated from the maximum flow rate and corresponding detrusor pressure.
Schäfer’s obstruction grade
A simplification of the PURR is the linear PURR (linPURR)5, which allows clear identi-
fication of individual outflow conditions with distinction of different obstruction types6.
Reduction to single-value grading is reached when the linear PURR is plotted in a spe-
cific pressure-flow diagram, which is divided in seven areas corresponding to different
outflow conditions: Schäfer’s obstruction grade (0, no obstruction to 6, severe obstruc-
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tion). Classification of what is more or less obstructed is to a minor degree influenced
by subjective judgement7. 
AG number
Based upon the Abrams-Griffiths nomogram8, Lim and Abrams9 introduced the
Abrams-Griffiths (AG) number for quantifying the urethral resistance. Each pressure-
flow plot can be represented by an AG number that can be easily calculated by the fol-
lowing equation (where pdet.Qmax is detrusor pressure in cm H2O at maximum flow rate
and Qmax is maximum flow rate in ml/s):
AG number = pdet.Qmax - 2 * Qmax
Obstructed, unobstructed, equivocal
URA and AG number are continuous variables and Schäfer’s grade is a discrete vari-
able, all allowing quantification of urethral resistance. Special values of URA, Schäfer’s
grade, and AG number offer the possibility to classify men in obstructed, unobstructed,
and equivocal categories. Patients with URA>29 cm H2O were classified as
obstructed10 and those with URA<21 cm H2O as unobstructed (see results and discus-
sion). The remaining patients were classified as equivocal.
Patients with Schäfer grade 0 or 1 are defined as unobstructed and those with grade 3
or higher as obstructed5. We defined men with Schäfer grade 2 as equivocal.
In 1997, the International Continence Society published a provisional nomogram,
which is a modification of the Abrams-Griffiths nomogram8. Classification is based
upon where a plot of (Qmax, pdet.Qmax) is positioned in the nomogram
2. Because the AG
number also originates from the Abrams-Griffiths nomogram, the ICS cut-off values
are particular values of the AG number:
If: (pdet.Qmax - 2 * Qmax) < 20 : ICS unobstructed
If: 20 ≤ (pdet.Qmax - 2 * Qmax) ≤ 40 : ICS equivocal
If: (pdet.Qmax - 2 * Qmax) > 40 : ICS obstructed
Aim of study
Our aim is to quantify the extent of (dis)agreement among the different methods of
analysing pressure-flow plots to define bladder outlet obstruction in a large group of
men with LUTS suggestive of BPH. 
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Materials and Methods
From October 1993 on, in consecutive men with LUTS basic initial evaluations (history, quan-
tification of symptoms, physical examination and digital rectal examination, urinalysis and
renal function assessment) and recommended diagnostic tests (uroflowmetry and residual
urine estimation) were performed, conforming to the recommendations of the International
Consensus Committee on Benign Prostatic Hyperplasia (BPH) 11.
Men were included if they were over the age of 50 years, without any of the other specified
exclusion criteria of the International Consensus Committee on BPH12, they voided a suffi-
cient volume (>150 ml) during one or more free uroflowmetry studies, residual urine was
estimated reliably and prostate size was determined by transrectal ultrasound. International
Prostate Symptom Index (S) for BPH and quality of life assessment (L) as developed and vali-
dated by the American Urological Association Measurement Committee13, were used to
quantify symptoms. In case the results of these evaluations were suggestive of bladder out-
flow obstruction, these patients were also evaluated urodynamically by filling cystometry and
pressure-flow studies. Filling cystometric studies were performed with the patient supine
and erect. Pressure-flow studies were done twice with the patient erect. Bladder pressure
was recorded with a 5F catheter and rectal pressure was measured with a 14F catheter con-
nected to external pressure transducers. The bladder was filled with saline at 37oC, through a
second 5F catheter, at a constant rate of 50 ml/min. In some men an 8F double lumen catheter
was used for bladder pressure measurement and bladder filling. Filling was stopped when the
patient had a strong desire to void. The first pressure-flow study was done with measuring
and filling catheters in the bladder, and the second study was done after removal of the filling
catheter. The pressure-flow study with the lowest urethral resistance (usually during voiding
with only the measuring catheter in the bladder) was used for further analysis. 
In all patients residual urine was estimated during one of the visits at the outpatient depart-
ment by transabdominal ultrasound or catheterisation. If residual urine was significant, this
test was repeated. The urodynamic investigation always started with uroflowmetry and deter-
mination of the residual volume by catheterisation. Some patients were not able to arrive with
a full bladder and sometimes were not able to produce a flow curve. At the end of the urody-
namic investigation the bladder of these patients was refilled and after removal of the
catheters uroflowmetry was performed. If these patients were known to have significant
residual volume, catheterisation was performed once more.
From pressure-flow studies, the group-specific resistance factor URA and Schäfer’s obstruc-
tion grade were estimated and the provisional ICS method for definition of obstruction was
applied, using the values of the maximum flow rate and corresponding detrusor pressure. 
Patients with URA>29 cm H2O were classified as obstructed
10. We defined patients with 21
cm H2O≤ URA≤ 29 cm H2O as equivocal and patients with URA<21 cm H2O as unobstructed
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(see results and discussion). Patients with Schäfer grade 0 or 1 were classified as unobstruct-
ed, with grade 2 as equivocal and with grade ≥ 3 as obstructed. 
Patients with AG number>40 were classified as obstructed, with AG number<20 as unob-
structed, and with 20≤ AG number≤ 40 as equivocal.
Descriptive statistics were used, including Spearman’s distribution-free correlation coeffi-
cient. The Kolmogorov-Smirnov goodness of fit test14 was used to examine whether or not
the distribution of a variable was normal.
Results
Results were obtained from 565 included men. Table 6.1 describes baseline character-
istics of the evaluated patients.
A capacity of 1100 ml was found in one patient. The maximum capacity in the other
men was 900 ml. In 218 patients (39%) no residual volume was found. In men with a
residual volume, this volume was lower than or equal to 50 ml in 131 men (23%),
between 50 and 100 ml in 107 men (19%) and higher than 100 ml in 109 men (19%).
From 511 (90%) of our 565 men the pressure-flow point lies in the area enclosed by
maximum flow between 0 and 25 ml/s and detrusor pressure between 0 and 100 cm
H2O.
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Table 6.1 Mean, standard deviation (SD) and range of different baseline characteristics of
the evaluated population (N=565).
Mean SD Range
Age (yrs) 66 8 50-90
Prostate volume (ml) 39 19 10-155
Qmax.free (ml/s) 13 5 3-35
Qmax (ml/s) 10 5 1-31
pdet.Qmax (cm H2O) 65 26 17-265
Capacity (ml) 416 153 150-1100
Residual volume (ml) 63 92 0-630
Symptom Index (S) 17 7 1-35
Quality of Life (L) 3.6 1.5 0-6
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Figure 6.1 shows the distribution of these 511 men with respect to detrusor pressure
(cm H2O) at maximum flow and with respect to maximum flow (ml/s). The upper
boundary values of 25 ml/s and 100 cm H2O were chosen in order to exclude extreme
pressure-flow points.
Figure 6.2 shows frequencies of URA, Schäfer’s grade and AG number for all 565 men.
Normal curves are displayed. Distributions of all three variables are not normal
(Kolmogorov-Smirnov test).
In our group, highest agreement between URA classification and Schäfer’s classifica-
tion of unobstructed and equivocal was reached by choosing URA=21.3 cm H2O.
Highest agreement between URA and ICS classification was obtained by setting
URA=21.1 cm H2O. Therefore, as boundary value between unobstructed and equivocal
men URA=21 cm H2O was chosen. 
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Figure 6.1 Distribution of men with respect to detrusor pressure (cm H2O) and maximum flow
(ml/s). Note: 54 men are not included (detrusor pressure >100 cm H2O or maximum flow rate >25
ml/s). 
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Figure 6.2 Frequencies of URA, Schäfer’s grade and AG number. Normal curves are displayed.
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Although in our study we defined URA=29 cm H2O as the limit between equivocal and
obstructed, in our well-defined group most agreement with Schäfer’s classification and
with ICS classification was reached when we defined URA>30 cm H2O as obstructed.
In that case, agreement of 7 more patients was reached between URA and Schäfer’s
classification and between URA and ICS classification. 
Table 6.2 shows the distribution of the patients in unobstructed, equivocal, and
obstructed, following URA, Schäfer’s grade, and the definition of the ICS. According to
all three possible classifications, about 50% of our patient group is defined as obstruct-
ed and about 20% as unobstructed.
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Table 6.2 Distribution of 565 patients in unobstructed, equivocal and obstructed, following
URA, Schäfer’s grade and the definition of the ICS
Unobstructed Equivocal Obstructed
URA 21% 26% 53%
Schäfer’s grade 20% 27% 53%
ICS 19% 30% 51%
Figure 6.3A Scatterplot of patients where ICS classification differs from URA classification.
Borderlines in URA and ICS nomograms are indicated. Note: Due to overlapping data, the number
of points in the figure may be lower than the actual number of men. 
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Figure 6.3B Scatterplot of patients where Schäfer’s classification differs from URA classifica-
tion. Borderlines in URA and Schäfer’s nomograms are indicated. See note figure 6.3A. Due to the
properties of the printer program, minimal differences may be observed between the positions of
common men in the figures 6.3A and 6.3B. 
Figure 6.3C Scatterplot of patients where Schäfer’s classification differs from ICS classification.
Borderlines in Schäfer’s and ICS nomograms are indicated. See note figure 6.3A. 
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In figure 6.3A-C patients are shown where the three classification methods differ from
each other. Borderlines in URA, ICS, and Schäfer’s nomograms are indicated. The area
enclosed by maximum flow from 0 to 25 ml/s and detrusor pressure from 0 to 100 cm
H2O is displayed.
Discussion
Extensive scientific and clinical considerations led to the recommendations of the
International Consensus Committee on BPH11. Our inclusion criteria were based on
these recommendations and we considered it not reasonable to change any of these
recommendations. However, we realise that the condition that men were included only
if they could void a volume of at least 150 ml during free uroflowmetry may have
excluded men with severe and prolonged obstruction. In a reasonable number of these
excluded men, however, bladder properties may have changed resulting in (partly)
decompensated bladders. We assume that our group included men who were able to
compensate more or less for the impaired outflow condition. In our group most men
(81%) did not have a residual volume, or had a residual volume lower than 100 ml.
In our urodynamic department measures are taken to guarantee the privacy of the
patients. Telephone calls are not allowed, personnel are not allowed to enter the exam-
ination room during the investigation, buzzers are forbidden. The number of investiga-
tors is restricted to a minimum. During voiding the investigators withdraw in a room
with a second display showing the actual pressure and flow curves. It is always verified
whether the patient has voided like at home. If not, the study is not suited for analysis
and a new attempt is made to obtain a reliable measurement. On an average an exami-
nation lasted one hour. Patients who met the inclusion criteria of the consensus com-
mittee but were not able to produce a reliable pressure-flow study were exceptional.
We have computerised systems to abstract data from the curves. Nevertheless, it is
always checked by visual inspection of the curves whether these data are correct and if
necessary data are adjusted.
Schäfer5 defines the line between grade 1 and grade 2 as the upper limit of non-
obstruction and the line between grade 2 and 3 as the lower limit of real obstruction.
The authors of the provisional ICS definition2 recommend among others the use of an
equivocal zone. Schäfer5 has objections against the use of the term equivocal. In men
who are urodynamically clearly unobstructed or who are urodynamically clearly
obstructed this finding will play a prominent role, but not the only one, in the decision
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whether or not to perform surgery. In patients falling in the equivocal zone other clini-
cal findings will dominate that decision. Based on the knowledge we have now, this is
our interpretation of the term equivocal. Strictly speaking, urodynamic findings can not
be equivocal but a classification can. Whether Schäfer’s grade 2 or the ICS zone should
be taken as equivocal zone is a question we can not (yet) answer; nevertheless the
equivocal zone of the provisional method of the ICS is similar, but not identical, to the
region defining Schäfer’s grade 2. 
According to Rollema et al.10 patients with URA>29 cm H2O were classified as
obstructed. No URA value was defined to discriminate between unobstructed and
equivocal. We calculated the values of URA with the best agreement between classifi-
cation by Schäfer’s grade and by URA of equivocal and unobstructed men (URA=21.3
cm H2O) and between classification by ICS and by URA of these men (URA=21.1 cm
H2O). For reasons of simplicity we finally took URA=21 cm H2O as the cut-off point. In
order to be able to compare the consequences of the use of the ICS classification with
those of the URA classification, we recommend definition of the zone 21 cm
H2O≤ URA≤ 29 cm H2O as equivocal. Despite the fact that the URA equivocal zone is
based on ICS equivocal zone, still 20 men are classified as unobstructed by URA and
equivocal by ICS and nine more are classified as equivocal by URA and unobstructed by
ICS (see figure 6.3A).
In our group of 565 men with LUTS suggestive of BPH, in 127 men (22%) classification
according to Schäfer differs from that by URA. In 100 men (18%) classification by ICS
differs from that by URA. 
Using URA=30 cm H2O as boundary between equivocal and obstructed increased the
agreement between classification by URA on the one side and classification by
Schäfer’s grade and ICS on the other side. However, this increase related to 7 men of
127 and 7 men of 100, respectively. In 33 men (6%), Schäfer’s grade differs from ICS.
No patient was classified more than one class different. 
Fifty-four men had a point in the pressure-flow plot outside the area enclosed by maxi-
mum flow between 0 and 25 ml/s and detrusor pressure between 0 and 100 cm H2O.
No disagreement among the different methods existed in these patients. Thus all dif-
ferences between the classifications by URA, Schäfer, and ICS are concentrated near
the points of intersection of the different boundaries. The decision whether or not to
perform surgery is not likely to change when in these cases another classification is
applied. Not only degree of obstruction, but also many more, objective and subjective,
variables will lead to this decision.
Lim et al.15 reviewed urodynamic tracings of 85 patients who had pressure-flow studies
before and after prostatectomy. They classified equivocal patients as unobstructed.
Like in our study, AG number>40, URA>29 cm H2O, and Schäfer’s grade≥ 3 were
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considered as obstructed. About 73% of these 85 patients were classified as obstruct-
ed. In our study only about 50% of the patients were obstructed. This difference could
be expected, because Lim et al.15, in contrast to our inclusion, studied men who were
already selected for surgery.
The classification agreement between URA and Schäfer’s grade was 95% (in our study
it was 86%, defining only two categories of patients: unobstructed and obstructed).
Agreement between URA and ICS was 94% (in our study it was 87%) and between
Schäfer’s grade and ICS 98% (in our study it was 97%). The higher agreement in the
study of Lim et al.15 may be due to the higher prevalence of men who are obstructed.
Defining just two classes of obstruction, unobstructed and obstructed, will increase the
agreement between URA, Schäfer’s grade and AG number. 
In figure 6.1 men are concentrated in the area around a detrusor pressure at maximum
flow of about 60 cm H2O and a maximum flow of about 10 ml/s. In 127 men of our well-
defined group of 565 men, classification according to Schäfer’s grade differs from that
by URA. Of these 127 men, 41 (32%) lie in the area in which URA classified them as
obstructed and Schäfer’s grade as equivocal. In 100 men of the 565 men ICS-classifica-
tion differs from that by URA. Of these 100 men 44 (44%) lie in the area in which URA
classified them as obstructed and ICS as equivocal. Thus men with relatively low
detrusor pressure at maximum flow and relatively low maximum flow have the highest
prevalence among those in which URA and Schäfer’s grade classifications and among
those in which URA and ICS classifications differ.
We want to emphasise that these conclusions are formulated for our well-defined group
of men with LUTS suggestive of BPH. However, we assume that the men included in
our study form a reasonable representative sample of the population of men who attend
a urology clinic, and for whom there is some suspicion of prostatic obstruction.
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Conclusions
In our group of 565 included men with LUTS due to BPH, in 438 men (78%) classifica-
tion according to Schäfer’s grade agrees with classification according to URA. In 465
men (82%) agreement exists between classification by URA and ICS. Disagreement
between the methods of classification exists only near the points of intersection of the
different boundaries, and a decision whether or not to perform surgery is not likely to
be influenced by this disagreement. 
Men with relatively low detrusor pressure at maximum flow and relatively low maxi-
mum flow have a high prevalence among those in which URA and Schäfer’s grade clas-
sifications and among those in which URA and ICS classifications differ.
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Abstract
Objective: The aim of this study was to establish the characteristics and to investigate
the interactions between  prostate volume, degree of obstruction, bladder contractility,
the prevalence of residual volume, bladder compliance, bladder capacities, and the
prevalence of instability in a large, well-defined group of men with lower urinary tract
symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Methods: The 565 consecutive men included in the study met the criteria of the
International Consensus Committee on BPH and voided more than 150 ml during
uroflowmetry. Their residual urine volume and prostate size were estimated, and filling
cystometry and pressure-flow studies were performed.
Results: Fifty-three percent of the men appeared to have obstruction. We found a posi-
tive correlation between prostate volume and Schäfer’s obstruction grade, except that
mean prostate volume decreased at Schäfer’s grades 5 and 6. Significant negative cor-
relations existed between Schäfer’s grade and cystometric bladder capacity and effec-
tive capacity. Bladder outlet obstruction results in incomplete emptying. Of all men,
26% had a significant residual volume (>20% of cystometric capacity). Thirty-nine per-
cent did not have residual volume. Of the 565 men, 46% had an unstable bladder. In
particular, patients with an unstable bladder in the sitting and lying positions had a sig-
nificantly higher Schäfer’s grade and contractility grade and a significantly lower cysto-
metric and effective bladder capacity compared to patients without instability. Patients
with a residual volume or instability were significantly older.
Conclusions: We conclude that in men with LUTS suggestive of BPH, abnormalities
of bladder and bladder outlet function vary greatly and have complex mutual interac-
tions.
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Introduction
In the past, urodynamics in men with lower urinary tract symptoms (LUTS) due to
benign prostatic hyperplasia (BPH) focused on distinguishing between prostatic
obstruction and impaired detrusor contractility. 
If improvement in symptoms and quality of life is considered the primary outcome, the
results after laser prostatectomy in men with obstruction appeared to be significantly
better than in men without obstruction, but those without obstruction also derived
benefit1. If improvement of maximum flow rate, average flow rate, and postvoid resi-
dual volume is taken into account, even patients with impaired detrusor contractility
and minimal obstruction appeared to have a good outcome2.
In the recent years, it has become clear that the interrelationships between BPH, pros-
tatic enlargement, LUTS, and bladder outlet obstruction are not simple3. Even elderly
women develop LUTS very similar to LUTS in men4.
Decreased bladder compliance, reduced bladder capacity, residual urine volume, and/or
detrusor instability all play a role in the genesis of symptoms as well as in the severity
of BPH. These pathophysiological elements are all common in the elderly man and may
be present alone or in all possible combinations, each giving rise to specific com-
plaints3. 
The probability of having an unstable bladder in men with BPH is approximately 60%,
decreasing to approximately 25% after surgery5-7. Surprisingly, even in a group of 17
healthy older men, the prevalence of detrusor instability was 53%8. Thus, the associa-
tion of detrusor instability and LUTS suggestive of BPH is non-specific.
A decrease in bladder compliance does not appear to be a consistent finding in patients
with outlet obstruction, although the proportion of men with low bladder compliance is
higher in the group with obstruction and/or detrusor instability than in those with nor-
mal urodynamic findings9. 
Residual urine was present in 69% of the obstructed men and in 52% of the unob-
structed men as well10.
When evaluating these characteristics in men with BPH, it is not fair to compare men
with recent onset of BPH with those who have severe and prolonged obstruction. In
the latter group, the long-term effects of obstruction may result in detrusor decompen-
sation or other changes. 
The aim of this study was to establish the characteristics of a large, well-defined group
of men with LUTS due to BPH who are able to compensate more or less for the
impaired outflow condition. Further, we investigated the interactions between prostate
volume, degree of obstruction, bladder contractility, the prevalence of residual volume,
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bladder compliance, bladder capacities and the prevalence of instability in this large,
well-defined group. 
Materials and Methods
From October 1993 on, in consecutive men with LUTS presenting to the outpatient urology
department, a basic initial evaluation (history, physical examination, digital rectal examina-
tion, urinalysis, and renal function assessment) and recommended diagnostic tests
(uroflowmetry and residual urine estimation) were performed, conforming to the recommen-
dations of the International Consensus Committee on BPH11.
Men were included if 1) they were older than 50 years of age, 2) they had no exclusion crite-
ria according to the International Consensus Committee on BPH11, 3) they voided >150 ml
during one or more free uroflowmetry studies, 4) their residual urine was estimated reliably,
and 5) their prostate size was determined by transrectal ultrasound. They also underwent fill-
ing cystometry and pressure-flow studies. 
Cystometric studies were performed with the patient supine and erect. Pressure-flow studies
were done twice with the patient erect. Vesical pressure was recorded with a 5F catheter, and
rectal pressure was measured with a 14F catheter connected to external pressure transduc-
ers. The bladder was filled with saline at 370C, through a second 5F catheter, at a constant
rate of 50 ml/min. In some men, an 8F double-lumen catheter was used for vesical pressure
measurement and bladder filling. Filling was stopped when the patient had a strong desire to
void. If two catheters were used, the first pressure-flow study was done with the measuring
and filling catheters in the bladder, and the second study was done after removal of the filling
catheter. The pressure-flow study with the lowest urethral resistance (usually during voiding
with only the measuring catheter in the bladder) was used for further analysis.
Residual urine was estimated during one of the visits at the outpatient department by trans-
abdominal ultrasonography or catheterisation. If residual urine was significant, this test was
repeated. The urodynamic investigation always started with a uroflowmetry and determina-
tion of the residual volume by catheterisation. Some patients were not able to arrive with a
full bladder and sometimes were not able to produce a flow curve. At the end of the urody-
namic investigation, the bladder of these patients was refilled, and after removal of the
catheter uroflowmetry was performed. If these patients were known to have significant resid-
ual volume, catheterisation was performed once more. The smallest residual volume was
used for further analysis.
From pressure-flow studies, obstruction grade (range 0 - no obstruction to 6 - severe obstruc-
tion) and detrusor contractility grade (range 0 - very weak to 5 - strong bladder) as proposed
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by Schäfer12 and the Abrams-Griffiths (AG) number13 and urethral resistance factor (URA)14
were estimated, using the values of the maximum flow rate and corresponding detrusor pres-
sure. Men with an obstruction grade of 0 or 1 were considered not to have infravesical
obstruction, those with obstruction grade 2 were considered as equivocal, and those with an
obstruction grade of 3 or more were considered to have obstruction.
Effective bladder capacity was defined as maximum cystometric bladder capacity minus resi-
dual volume.
Statistical analyses were performed with the Kendall and Gibbons distribution-free correla-
tion method and Mann-Whitney test. The Kolmogorov-Smirnov goodness-of-fit test was used
to analyse normal distribution of variables15. The level of significance (two-tailed) was set at
p<0.05.
Results
Results were obtained from the 565 included men. Figure 7.1 shows distributions of
different parameters for all men.
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Table 7.1 Mean, standard deviation (SD), and range of different baseline characteristics of
the evaluated population (n=565).
Characteristic Mean SD Range
Age (yr) 66 8 50-90
Prostate volume (ml) 38 19 10-155
Maximum free flow rate (ml/s) 12 5 3-35
Schäfer’s grade 2.7 1.3 0-6
AG number 46 30 –22-264
URA (cm H2O) 34 19 9-259
Contractility degree 3.0 1.2 0-5
Cystometric capacity (ml) 415 155 150-1100
Effective capacity (ml) 355 140 100-850
Residual volume (ml) 65 90 0-630
Symptom index 17 7 1-35
Quality of life score 3.6 1.5 0-6
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Figure 7.1 Distribution of age, prostate volume, Schäfer’s obstruction grade, AG number, maxi-
mum free flow rate (Qmax.free), effective capacity, residual volume, and instability.
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Except age, no parameter was normally distributed (Kolmogorov-Smirnov test).
Table 7.1 describes baseline characteristics of the evaluated patients. In the literature,
it is not unusual to calculate the standard deviation, despite nonuniform distributions.
Therefore, these values are listed as well.
According to our definition, 112 of 565 men (20%) appeared not to have obstruction,
152 (27%) were equivocal, and 301 (53%) appeared to have obstruction. 
Mean maximum flow during free uroflowmetry (Qmax.free) was 16±6 ml/s in the non-
obstructed group, 13±5 ml/s in the equivocal group, and 11±4 ml/s in the obstructed
group. These differences are significant (p<0.001). Nevertheless, the maximum flow
during uroflowmetry was <15 ml/s in 47% of patients without obstruction and ≥ 15
ml/s in 11% of patients with obstruction. 
Correlation coefficients between different urodynamic parameters are listed in table
7.2. Only significant correlations are listed.
One hundred forty-eight patients (26%) had a residual volume of >20% of cystometric
capacity, 199 (35%) had residual volume ≤ 20% of cystometric capacity, and 218 (39%)
did not have residual volume. Table 7.3 shows urodynamic parameters in these three
groups. Patients with a significant residual volume (>20% of cystometric capacity) are
older and have slightly larger prostates and more obstruction than patients without
residual volume. Their cystometric capacity is higher and their effective capacity is
lower.
Table 7.3 Mean±SD of age, prostate size, and urodynamic parameters in patients with and
without residual volume (p value obtained with Mann-Whitney test; n.s. = not significant).
Residual volume
0 0< and ≤ 20 % of >20 % of Significance
cystometric cystometric (no residual 
(n=218) capacity capacity against >20 %)
(n=199) (n=148) (p value)
Age (yr) 65±8 65±8 68±7 <0.001
Prostate volume (ml) 37±16 39±21 41±20 <0.05
Schäfer’s grade 2.4±1.2 2.7±1.3 3.2±1.4 <0.001
Contractility 3.0±1.1 3.0±1.0 2.8±1.2 n.s.
Cystometric capacity (ml) 385±140 425±155 450±160 <0.001
Effective capacity (ml) 385±140 375±140 275±105 <0.001
Qmax.free (ml/s) 14±5 13±5 11±4 <0.001
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Figure 7.2 Prostate volume (A), cystometric capacity (B) and effective capacity (C) (mean±SD)
plotted against Schäfer’s obstruction grade. Note: Schäfer’s obstruction grades 0 and 1, and 5 and
6 were united.
A
B
C
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Of the men, 259 (46%) had an unstable bladder; in 55 of whom it occurred only in the
supine position, in 106 only in the erect position, and in 98 in both positions. Table 7.4
shows urodynamic parameters in patients with and without detrusor instability. No sig-
nificant differences appeared to exist between men with instability only in the supine
position and those with instability only in the erect position.
Because of the relatively large number of men in both groups, significant differences
appeared to exist between the men with instability only in the erect position and those
with instability in the supine and erect positions with respect to obstruction grade
(p<0.01), contractility (p=0.03), cystometric capacity (p<0.01), and effective capacity
(p<0.01).
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Figure 7.3 Prevalence of residual volume (%) plotted against Schäfer’s obstruction grade (A)
and Schäfer’s contractility grade (B). Note: Schäfer’s obstruction grade 0 and 1, and grade 5 and 6
were united and Schäfer’s contractility grades 0 and 1 were united. 
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A significant negative correlation was found in the unstable group between highest
magnitude of instability and cystometric bladder capacity (correlation coefficient -0.11,
p=0.02), and effective bladder capacity (correlation coefficient -0.16, p<0.001).
Figure 7.2 shows prostate size, cystometric bladder capacity, and effective bladder
capacity plotted against Schäfer’s obstruction grade. Due to the fact that just a small
number of patients had Schäfer’s grade 0 (11 patients) and Schäfer’s grade 6 (8
patients), grades 0 and 1, and grades 5 and 6 were combined.
In figure 7.3, prevalence of residual volume is plotted against Schäfer’s obstruction
grade and Schäfer’s detrusor contractility grade. Because only 5 patients had contrac-
tility grade 0, contractility grades 0 and 1 were combined.
Prevalence of instability is plotted against Schäfer’s obstruction grade and contractility
grade in figure 7.4 .
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Figure 7.4 Prevalence of instabilities (%) plotted against Schäfer’s obstruction grade (A) and
Schäfer’s contractility grade (B). See note figure 7.3. 
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Discussion
Age, cystometric capacity, residual urine, and symptom index (table 7.1) in our group
were comparable with those reported by Rosier and de la Rosette16 for a group of 521
men with LUTS. Nevertheless, in their group, prostate volume (44.1 cm3) and URA
(37.6 cm H2O) were higher than in our group (38 cm
3 and 34 cm H2O, respectively). In
contrast to Madersbacher et al.17, the detection of a significantly low (<40 ml/cm H2O)
bladder compliance was exceptional in our group. However, in their group, mean
prostate volume was 47 cm3. We found 53% of the men to be obstructed, which is
slightly lower than reported by the ICS-BPH study group (60%)18. These differences
may be due to different inclusion criteria. Our criterion that men were included only if
they could void a volume of more than 150 ml during free uroflowmetry may have
excluded men with severe and prolonged obstruction. In a reasonable number of these
excluded men, however, bladder properties may have been changed, resulting in a
lower compliance and/or (partly) decompensated bladders. Mean prostate volume and
obstruction grade in these excluded men will be greater than in the included men,
explaining the above mentioned differences in prostate volume and obstruction grade.
Our inclusion criteria were based on the recommendations of the International
Consensus Committee on BPH11. 
Conforming to the findings of Rosier and de la Rosette16, prostate volume was signifi-
cantly positively correlated with Schäfer’s obstruction grade (p<0.001), although mean
prostate volume slightly decreased at Schäfer’s grade 5 and 6 (fig. 7.2A).
Although maximum free flow rate in men without obstruction differs significantly from
that in men with obstruction, 47% of the former patients have a low maximum free
flow rate (<15 ml/s).
Significant negative correlations existed between Schäfer’s grade and cystometric blad-
der capacity and effective capacity (table 7.2, fig. 7.2B,C). Increasing Schäfer’s obstruc-
tion grade leads logically to an increase in detrusor contractility. Maximum free flow
rate is negatively correlated with Schäfer’s grade and prostate volume but of course
positively correlated with contractility (table 7.2). Such a compensatory response to
obstruction was previously demonstrated9.
Patients with increased residual urine volume or detrusor instability were significantly
older (tables 7.3, 7.4). Older patients have a significantly greater prostate volume, but
age does not correlate with Schäfer’s obstruction grade (table 7.2). 
Bladder outlet obstruction results in incomplete emptying. Patients with a significant
residual volume have a higher prostate volume and higher Schäfer’s grade but no sig-
nificantly lower contractility grade (table 7.3). These associations also can be seen in
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figure 7.3A,B. Despite the increase in cystometric capacity of approximately 65 ml,
residual volume results in a significantly lower effective bladder capacity of approxi-
mately 90 ml (table 7.3).
Having a significant residual volume leads to a significantly lower maximum free flow
rate despite the unchanged contractility grade. This can be explained by the significant
positive correlation between residual volume and Schäfer’s grade and by the significant
negative correlation between residual volume and effective capacity in that group (cor-
relation coefficient -0.19, p<0.001), leading to lower maximum flow rates19.
Of the 565 men, 46% had an unstable bladder as estimated by our filling cystometries.
This percentage is lower than the reported preoperative incidence between 49% and
74% in 12 clinical studies20. However, it is unclear whether these reports are based on
patients with BPH who were already selected for operation. 
No significant differences appeared to exist between men with detrusor instability in
the supine position compared with those with instability only in the erect position.
Patients with an unstable bladder in the erect and supine positions have a significantly
higher Schäfer’s grade and contractility grade and a significantly lower cystometric and
effective bladder capacity, compared with patients without instability (table 7.4, fig.
7.4A,B).
Conclusions
In our group of 565 men with LUTS due to BPH, we found 53% to be obstructed.
We found a significant increase in prostate volume from unobstructed to obstructed
men, although mean prostate volume decreased at Schäfer’s obstruction grades 5 and
6.
Significant negative correlations existed between Schäfer’s grade and cystometric and
effective bladder capacity and maximum free flow rate.
Patients with increased residual urine volume or detrusor instability were significantly
older. Patients with a significant residual volume have a greater prostate volume and
higher Schäfer’s grade but not a lower contractility grade.
Forty-six percent of the men had an unstable bladder during filling cystometries.
Patients with an unstable bladder had a significantly higher Schäfer’s obstruction and
contractility grade and significantly lower bladder capacities.
We conclude that in men with LUTS suggestive of BPH, abnormalities of bladder and
bladder outlet function vary greatly and have complex mutual interactions.
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Abstract
Objective: The aim was to estimate differences between symptoms, prostate volume
and urodynamic variables of symptom-free elderly volunteers, of volunteers with lower
urinary tract symptoms (LUTS), and of urologic patients with LUTS suggestive of
benign prostatic hyperplasia (BPH).
Methods: The included 14 male volunteers without LUTS, the 17 male volunteers
with LUTS and the 565 urologic patients with LUTS met the criteria of the
International Consensus Committee on BPH. They were older than 50 years, they
voided more than 150 ml during free uroflowmetry, their residual volume and prostate
volume were estimated and AUA symptom scores were collected. All males were eval-
uated by urodynamics as well.
Results: Prostate volume, residual volume, urethral resistance factor, and symptom
scores were significantly lower, and maximum free flow rate and effective capacity sig-
nificantly higher in symptom-free volunteers than in volunteers and patients with
LUTS. Except prostate volume, the variables in volunteers with LUTS closely approxi-
mate those of the patients with LUTS. Volunteers with LUTS had a smaller prostate
volume than patients with LUTS. Nevertheless, maximum free flow rate, symptoms,
degree of obstruction and prevalence of residual volume did not differ between both
groups. In all groups, males with an unstable bladder were present.
Conclusions: Symptom-free volunteers have smaller prostate volumes, less residual
volume, lower symptom scores, lower urethral resistance factor, higher maximum free
flow rate and higher effective capacity than males with LUTS. Except a smaller
prostate volume, findings in volunteers with LUTS closely approximate those of uro-
logic patients with LUTS.
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Introduction
Urodynamics in patients with lower urinary tract symptoms (LUTS) is used for objec-
tive assessment of bladder and bladder outlet behaviour. However, to decide what is
pathological it seems mandatory to agree on what can be considered normal1. Objective
parameters obtained from urodynamic tests on which functional diagnoses are based
should be related to normal standardised reference values. Although urodynamics is
used frequently to evaluate voiding disorders in elderly men with LUTS suggestive of
benign prostatic hyperplasia (BPH)2, only a few studies have included sufficient age-
matched controls. 
A number of studies in symptom-free persons have dealt with young men and women
(mean age less than 40 years). In the studies of Robertson et al.3 and Wyndaele et al.1
of young adults, most urodynamic parameters showed large variations. Different and
changing flow patterns, low maximum flow rate, large bladder capacity, bladder overac-
tivity and residual urine, which are all usually considered signs of pathological condi-
tions, were seen.
Considering obstruction, Schäfer et al.4 found 10% of 30 healthy young male volunteers
(mean age 28 years) to be classified in the ICS “equivocal zone”, and Griffiths et al.5
found 60% of 7 asymptomatic volunteers (all members of the urology department6 with
a mean age of 42 years, range 34-53) to be classified as “equivocal”.
The filling and voiding phase of the bladder in the elderly symptom-free man was stud-
ied by urodynamic investigations in 17 men by Andersen et al.7, in 13 men by Jensen et
al.8, in 25 men by Walker et al.9, in 29 men by Bøtker-Rasmussen et al.10 and in 19 men
by Diokno et al11. Some of these studies show a surprising number of apparently “nor-
mal” elderly men to be classified as obstructed on pressure flow study9-11. In addition, a
large proportion of these men exhibits in some studies detrusor instability on filling
cystometry7,9. 
The urodynamic study of Homma et al.12 involving 65 subjectively symptom-free men
aged over 30 (mean age 55 years, range 34-84) indicated that urodynamic variables
change with age, even in “normal” subjects. Urodynamics showed reduced urinary
flow rate and increased residual urine with advancing age. This warrants a careful
interpretation of urodynamic variables in elderly subjects.
Above mentioned studies support the statement of Wyndaele1 that since normality in
urodynamics may include so many different features, the interpretation of urodynamic
evaluations should be made with caution. To decide what is pathological, it is important
to know what can be considered normal in elderly men. Only by fully understanding the
range of values seen in the normal population can we be sure that our observation of
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the “abnormal” is genuine and relevant to clinical management3.
The aims of this study are to describe and to compare symptoms, prostate volume and
urodynamic findings in symptom-free elderly community-based male volunteers, in
elderly community-based volunteers with LUTS suggestive of BPH and in elderly uro-
logic patients with LUTS suggestive of BPH. 
Materials and Methods
For research objectives two groups of elderly volunteers were recruited. The first group was
selected from men who responded to an advertisement recruiting healthy men with an age
between 45 and 75 years. The second group was selected from men who responded to an
advertisement recruiting men with an age between 45 and 75 years, with lower urinary tract
symptoms like hesitancy, weak urinary stream, feeling of inability to empty the bladder com-
pletely, frequent voiding of small volumes and/or postvoid dribbling. The local ethical commit-
tee approved the research program and informed consent was obtained.
The volunteers were examined conform to the recommendations of the International
Consensus Committee (ICC) on BPH13 and were without any of the specified exclusion crite-
ria of the committee (prostate cancer, neurological disease, previous prostate surgery, or tak-
ing medication active on the urinary tract). They voided a sufficient volume (>150 ml) during
one or more free uroflowmetry studies, their residual urine was estimated reliably, and their
prostate size was determined by transrectal ultrasound. A practised urologist examined all
men.
The AUA Symptom Index14 on incomplete emptying, frequency, intermittency, urgency, weak
urinary stream, hesitancy and nocturia were collected for all men. Each question could be
answered on a scale of 0 (not at all) to 5 (almost always). The AUA Symptom Score (range 0
to 35) was calculated by summing the 7 scores on question 1 through 7.
All volunteers who claimed to be without LUTS were included in the present paper when,
conform to the recommendations of the ICC, they were older than 50 years of age and when
the practised urologist qualified them as healthy without LUTS. All volunteers who claimed
to have LUTS were included when they were older than 50 years and when the urologist
qualified them as “men with LUTS suggestive of BPH”.
Filling cystometric studies were performed with the volunteer supine or erect. Bladder pres-
sure was recorded with a 10F double lumen catheter and rectal pressure was measured with a
14F catheter connected to external pressure transducers. The bladder was filled with saline
at 370C, at a constant rate of 50 ml/min. Filling was stopped when the volunteer had a strong
desire to void. The pressure-flow study was done with the volunteer erect. When the results
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of the pressure-flow study were not reliable, the test was repeated.
From pressure-flow studies, obstruction grade (range 0 - no obstruction to 6 - severe obstruc-
tion) and detrusor contractility grade (range 0 - very weak to 5 - strong bladder) as proposed
by Schäfer15, the Abrams-Griffiths (AG) number16 and urethral resistance factor (URA) 17
were estimated, using the values of the maximum flow rate and the corresponding detrusor
pressure. Men with obstruction grade 0 or 1 were considered not to have infravesical obstruc-
tion, those with obstruction grade 2 were considered as equivocal. And those with an obstruc-
tion grade of 3 or more were considered to have obstruction.
Effective bladder capacity was defined as maximum cystometric bladder capacity minus resi-
dual volume.
The findings in the two groups of volunteers were compared with those of a group of 565 con-
secutive men who presented to our outpatient department of urology with LUTS suggestive
of BPH. The patients fulfilled the same criteria and were examined in the same way as the
volunteers. Only urodynamic investigations in these patients were performed with one or two
F5 bladder catheters or one F8 bladder catheter.
Data of all groups are reported as mean plus or minus standard deviation and range. Statistical
analyses were performed with the Fisher-Irwin test for two-by-two tables and the distribu-
tion-free Kendall and Gibbons correlation method and Mann-Whitney test. The level of signi-
ficance was set at p<0.05.
Results
Of the 16 male volunteers without LUTS, participating in the research project, 2 were
excluded from the present study because they were younger than 50 years. For the
same reason 1 of 18 volunteers with LUTS was excluded.
Table 8.1 shows parameters in the 14 volunteers without LUTS, in the 17 volunteers
with LUTS suggestive of BPH and in the 565 patients with LUTS suggestive of BPH.
In only one volunteer with LUTS the pressure-flow study had to be done twice because
of excessive straining during the first study.
Prostate volume was significantly lower in the volunteers without complaints com-
pared to the prostate volume in volunteers with complaints. The prostate volume in
the latter group was in turn significantly lower than prostate volume in the patient
group. Maximum free flow rate was significantly higher and residual volume signifi-
cantly lower in the volunteers without LUTS compared to the volunteers with LUTS.
From the variables Schäfer’s grade, AG number and URA, only URA was significantly
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higher in the volunteers with LUTS compared with those without complaints. Effective
capacity in the symptom-free group was significantly higher than in the group with
LUTS.
Despite the fact that prostate volume in the volunteers with LUTS was between
prostate volume of patients and that of volunteers without LUTS, the other parameters
of the volunteers with LUTS in table 8.1 approximate those of the patients with LUTS.
In the group volunteers without LUTS, 4 (28%) of 14 men were unobstructed, 5 (36%)
were equivocal and 5 (36%) were obstructed. In the volunteers with LUTS 2 (12%) of
17 men were unobstructed, 4 (23%) were equivocal and 11 (65%) were obstructed. In
the patient group 112 (20%) of 565 men were unobstructed, 152 (27%) were equivocal
and 301 (53%) were obstructed. The distribution of the volunteers with LUTS again
approximates that of the patients, however the numbers of volunteers are to small to
proof significant differences.
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Figure 8.1 Mean scores on each symptom and symptom index together with the standard devia-
tion for asymptomatic volunteers (AV), symptomatic volunteers (SV) and patients with LUTS
(P). 
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After micturition the bladder was empty in 8 (57%) out of 14 volunteers without LUTS.
This proportion is significantly greater than 1 (6%) out of 17 volunteers with LUTS
(p<0.01) and than 220 (39%) out of 565 patients with LUTS. In 29% of the volunteers
without LUTS, in 47% of the volunteers with LUTS and in 44% of the patients residual
volume was 50 ml or more.
Of the volunteers without LUTS, 6 (43%) out of 14 had an unstable bladder during fill-
ing cystometry, with instabilities of 12 to 67 cm H2O. In the group volunteers with
LUTS 5 (29%) out of 17 had an unstable bladder with instabilities of 15 to 85 cm H2O.
In the patient group 259 (46%) out of 565 showed an unstable bladder. Any significant
differences between the prevalence of instabilities in the groups could not be proved.
In figure 8.1 scores on the symptom questions are shown for the three groups.
Healthy volunteers had significantly lower symptom scores than volunteers and
patients with LUTS (p<0.01 for all questions). No significant difference was found
between a score in the group volunteers with LUTS and that score in the patient group.
Discussion
In most studies older volunteers were usually patients and were classified as ‘normal’
because of their history and subjective symptom assessment. We included community
men in stead of patients, and compared them with the patient population visiting our
outpatient clinic.
Age in our group volunteers without LUTS was similar to other studies7-10. Prostate
volume in this group was 21±4 ml, and was somewhat lower than in the study of
Walker et al.9 with prostate volumes of 26±13 ml. The AUA symptom index of our
healthy volunteers was low (3±3; range 0-8), and agreed with the index reported by
Walker et al.9 (4±5).
Values of maximum free flow rate exceeding 15 ml/s are generally accepted as normal,
while values less than 10 ml/s indicate infravesical obstruction, provided detrusor
insufficiency is absent18. Mean maximum free flow rate in our group healthy volunteers
was 18±3 ml/s and similar to the values reported by Walker et al.9 and Jensen et al.8
which show a maximum free flow rate of 18±8 and 16 (range 5-33) ml/s, respectively.
Andersen et al.7 and Bøtker-Rasmussen et al.10 found lower free flow rates (12 ml/s
and 13 ml/s, respectively). No healthy volunteer had a maximum free flow rate less
than 10 ml/s.
After micturition the bladder was empty in 57% of the elderly volunteers without
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LUTS (versus 6% of our volunteers with LUTS and 39% of our patients with LUTS).
Mean residual volume in men without LUTS was 35 ml (range 0-140), and somewhat
higher than reported residual volumes of 10 to 28 ml (range 0 to 160) in literature7-10.
Normal bladder capacity can vary widely, although in the literature a range between
300 and 550 ml is accepted as normal1. We found a large mean maximum cystometric
bladder capacity of 505±150 ml (range 200-750). Also in other studies wider ranges
than 300 to 550 ml were found7,8,10.
Many observers agree that the minimal natural prevalence of detrusor instability is at
least 10 percent19. It thus becomes questionable whether it is reasonable to regard
instability as abnormal. The prevalence of instability appears to be at lowest between
about the ages of ten and thirty, probably in the region of 10 percent of the population.
By the age of 50, urodynamic clinic studies indicate that the incidence is higher than
this and that it rises still further in the elderly19.
Of our volunteers without LUTS, 43% had an unstable bladder. Andersen et al.7 found
in 53% of 17 healthy elderly men bladder instabilities (with an amplitude >15 cm H2O),
and Jensen et al.8 found in 25% of 13 elderly asymptomatic men uninhibited detrusor
contractions. Thus, detrusor instability seemed to be a common finding in elderly men
without LUTS and without signs of neurological disease.
According to Schäfer and according to the AG number, 36% (5 of 14) of our healthy eld-
erly volunteers were obstructed. Walker et al.9 found 23% of healthy men to be
obstructed according to Schäfer, and 17% according to the AG number. Bøtker-
Rasmussen et al.10 found 52% of 29 healthy community-based volunteers to be
obstructed, according to AG nomogram. Diokno et al.11 found 47% of 19 men over 60
years of age to be obstructed, but the criteria for diagnosing obstruction were not well
described. Mean URA (25±8) in our healthy men approximated mean URA (22±15) of
Walker et al9. During the extensive urodynamic examinations of the volunteers, it was
required to empty the bladder quickly at regular times. To avoid repeated catheterisa-
tions for measurements and bladder emptying, we were restricted to use a double-
lumen catheter with a dimension of at least 10F. This could introduce differences
between the pressure-flow data of volunteers with LUTS and of patients with LUTS.
Nevertheless, such differences were not detected.
Prostate volume, residual volume, URA, every symptom score and AUA symptom
index were significantly lower, and maximum free flow rate and effective bladder capac-
ity were significantly higher in the group healthy elderly volunteers compared to the
group volunteers with LUTS. However, there was an overlap of values between the
two groups. These results were similar to those of a study of Jensen et al.8, who com-
pared 13 asymptomatic male volunteers to 83 patients who were awaiting transurethral
resection of the prostate.
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The variables in the volunteers with LUTS, who responded on the advertisement,
approximate those of the patients with LUTS, visiting our outpatient department of
urology. Only prostate volume was significantly lower in the group volunteers with
LUTS, although maximum free flow rate, AUA symptom index and degree of obstruc-
tion were comparable to our patients with LUTS. Like in our patients with LUTS weak
urinary stream, frequency and urgency were the symptoms with the highest preva-
lence in the group volunteers with LUTS (fig. 8.1).
The symptoms of the volunteers with LUTS did not differ from those of the patients
with LUTS. Nevertheless the volunteers did not seek treatment. We do not know why
the prostates of the patients are significantly bigger than those of the volunteers with
LUTS. Is this why they became patients?
A shortcoming of our study is still the small number of volunteers. Moreover, we per-
formed a cross-section study and longitudinal relations to (adverse) outcomes are
needed to define what is normal and what is abnormal.
Conclusions
Prostate volume, the prevalence of residual volume, URA, symptom scores, AUA
symptom index were significantly lower, and maximum free flow rate and effective
bladder capacity were significantly higher in elderly symptom-free volunteers com-
pared to the volunteers and patients with LUTS. Except prostate volume, the variables
in the volunteers with LUTS approximate those of the patients with LUTS. Prostate
volume was significantly lower in the volunteers with LUTS compared to the patients
with LUTS, although maximum free flow rate, symptoms, degree of obstruction and
prevalence of residual volume did not differ. In all three groups, men with an unstable
bladder were present and no difference in prevalence between the groups was found.
Like in patients with LUTS weak urinary stream, frequency and urgency were the
symptoms with the highest prevalence in volunteers with LUTS.
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Abstract
Objective: The aim is to examine associations of filling cystometric estimated compli-
ance, capacities and prevalence of bladder instability with data from frequency-volume
charts in a well-defined group of men with lower urinary tract symptoms (LUTS) sug-
gestive of benign prostatic hyperplasia (BPH).
Methods: Men with LUTS suggestive of BPH, were included if they met the criteria of
the International Consensus Committee on BPH, i.e., they voided more than 150 ml
during uroflowmetry, their residual volume and prostate size were estimated and they
completed frequency-volume charts correctly. From the frequency-volume charts,
voiding habits and fluid intake in the daytime and at night were evaluated. Filling cysto-
metric studies were performed in these men as well. 
Results: Decreased compliance was an exceptional finding. Cystometric capacity and
especially effective capacity (cystometric capacity minus residual volume) correspond-
ed significantly with the maximum voided volume on the frequency-volume charts.
Effective capacity was almost twice as high as the average voided volume. Minimum
voided volume on frequency-volume charts was not related to filling cystometric data.
The presence of instability in supine or sitting positions, or in both positions, was not
significantly associated with smaller voided volumes, higher nocturia or diuria. 
Conclusions: Filling cystometric capacities were strongly associated with maximal
and mean voided volumes derived from frequency-volume charts. The presence of
detrusor instability during filling cystometry did not significantly affect voided vol-
umes, diuria or nocturia. 
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Introduction
The aims of performing filling cystometry in men with lower urinary tract symptoms
(LUTS) suggestive of benign prostatic hyperplasia (BPH) are to estimate bladder com-
pliance and bladder capacities and to detect the presence of detrusor instability.
Previously1, we studied the relation between data from frequency-volume charts and
symptoms and quality of life in BPH. High diuria, and small voided volumes at night
and in daytime appeared to contribute significantly to high symptom scores and low
quality of life. Thus, low bladder compliance, small cystometric bladder capacity or
small effective bladder capacity (cystometric bladder capacity minus residual volume)
and/or the presence of an unstable bladder during filling cystometry are expected to be
common in men with severe LUTS.
However, a decrease in bladder compliance does not appear to be a consistent finding
in patients with outlet obstruction, although the proportion of men with poor compli-
ance is higher in the group with obstruction and/or detrusor instability than in those
with normal urodynamic findings2. The probability of having an unstable bladder in men
with BPH is about 60%, decreasing to about 25% after surgery3-5. However, in a group
of 17 healthy older men the prevalence of detrusor instability was 53%6. Thus, it
seems that the association of detrusor instability with LUTS due to BPH is non-speci-
fic. When the subjective evaluation of the patient at 6 months after surgery is taken as
criterion for the evaluation of postoperative success or failure, the preoperative pre-
dominance of irritative symptoms or the combination of irritative symptoms and detru-
sor instability did not attain prognostic significance7. A preoperative maximum
cystometric capacity less than 300 ml only appeared to indicate some post-surgical fail-
ure in prostatism8.
In view of these considerations, the International Consensus Committee on BPH9 con-
cluded that filling cystometry did not provide useful information in the assessment of
patients with LUTS. The Committee decided not to recommend filling cystometry in
routine cases. Several explanations are possible for why filling cystometry is not
expected to contribute to the diagnostics in men with LUTS suggestive of BPH. One
explanation may be the artificial way the bladder is filled. Artificial bladder filling may
mask or even provoke detrusor instability. Moreover bladder content sensation may be
influenced by the rate of bladder filling and by the temperature of the filling fluid. The
presence of a transurethral catheter may influence the outcomes. Results will strongly
depend on the measures taken to guarantee the privacy of the patients during the
investigations. These considerations suggest that findings during filling cystometry
may not be representative for bladder properties during natural bladder filling at home.
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If this statement is true, one would expect a lack of association between data obtained
during filling cystometry and those obtained from frequency-volume charts.
Frequency-volume charts appear to be reliable in the investigation of patients with
LUTS suggestive of BPH10. The aim of this paper is to examine whether associations
exist or whether there is a lack of associations of filling cystometric parameters (com-
pliance, capacities and prevalence of instability) with voided volumes and voiding fre-
quencies derived from frequency-volume charts. We perform the analyses in a group of
men who form a reasonable representative sample of the population of men who attend
a urology clinic, and for whom there is some suspicion of prostatic obstruction.
Materials and Methods
Methods, definitions and units conform to the standards proposed by the International
Continence Society (ICS) except when specifically noted.
In consecutive men presenting to the outpatient department of urology with LUTS, basic
standard evaluation (history, quantification of symptoms and quality of life, physical examina-
tion and digital rectal examination, urinalysis and renal function assessment) and recommend-
ed tests (uroflowmetry and residual urine estimation) conforming to the recommendations of
The International Consensus Committee on BPH11 were performed. Men with LUTS were
included if they were older than 50 years without any of the specified exclusion criteria of the
International Consensus Committee on BPH11, they voided a sufficient volume (>150 ml)
during one or more free uroflowmetry studies, residual volume was estimated reliably,
prostate size was determined by transrectal ultrasound and frequency-volume charts were
available showing voiding and also drinking habits during at least one normal 24-hour period.
These patients were examined urodynamically as well. Filling cystometric studies were per-
formed with the patient in supine and sitting positions. Bladder pressure was recorded with a
5F catheter and rectal pressure was measured with a 14F catheter, both connected to exter-
nal pressure transducers. The bladder was filled with saline at 370C, through a second 5F
catheter, at a constant rate of 50 ml/min. In some men an 8F double lumen catheter was used
for bladder pressure measurement and bladder filling. Filling was stopped when the patient
had a strong desire to void. This filling volume was defined as cystometric capacity (Ccys).
In all men, residual volume was estimated by transabdominal ultrasonography or catheterisa-
tion during one of the visits at the outpatient department. Conforming to the recommenda-
tions of the consensus committee9, this test was repeated if residual volume was significant.
Effective capacity (Ceff) was defined as cystometric capacity minus residual volume. 
From the frequency-volume charts, the minimum voided volume (Vmin), the mean voided vol-
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ume (Vmean), the maximum voided volume (Vmax), mean diuria (Ndiuria) and mean voided vol-
ume in the daytime (Vmean,day), mean nocturia (Nnocturia) and mean voided volume at night
(Vmean,night) were estimated. Nighttime was defined as the period between 23:00 and 07:00 h.
Voided volumes on the frequency-volume charts at which the patient did not indicate desire
to void were excluded from these analyses but were included for estimation of mean total
urine production in the daytime (Vtotal,day) and of mean total urine production at night
(Vtotal,night). Mean fluid intake in daytime (Vintake,day) and mean fluid intake at night (Vintake,night)
were also calculated.
The Kolmogorov-Smirnov goodness of fit test was used to examine whether or not the distri-
bution of a variable was normal. Statistical analyses were done with Kendall and Gibbons dis-
tribution-free rank correlation method and Mann-Whitney test. Significance (two-tailed) was
set at p<0.05.
Results
The included 160 men (age 64.9±8.3 years, range 50 to 89) had an average cystometric
capacity of 406±144 ml (range 175 to 850 ml) and an effective cystometric capacity of
355±141 ml (range 100 to 850 ml). The average lowest value (Vmin) on the frequency-
volume chart was 95±58 ml (range 10 to 350 ml), the average highest value (Vmax) was
351±142 ml (range 100 to 850 ml) and the average mean value (Vmean) was 195±74 ml
(range 65 to 495 ml). Average diurnal voided volume (Vmean,day) was 188±77 ml (range
65 to 565 ml) and average nocturnal voided volume (Vmean,night) 222±101 ml (range 55
to 660 ml). From these parameters only age, mean voided volume (Vmean) and average
nocturnal voided volume (Vmean,night) were normally distributed. 
Minimum voided volume was on average about 50±20% of mean voided volume.
Maximum voided volume was on average 185±55% of mean voided volume.
A significantly low (<40 ml/cm H2O) bladder compliance was an exceptional finding in
our group and therefore was not suited for further analysis.
Table 9.1 shows ratios between voiding data and cystometric capacity (Ccys) and
between voiding data and effective capacity (Ceff). 
Of the 160 men, 93 (58%) had a stable bladder and 67 (42%) had an unstable bladder.
Table 9.2 shows correlation coefficients between these voiding data and filling cysto-
metric capacities for all men, for men with a stable bladder and for men with an unsta-
ble bladder.
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Average fluid intakes in daytime or at night of men with a stable bladder did not differ
from those of men with an unstable bladder.
Table 9.3 compares voiding data at night and in the daytime in men with a stable blad-
der to those of men with an unstable bladder.
Voiding parameters in men with a stable bladder (n=93) did not differ significantly from
those with an unstable bladder (n=67). Including only men from the unstable group
with amplitudes higher than 15 cm H2O did not affect these findings.
Of the 67 men with an unstable bladder, 11 showed instabilities during filling cystome-
try in the supine position, 36 in the sitting position and 20 in both the supine and sitting
positions. No parameter in these groups appeared to have a significantly different value
compared to the value of the corresponding parameter in the group without an unstable
bladder.
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Table 9.1 Ratios between data from frequency-volume charts and cystometric capacity
(Ccys) and between these data and effective capacity (Ceff).
Parameter Value S.D. Range
Vmax / Ccys 0.92 0.36 0.3-2.5
Vmin / Ccys 0.26 0.16 0.1-1.0
Vmean / Ccys 0.51 0.19 0.1-1.3
Vmax / Ceff 1.06 0.45 0.4-3.2
Vmin / Ceff 0.30 0.21 0.1-1.5
Vmean / Ceff 0.59 0.25 0.2-2.3
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Discussion
The inclusion criteria we used are recommended by the International Consensus
Committee11. We consider it not reasonable to change any of these criteria because of
the extensive scientific and clinical considerations, which led to the recommendations
of the Committee. This means that patients with prior failed invasive treatment of
BPH, and patients with suggestion of neurological disease were excluded. In this latter
group bladder outlet obstruction may be active. Also, men taking drugs affecting lower
urinary tract function were excluded. We also excluded patients who were not able to
void more than 150 ml during free flow recording. The number of patients excluded for
this reason strongly depends on the efforts made to obtain reliable flow registration. At
our outpatient department the incidence of unsuccessful uroflowmetry studies was
about 5% in this group. This percentage agrees with the 8% reported by Ezz el Din12.
Of course men who visited the emergency department because of acute retention with
the need for a transurethral catheter were not at all included in our study. Excluding
men who not voided a volume of more than 150 ml will lead to an exclusion of those
men with (starting) decompensation of the bladder. Thus, it is reasonable to assume
that we selected a group of men in whom obstruction is developing or who are in the
early phase of obstruction. We judged these men to be a reasonable representative
sample of the population of men who attend a urology clinic and for whom there is
some suspicion of prostatic obstruction.
From 188 men who met all other inclusion criteria, 28 (15%) did not complete the fre-
quency-volume charts correctly during at least 24 h (they reported accumulated vol-
umes, they reported only during parts of days, or they were not willing to complete the
charts). The reliability of the frequency-volume charts in the remaining 160 men is
demonstrated and discussed extensively elsewhere10.
Despite the strict selection of our men, minimum voided volume in an individual was
about 50% of mean voided volume and maximum voided volume was about twice mean
voided volume. This illustrates the well-known large variation of voided volume at an
individual level. Variability is not caused by measurement errors but by the nature of
the parameter: no person has a unique functional capacity. This also applies to the
effective capacity. For these reasons it is not surprising that there is a wide spread in
the relations between voiding parameters and filling cystometric parameters. This can
be demonstrated by plotting the maximum voided volume against the effective capacity
(figure 9.1). 
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In figure 9.2 the cumulative percentage of men is plotted for which 100 times the
absolute value of (maximum voided volume, Vmax, minus effective capacity, Ceff) divided
by maximum voided volume is lower than the upper limit; mathematically formulated:
the cumulative percentage of men for which 100 x|(Vmax - Ceff) / Vmax|< upper limit. 
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Figure 9.1 Plot of maximum voided volume versus effective capacity.
Figure 9.2 Cumulative percentage of men in which 100 x | (Vmax - Ceff ) / Vmax | < upper limit.
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For instance: in about 50% of the men the relative difference between maximum void-
ed volume and effective capacity is lower than 25%.
Keeping in mind these large variations, the significant associations found are quite rea-
sonable. 
We excluded voided volumes when the patients did not indicate a desire to void. These
voidings are likely to have no relation to LUTS.
Most parameters did not show a normal distribution. Therefore, distribution-free sta-
tistical tests were used. Since the standard deviation is often reported in the literature,
we have listed standard deviations together with the range of the parameter.
We defined the 8-hour period between 23:00 and 07:00 h as nighttime. Shortening this
period in our group to 24:00 -06:00 h only resulted in a proportional reduction (about
25%) of mean nocturia and a proportional increase (about 10%) of mean diuria10. Mean
voided volume at night and in daytime were little affected by this shorter time period10. 
In agreement with the paper of Sullivan and Yalla2, a decrease in compliance does not
appear to be a consistent finding in our patients with LUTS. A compliance of less than
40 ml/cm H2O was an exceptional finding. Moreover one has to keep in mind that a
compliance of 40 ml/cm H2O may be partially artificial. When the bladder behaves like
an ideal sphere and the measurement catheter is positioned at the bottom of the blad-
der during filling from 0 (diameter 0) until 400 ml (diameter 9 cm), a pressure rise of 9
cm H2O will be measured due to the increasing water level above the catheter.
In our men, the average cystometric capacity was 406±144 ml, the average effective
capacity was 355±141 ml and the average voided volume was 195±74 ml. In a group of
200 incontinent women 55 or more years old, Diokno et al.13 found an average cysto-
metric capacity of 377 ml and an average voided volume of 196 ml. Average largest
voided volume in Diokno’s group was 483 ml and in our group 351±142 ml. The simi-
larity of their data and ours is surprising. Moreover, Diokno et al. found a significant
positive correlation between the cystometric capacity and maximum voided volume
(Pearson’s r=0.493, p<0.01). Calculation of Pearson’s r in our group (however, for non-
normally distributed samples) revealed a value of 0.497, p<0.01.
In 88 consecutive patients (men and females) consulting the out-patient clinic,
McCormack et al.14 found an average cystoscopic capacity of 382±149 ml, an average
diurnal voided volume of 176±64 ml and an average nocturnal voided volume of
233±130 ml. Also, the similarity of these findings and our findings (406±144 ml,
188±77 ml and 222±101 ml respectively) is striking.
The strong association between effective capacity (cystometric capacity minus residual
volume) and maximum voided volume from the frequency-volume chart (table 9.1 and
9.2) is not surprising. Cystometric capacity is defined as the bladder volume at which
the patient has a strong desire to void. In everyday life patients shall void at their “first
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or normal desire to void” volume. Cystometric determined bladder capacity represents
the “strong desire to void” volume, which will not be frequently used by patients in
everyday life. As another consequence, functional capacity (average voided volume
derived from the frequency-volume charts) is only about half the effective capacity
(table 9.1).
Minimum voided volume on frequency-volume charts is not related to cystometric
findings (table 9.2) and may be a response to some early urgency to void.
Of the 160 men, 67 (42%) had an unstable bladder as estimated by our filling cystome-
tries. This percentage is lower than the reported preoperative incidence between 49
and 74.3% in 12 clinical studies9. However, it is unclear whether these reports are
based on patients with BPH who were already selected for operation. In contradiction
to the reported preoperative incidence, analysis of data from 185 consecutive unselect-
ed men by Rosier et al.15, revealed concomitant detrusor instability in only 20% of the
men.
Correlations between voiding parameters and effective capacity were slightly higher in
men with a stable bladder than in men with an unstable bladder (table 9.2). We assume
that the voiding habits of men with an unstable bladder may be slightly irregular com-
pared to those of men with a stable bladder. Moreover, cystometric capacity estimated
during a period of instability may be lower than this capacity estimated during a stable
period.
In men with an unstable bladder, nocturia and diuria were slightly higher and voided
volumes slightly lower than in men with a stable bladder, however, the differences
were not significant (table 9.3). This finding was not dependent on the amplitude of the
instabilities, as including only patients with instabilities higher than 15 cm H2O did not
affect these differences (table 9.3). We could not detect any relation between the posi-
tion (supine or sitting) in which instabilities occurred and voiding data. That no mean-
ingful differences are found between patients with a stable bladder and patients with an
unstable bladder can not be due to the exclusion of men with voided volumes lower
than 150 ml during free flowmetry. It is not likely that including the 5% of men who
were unsuccessful in voiding a volume of more than 150 ml would change the results
significantly. Our results suggest that the detection of detrusor instability in men with
LUTS suggestive of BPH is of minor diagnostic importance.
We want to emphasise that conclusions are formulated for our well-defined group of
men with LUTS suggestive of BPH.
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Conclusions 
Decreased compliance was an exceptional finding. Effective capacity (cystometric
capacity minus post-void residual volume) was significantly associated with the maxi-
mum voided volume on the frequency-volume charts and was almost twice as high as
the average voided volume. Minimum voided volume on frequency-volume charts was
not related to filling cystometric data. The presence of instability in supine or sitting
position or in both positions was not significantly associated with smaller voided vol-
umes, higher diuria or nocturia.
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Abstract
Objective: To examine associations of data from frequency-volume charts with maxi-
mum free flow rate, residual volume and voiding cystometric estimated urethral
obstruction grade and detrusor contractility in men with lower urinary tract symptoms
suggestive of benign prostatic hyperplasia (BPH).
Methods: Included men met the criteria of the International Scientific Committee on
BPH. They voided more than 150 ml during uroflowmetry, their residual volume and
prostate size were estimated and they completed frequency-volume charts correctly.
From the frequency-volume charts voiding habits and fluid intake were evaluated.
Pressure-flow studies were performed as well.
Results: Increasing residual volume was coupled with a decrease of maximum voided
volume and with a decrease of maximum free flow rate. Cystometric capacity was hard-
ly affected by residual volume. Low contractility did not result in high residual volume.
A marked decrease in voided volumes with increasing obstruction grade was observed,
due to a decrease of cystometric capacity and an increase of residual volume. Detrusor
contractility was hardly associated with voided volumes. A higher voiding frequency
was coupled with a higher fluid intake. However, increased standardised frequency
(number of voidings per 1000 ml) was associated with a substantial reduction of fluid
intake.
Conclusions: Increase of residual volume was coupled with a decrease of maximum
voided volume and with a decrease of maximum flow rate. A marked decrease of voided
volumes with increasing obstruction grade was observed. Detrusor contractility was
hardly associated with residual volume and voided volumes. Increased standardised
frequency resulted in a substantial reduction of fluid intake.
148
CHAPTER 10
hoofdstuk 10  19-12-2001  09:54  Pagina 148
Introduction
Frequency-volume charts play an important role in the investigation of people with
voiding disorders and give the urologist information about frequency in the daytime
and at night together with the voided volumes1. They are used for objectively recording
patient’s symptoms, both as baseline and after therapeutic intervention. 
Analyses of frequency-volume charts in elderly focus on relations between increased
nocturia, diuresis, and functional bladder capacity2, on the physiological cause of noc-
turnal polyuria3 or on the aetiology of nocturia4. 
From 1991 on, extensive scientific and clinical considerations have led to the interna-
tional consensus5 about the diagnostic work-up of elderly men presenting with lower
urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). In
1997, the International Scientific Committee recommended frequency-volume charts
too in the initial diagnostic evaluation of men with LUTS suggestive of BPH when noc-
turia is the dominant symptom. Reason for this recommendation was that a voiding
diary filled out over several 24-hour periods, would help to identify patients with noc-
turnal polyuria or excessive fluid intake, which were supposed to be common in the
ageing man5. 
Recently, it has been shown6 that frequency-volume charts are completed reliably by
men with LUTS suggestive BPH and who met the inclusion criteria of the Scientific
Committee. In these men nocturia due to polyuria was an exceptional finding6. From
further analyses of the frequency-volume charts in the same group, it appeared that not
nocturia but high diuria, and small voided volumes at night and in daytime contribute
significantly to high symptoms and low quality of life. Quality of life was hardly affected
by nocturia7. 
LUTS refer to storage and emptying functions of the bladder. From frequency-volume
charts a lot of information is available concerning voiding habits. It seems logical to
attach more importance to the frequency-volume charts in the diagnostic work-up of
men with LUTS suggestive of BPH, than only to identify patients with nocturnal
polyuria or excessive fluid intake. Whereas, for instance, nocturia is strongly associated
with BPH8, hardly any study has been performed with respect to the diagnostic contri-
bution of frequency-volume charts in men with LUTS suggestive of BPH, and concern-
ing the relation of data from these charts with other diagnostic findings.
We wondered whether data from frequency-volume charts in men with LUTS sugges-
tive of BPH, are correlated with filling cystometric and voiding cystometric data. In a
previous paper9 we investigated already the relation between data from frequency-vol-
ume charts with filling cystometric estimated capacities and prevalence of instability in
149
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men with LUTS suggestive of BPH. Decreased compliance was an exceptional finding.
Effective capacity (cystometric capacity minus residual volume) was strongly associat-
ed with maximum voided volume on the frequency-volume charts, which was almost
twice as high as the average voided volume. The presence of detrusor instability was
not associated with smaller voided volumes or higher diuria or nocturia. 
The present paper deals with the associations of data from frequency-volume charts
with maximum free flow rate, residual volume and voiding cystometric estimated ure-
thral obstruction grade and detrusor contractility in these men.
Besides we investigated the impact of the amount of fluid intake on nocturia and diuria.
Materials and Methods
Methods, definitions and units conform to the standards proposed by the International
Continence Society (ICS) except when specifically noted.
In consecutive men presenting to the outpatient department of urology with LUTS, basic
standard evaluation (history, quantification of symptoms and quality of life, physical examina-
tion and digital rectal examination, urinalysis and renal function assessment) and recommend-
ed tests (uroflowmetry and residual urine estimation) conforming to the recommendations of
The International Consensus Committee on BPH from 1991 (republished by The
International Scientific Committee in 19985) were performed. Men with LUTS were included
if they were older than 50 years without any of the specified exclusion criteria of the
International Scientific Committee on BPH5, they voided a sufficient volume (>150 ml) dur-
ing one or more free uroflowmetry studies, residual volume was estimated reliably, prostate
size was determined by transrectal ultrasound and frequency-volume charts were available
showing voiding and also drinking habits during at least one normal 24-hour period. These
patients were examined urodynamically as well. Filling cystometric studies were performed
with the patient in supine and sitting positions. Pressure-flow studies were done twice with
the patient erect. Bladder pressure was recorded with a 5F catheter and rectal pressure was
measured with a 14F catheter connected to external pressure transducers. The bladder was
filled with saline at 370C, through a second 5F catheter, at a constant rate of 50 ml/min. In
some men an 8F double lumen catheter was used for bladder pressure measurement and
bladder filling. Filling was stopped when the patient had a strong desire to void. This filling
volume was defined as cystometric capacity. The first pressure-flow study was done with
measuring and filling catheters in the bladder, and the second study was done after removal of
the filling catheter. The pressure-flow study with the lowest urethral resistance (usually dur-
ing voiding with only the measuring catheter in the bladder) was used for further analysis.
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In all men residual volume was estimated during one of the visits at the outpatient depart-
ment by transabdominal ultrasonography or catheterisation. Conforming the recommenda-
tions of the Scientific Committee5 this test was repeated if residual volume was significant.
The urodynamic investigation always started with a uroflowmetry and determination of the
residual volume by catheterisation. Some patients were not able to arrive with a full bladder
and sometimes were not able to produce a flow curve. At the end of the urodynamic investiga-
tion the bladder of these patients was refilled via the measurement catheter and after removal
of the catheter uroflowmetry was performed. If these patients were known to have significant
residual volume, catheterisation was performed once more. The smallest residual volume
was used for further analysis.
Effective capacity was defined as cystometric capacity minus residual volume, and relative
residual volume as residual volume divided by cystometric capacity.
From pressure-flow studies Schäfer’s obstruction grade and contractility grade were estimat-
ed10.
From the frequency-volume charts the minimum voided volume, the mean voided volume,
the maximum voided volume, number of voidings in 24 h, mean diuria and mean voided vol-
ume in the daytime, mean nocturia and mean voided volume at night were estimated.
Nighttime was defined as the period between 23:00 and 07:00 h. Voided volumes on the fre-
quency-volume charts at which patient did not indicate desire to void, were excluded from
these analyses, but were included for estimation of mean total urine production in the day-
time and of mean total urine production at night. Because we asked the patients also to record
their fluid intake, mean fluid intake in daytime and mean fluid intake at night could be calculat-
ed too. We defined standardised frequency as number of voidings per 1000 ml.
The Kolmogorov-Smirnov goodness of fit test was used to examine whether or not the distri-
bution of a variable was normal. Statistical analyses were done with the distribution-free
Kendall and Gibbons rank correlation method and Mann-Whitney test. Significance (two-
tailed) was set at p<0.05.
Quadratic curve estimation was performed to quantify the relation between two parameters.
Results
In literature it is usual to calculate mean and standard deviation, despite non-normal
distributions. Therefore these values will be listed as well.
Of the 160 included men, 71 (44%) did not have a postvoid residual volume, 57 (36%)
did have residual volume but equal or less than 20% of the cystometric capacity, and 32
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(20%) had residual volume greater than 20% of cystometric capacity. In 52 men (33%)
residual urine volume was greater than 50 ml.
Table 10.1 shows the relations between the severity of residual volume and age, maxi-
mum free flow rate, voided volumes, diuria, nocturia and capacities.
The increase of cystometric capacity from 395±140 ml (no residual volume) to
440±145 ml (relative residual volume >0.2) was not significant (p=0.16), but the
decrease of effective capacity from 395±140 ml to 265±110 ml was (p<0.01). Also the
decrease of maximum voided volume from 385±160 ml to 305±135 ml was significant
(p=0.02). Mean and minimum voided volume did not depend on residual volume. Also
diuria and nocturia were not significantly affected by residual volume.
Maximum urinary flow rate was significantly (p=0.02) lower in men with residual vol-
ume (relative residual volume >0.2) than in men without residual volume. 
The correlation coefficient between maximum free flow rate and obstruction grade was
-0.43 (p<0.01). Obstruction grade had a substantial impact on voided volumes and on
capacities and residual volume (table 10.2). 
Especially maximum voided volume and effective capacity were significantly negatively
associated with obstruction grade. Despite the variability is high, figure 10.1 shows a
significant reduction of maximum voided volume at increasing obstruction grade. 
Quadratic curve estimation in the scatter plot of maximum voided volume against
obstruction grade (figure 10.1), showed that the average maximum voided volume
Figure 10.1 Maximum voided volume (Vmax) versus Schäfer’s obstruction grade. The curve is
obtained by quadratic curve estimation. 
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decreased from 520 ml at obstruction grade 0, to 235 ml at obstruction grade 6.
Cystometric capacity is negatively and relative residual volume is positively associated
with obstruction grade, resulting in a substantial reduction of effective capacity from
500 ml (grade 0), to 230 ml (grade 6) (figure 10.2).
Mean voided volumes in daytime and at night are significantly negatively related with
obstruction. The positive correlations between obstruction grade and diuria and noc-
turia were not significant. Table 10.3 shows relations between obstruction grade and
mean voided volume in 24 h, number of voidings in 24 h, total urine production in 24 h
and total fluid intake in 24 h. We introduced a standardised frequency of voiding by the
number of voidings per 1000 ml.
Contractility grade had hardly impact on voiding parameters (tables 10.2 and 10.3).
Maximum free flow rate was significantly positively correlated with all voided volumes
(except minimum voided volume), with cystometric and effective capacities, and with
urine production and fluid intake. Increase in voiding frequency and in residual volume
resulted in a decrease of maximum free flow rate (tables 10.2 and 10.3)
We found a positive correlation (p=0.03) between number of voidings in 24 h and total
fluid intake in 24 h (figure 10.3) but a negative correlation (p<0.01) between fluid
intake in 24 h and standardised frequency (figure 10.4).
Figure 10.2 Mean values of cystometric capacity (), residual volume () and effective capaci-
ty () as function of Schäfer’s obstruction grade. Curves are obtained by quadratic curve fitting
using all values (not the mean values).
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Table 10.3 Kendall and Gibbons rank correlation coefficients between bladder outflow
parameters and mean voided volume, 24 h frequency, standardised frequency, total 24 h
urine production and total 24 h fluid intake.
Parameter Mean voided Number of Number of Total urine Total fluid
volume in 24h voidings in 24h voidings per production intake
1000 ml in 24h in 24h
Obstruction grade -0.23** 0.11 0.23** -0.11 -0.16**
Contractility grade 0.05 0.01 -0.05 0.09 0.07
Max. free flow rate 0.27** -0.13* -0.27** 0.17** 0.18**
* significant at the 0.05 level
** significant at the 0.01 level
Figure 10.3 Scatter plot of total fluid intake in 24 h versus number of voidings in 24 h. The
curve is obtained by quadratic curve fitting.
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In table 10.4 correlations are listed between total fluid intake in 24 h and nocturia, stan-
dardised nocturia, diuria and standardised diuria.
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Figure 10.4 Scatter plot of total fluid intake in 24 h versus number of voidings per 1000 ml
(standardised frequency). The curve is obtained by quadratic curve estimation.
Table 10.4 Kendall and Gibbons rank correlations of total fluid intake in 24 h with nocturia,
nocturia per 1000 ml, diuria and diuria per 1000 ml.
Parameter Correlation coefficient with fluid intake
Nocturia 0.14*
Nocturia per 1000 ml -0.26**
Diuria 0.12*
Diuria per 1000 ml -0.19**
* significant at the 0.05 level
** significant at the 0.01 level
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Discussion
The reliability of the frequency-volume charts in our population was discussed in a pre-
vious paper6.
Of the men, 52 (33%) had residual urine greater than 50 ml. This percentage is lower
than the reported incidence of 52% in unobstructed and 69% in obstructed men over
the age of 5511. Our condition that men were included only if they could void a volume
of at least 150 ml during free flowmetry may have excluded men with severe and pro-
longed obstruction or with impaired detrusor contractility. In a reasonable number of
these excluded men, however, bladder properties may have been changed resulting in
(partly) decompensated bladders. We assume that our group included men who were
able to compensate more or less for the impaired outflow conditions and thus the inci-
dence of severe residual volume will be low. Our inclusion criteria are recommended
by the International Scientific Committee on BPH5. We consider it not reasonable to
change any of these criteria because of the extensive scientific and clinical considera-
tions, which led to the recommendations of the Committee.
As residual volume increased, cystometric capacity increased (table 10.1). However,
this increase was only 10% and not significant. Effective bladder capacity decreased
with about 30% (p<0.01) (table 10.1). This significant decrease is reflected by a signifi-
cant decrease (20%) in maximum voided volumes on frequency-volume charts
(p=0.02) (table 10.1). The not significant increase of cystometric capacity with 10%
together with the significant decrease of effective capacity with 30% suggest that in
BPH the development of residual volume in the initial phase of BPH, is not compensa-
ted by a higher capacity. It also argues for expressing the severity of residual volume as
percentage of cystometric capacity, i.e. relative residual volume.
In functional capacity (mean voided volume), only a not significant (p=0.15) decrease
of 10% is observed. Also diuria and nocturia are slightly but not significantly higher in
the presence of postvoid residual volume (table 10.1). In contrast with effective capaci-
ty and maximum voided volume, the remaining voiding data on frequency-volume
charts are hardly associated with the prevalence of residual volume.
The small decreases of mean voided volumes in daytime and at night (table 10.1) are
coupled with a similar proportional increase in diuria and nocturia, resulting in an
unchanged 24 h urine production.
Increasing residual volume is coupled to decreasing flow rate (table 10.1). This agrees
with findings reported by Drach and Steinbronn12 and by those reported by Neal et al.13
and may be explained by the concomitant reduction of maximum voided volume.
Maximum free flow rate decreases when voided volume decreases14. Low contractility
158
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degree did not result in high residual volume (table 10.2). This is in agreement with the
findings of Neal et al.13 that low voiding pressures did not correlate with increased
residual volumes.
Obstruction grade was significantly related with all voided volumes, except minimum
voided volume (tables 10.2 and 10.3). Effective capacity was significantly reduced by an
increasing obstruction grade. This reduction is partly due to an increase in residual vol-
ume when obstruction grade increases (table 10.2). From the other hand cystometric
capacity decreases with increasing obstruction grade (table 10.2). Increase in residual
volume and concomitant decrease in cystometric capacity with increasing obstruction
grade result in an even higher decrease of effective capacity (figure 10.2). The relation
between effective capacity and obstruction grade is similar to that between maximum
voided volume and obstruction grade (figure 10.1). This agrees with the earlier report-
ed strong association between effective capacity and maximum voided volume9. The
decrease in cystometric capacity with increasing obstruction grade in our population is
in accordance with the marked decrease in capacity of rabbit bladders after creation of a
mild outlet obstruction15.
We used quadratic curve estimation to quantify the relation between two variables.
Higher order curve estimation is meaningless because of the wide variability of the
parameters. The curves, especially those in figures 10.3 and 10.4, approximate linear
curves.
Despite the negative correlation between obstruction grade and mean voided volume,
only a not significant positive correlation was found between obstruction grade and
number of voidings in 24 h (table 10.3). This implies that patients with a high obstruc-
tion grade produce less urine in 24 h then those with a low obstruction grade. Indeed a
negative, but not significant correlation is found between total urine production in 24 h
and obstruction grade. Anyhow men with a high obstruction grade have a significant
lower fluid intake than those with a low obstruction grade (table 10.3).
It seems logical to assume that a higher frequency is coupled with a higher fluid intake
and actually this coupling exists (figure 10.3). However if we investigate the relation
between standardised frequency and fluid intake, a substantial reduction in fluid intake
is observed at increasing standardised frequency (figure 10.4). Obviously, men in whom
voided volumes are becoming smaller due to increasing outlet obstruction try to com-
pensate the raised frequency by reducing their fluid intake. This implies that adaptation
of patient’s behaviour to his personal situation should be involved in the interpretation
of symptoms. This applies to diuria and nocturia as well (table 10.4).
In contrast to obstruction grade, detrusor contractility degree is much less associated
with voided volumes and capacities in our population.
Like expected a high negative correlation existed between obstruction degree and
159
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maximum free flow rate. However, it is not only the increased outlet obstruction that
contributes to the decrease of maximum free flow rate. Maximum flow rate increases
when voided volume increases (in the range of 50 to 500 ml14). This range roughly cor-
responds with the range of the maximum voided volumes in our population (table 10.1).
We found a sharp decrease of maximum voided volume as obstruction grade increases.
This decrease in turn will contribute to lower maximum flow rates as well.
In our group maximum flow rate is negatively correlated to relative residual volume
(table 10.2), which in turn is positively related to obstruction grade and negatively to
maximum voided volumes (table 10.2).
These examples illustrate the complex mutual interactions between changes in para-
meters during the development of obstructive BPH.
We want to emphasise that conclusions are formulated for our group of strictly selected
men with LUTS suggestive of BPH.
Conclusions
Increasing residual volume was coupled to a decrease of maximum voided volume and
to a decrease of maximum free flow rate. Cystometric capacity was hardly affected by
residual volume. Low contractility did not result in high residual volume. A marked
decrease in voided volumes with increasing obstruction grade was observed, due to a
decrease of cystometric capacity and an increase of residual volume. Men with a high
obstruction grade have a lower fluid intake than those with low obstruction grade. In
contrast to obstruction grade, detrusor contractility is much less associated with void-
ed volumes. A higher voiding frequency is coupled with a higher fluid intake. However,
increased standardised frequency (number of voidings per 1000 ml) resulted in a sub-
stantial reduction of fluid intake. 
The mutual interactions between parameters during the development of benign prosta-
tic hyperplasia are complex.160
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Abstract
Objective: Urodynamically, men with lower urinary tract symptoms (LUTS) sugges-
tive of benign prostatic hyperplasia (BPH) are classified as unobstructed, equivocal or
obstructed. Aim was to investigate what combination of easily available non-invasive
parameters allows such classification in optimal agreement with urodynamic classifica-
tion.
Methods: Mandatory and recommended tests were performed in 369 men with LUTS
suggestive of BPH. The provisional classification of the International Continence
Society (ICS), the group specific resistance factor URA, and Schäfer’s obstruction
grade, were estimated from urodynamic studies. Effective capacity was defined as void-
ed volume at strong desire. In a subgroup of 160 men frequency-volume charts were
analysed. A further group of 95 men were used for validation.
Results: The combination: prostate size (ml) minus 3 times maximum urinary free
flow rate (ml/s) minus 0.1 times effective capacity (ml), was optimal in the classification
compared to urodynamic classification. Extension of this formula to more than 3 para-
meters did not result in a better selection. The method of quantifying urethral resist-
ance did not affect the selecting power of the combination. Replacement of effective
capacity by two times mean voided volume estimated from the frequency-volume chart
did not affect the results.
Conclusion: Bladder outlet obstruction number (BOON) for optimal non-invasive clas-
sification of men with LUTS suggestive of BPH, can be calculated with a formula com-
posed of 3 readily available parameters: prostate size (ml) minus 3 times maximum
urinary free flow rate (ml/s) minus 0.2 times mean voided volume (ml).
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Introduction
In the past, methods were developed to non-invasively diagnose bladder outlet
obstruction in men with lower urinary tract symptoms (LUTS) suggestive of benign
prostatic hyperplasia (BPH). The clinical prostate score (CLIPS), introduced by Rosier
et al.1, was composed of scores for prostate volume, maximum urinary flow rate, post-
void residual volume and voided volume. The score had a superior correlation with uro-
dynamically objectivated bladder outlet obstruction than isolated parameters. The
bladder outlet obstruction number (BOON), introduced by van Venrooij and Boon2, was
calculated from prostate size, maximum urinary free flow rate and relative residual vol-
ume. Relative residual volume was defined as residual volume divided by bladder vol-
ume at strong desire to void (times 100%). Schacterle et al.3 combined maximum
urinary flow rate and American Urological Association symptom index4 for identifying
obstruction and non-obstruction. The proportion of patients that was correctly diag-
nosed appeared to be small. Steele et al.5 combined symptom score, maximum free
flow rate and prostate volume for predicting bladder outflow obstruction.
Disagreement exists about which parameters to use, and about the number of parame-
ters needed for optimal classification of men according to obstruction grade. Anyhow,
parameters should be easily to estimate and should be accepted as useful in daily uro-
logical practice.
The American Urological Association symptom index and quality of life question4 are
accepted as mandatory tools in the clinical evaluation of benign prostatic hyperplasia6.
Transrectal ultrasonography is accepted as a reliable method to estimate prostate size6.
Uroflowmetry, with measurement of the maximum flow rate, has become the most fre-
quently used urodynamic examination. However, maximal flow rate depends on voided
volume7. Therefore, flow rate recordings with a voided volume of at least 150 ml are
recommended8. Some patients may not void an adequate volume (>150 ml). The num-
ber depends on the efforts made on the outpatient clinic and could be decreased to
about 5% in our department2. 
In a significant number of patients, reliable estimation of residual urine is difficult9.
Drainage of the bladder by catheter gives a quantitative value, but is invasive and the
bladder may be incompletely drained in about 25% of patients10. Therefore, determina-
tion of residual urine by ultrasonography is recommended, but in the outpatient depart-
ment estimation of residual urine immediately after voiding is sometimes difficult to
realise.
A number of methods are developed to quantify degree of obstruction from pressure-
flow relations11. Because these methods are based on the passive urethral resistance
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relation12, all methods give the same results in classifying clearly obstructed and clear-
ly non-obstructed pressure-flow relations. In classifying intermediate urethral resist-
ance a lack of agreement exists13. 
The International Continence Society (ICS) Subcommittee on Standardisation of
Terminology of Pressure-Flow Studies recommends the provisional ICS method for
definition of obstruction11 in benign prostatic hyperplasia: patients are obstructed when
the AG-number, defined as detrusor pressure (cm H2O) at maximum flow minus 2
times maximal flow (ml/s), is higher than 40. If the AG-number is lower than 20,
patients are considered to be non-obstructed. All other cases are considered to be
equivocal. The group-specific resistance factor (URA)14 can be used to classify the
pressure-flow relation as well. The boundary value URA=29 cm H2O separates
obstructed and equivocal bladder outlet, and URA=21 cm H2O
13 between equivocal
and unobstructed. Finally, obstruction grade (range 0- no obstruction to 6- severe
obstruction) as proposed by Schäfer15, can be used to classify patients: men with an
obstruction grade of 0 or 1 do not have bladder outlet obstruction, those with an
obstruction grade of 3 or more have obstruction, and those with obstruction grade 2 are
equivocal13. 
We ranked different parameters according to their correlation with obstruction grade.
Parameters with the highest correlation were used to create linear combinations with
still higher correlation with obstruction grade. We studied the optimal number of
parameters to be used in these combinations. We compared the reliability of the combi-
nation with the reliability of the other classification methods. The impact of using the
different definitions of obstruction on our findings was evaluated as well. 
Materials and Methods
Methods, definitions and units conform to the standards proposed by the International
Continence Society except when specifically noted.
In men with LUTS suggestive of BPH, basic standard evaluation and recommended tests,
conforming to the recommendations of The International Consensus Committee on benign
prostatic hyperplasia (BPH) from 1993 (updated8 in 1997) were performed. According to the
clinical judgement of the urologists, when the results of the evaluation were suggestive of
bladder outflow obstruction due to BPH, the patients were evaluated urodynamically as well.
Filling cystometric studies were performed with the patient in the supine and erect positions.
Pressure-flow studies were done twice with the patient erect. Bladder pressure was recorded
with a 5F catheter and rectal pressure was measured with a 14F catheter connected to exter-
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nal pressure transducers. The bladder was filled with saline at 370C, through a second 5F
catheter, at a constant rate of 50 ml/min. Filling was stopped when the patient had a strong
desire to void. The first pressure-flow study was done with the measuring and filling
catheters in the bladder, and the second study was done after removal of the filling catheter.
Schäfer’s obstruction grade15 and the group-specific resistance factor (URA)14 were estimated
and pressure-flow studies were classified as well according to the provisional ICS definition11.
Patients were included in the study if they were 50 years of age or older, without any of the
other specified exclusion criteria (International Consensus Committee on BPH8), they voided
a sufficient volume (>150 ml) during 1 or more free uroflowmetry studies, reliable pressure-
flow relationships were obtained, bladder volume at strong desire was estimated, residual
urine was estimated reliably at repeated tests by transabdominal ultrasonography and/or
catheterisation and prostate size was determined by transrectal ultrasound. Effective capacity
was defined as the bladder volume at strong desire to void minus residual volume. Thus effec-
tive capacity represents the voided volume at strong desire. Functional capacity represents
the mean voided volume calculated from frequency-volume charts.
Consecutively, 369 men (65.6±8.0 years of age, range 50 to 90) were included for the analy-
ses of the different classification methods. From the last 160 consecutive men (65.1±8.3
years of age, range 50 to 85), frequency-volume charts were analysed. Finally, a group of 95
men (65.5±7.3 years of age, range 50 to 84) was used for validation. Correlations among
parameters were calculated with the distribution-free rank correlation test of Kendall and
Gibbons. The level of significance (two-tailed probability) was p=0.05.
Results
In the appendix it is mathematically proven that a linear combination of two parameters
may correlate better with another parameter than each parameter alone. If one of the
parameters does not correlate at all, such combination will not result in a higher corre-
lation coefficient.
Table 11.1 shows Kendall and Gibbons’ correlations of variables and combination of
variables with AG-number, URA and Schäfer’s obstruction grade.
Hardly any correlation was found between symptom score or quality of life score and
urethral resistance parameters. Thus including symptom score or quality life score in a
linear combination with the aim to increase correlation with obstruction grade has no
sense (see appendix). 
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By numerical analysis2, almost maximal correlation with urethral resistance was found
for the combination: prostate volume (V) - 3 times maximal urinary flow rate (Q) minus
0.1 times effective capacity (Ceff). We defined the expression V-3Q-0.1Ceff as bladder
outlet obstruction number (BOON). Extension of the bladder outlet obstruction num-
ber with relative residual volume makes no sense (see table 11.1). The optimal number
of parameters in a linear combination in order to improve correlation with urethral
grade appears to be 3.
The discriminating power of the BOON in the classification of men in unobstructed,
equivocal and obstructed men in relation to the urodynamic classifications by ICS, URA
and Schäfer, is illustrated in table 11.2.
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Table 11.1 Kendall and Gibbons correlations of variables and combination of variables with
AG-number, URA and Schäfer’s obstruction grade.
Variable AG-number URA Schäfer’s 
obstruction
grade
Effective capacity (Ceff) -0.28** -0.26** -0.29**
Maximal free flow rate (Qmax) -0.36** -0.42** -0.37**
Prostate volume (V) +0.25** +0.23** +0.28**
Relative residual volume (Rrel) +0.21** +0.24** +0.22**
Residual volume (R) +0.18** +0.21** +0.19**
Symptom index +0.02 +0.08* +0.07
Quality of life score +0.01 -0.01 +0.01
V-3xQmax 0.41** 0.43** 0.43**
V-3xQmax-0.1xCeff 0.45** 0.45** 0.46**
V-3xQmax-0.1xCeff+0.25xRrel 0.45** 0.46** 0.46**
Clinical prostate score1 0.40** 0.45** 0.42**
** Correlation is significant at the 0.01 level (two-tailed)
* Correlation is significant at the 0.05 level (two-tailed)
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Figure 11.1 A. Proportional number (%) of men with BOON>cut-off point. B. Proportional
number (%) of men with BOON>cut-off point who are obstructed, equivocal or unobstructed
according to the ICS definition.
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Figure 11.2 A. Proportional number (%) of men with BOON≤ cut-off point. B. Proportional
number (%) of men with BOON≤ cut-off point who are obstructed, equivocal or unobstructed
according to the ICS definition.
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Figure 11.1A shows the proportional number of patients with BOON>cut-off point, and
figure 11.1B the percentages of men who are obstructed, equivocal or unobstructed
according to the provisional definition of the ICS11.
Figures 11.2A and 11.2B show these numbers for BOON≤ cut-off point.
Kendall and Gibbons’ correlation coefficient between the clinical prostate score
(CLIPS) of Rosier et al.1 and URA in our 369 men was 0.45. Rosier reports a Pearson’s
correlation coefficient of 0.53 in his group (in our group, Pearson’s correlation coeffi-
cient was 0.54 between URA and CLIPS). Modifying CLIPS by omission of post-void
residual volume and by doubling the weight of voided volume did not change correla-
tion with URA in our group. Table 11.3 shows the discriminating power of the CLIPS
and of the modified CLIPS when URA is used for defining obstruction.
We applied the threshold values proposed by Schacterle et al.3 on our group. Of 38 men
(out of 369) with both maximal urinary flow lower than 10 ml/s and symptom score
higher than 20, 26 men (68%) were obstructed. In our group we could only select 24
men (6.5%) according to the cut-off values proposed by Steele5: maximum urine flow of
10 or less ml/s and prostate volume of 40 ml or greater and symptom index of greater
than 20. But even in these 24 men, only 18 (75%) were obstructed.
172
CHAPTER 11
Table 11.3 Total number of men and number of obstructed men according to URA>29 cm
H2O in relation to clinical prostate score (CLIPS) and modified CLIPS.
Number of men Number of obstructed men
All men 369 (100%) 213 (58%)
Men with CLIPS>4 242 (66%) 182
(100%) (75%)
Men with CLIPS>9 139 (36%) 118 
(100%) (85%)
Men with CLIPS>12 93 (23%) 86
(100%) (92%)
Men with modified CLIPS>4 231 (63%) 179
(100%) (77%)
Men with modified CLIPS>9 138 (37%) 116
(100%) (84%)
Men with modified CLIPS>11 88 (24%) 83
(100%) (94%)
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From the study of the 160 men who reported reliably16 their voidings on frequency-vol-
ume charts, it appeared that a strong individual association existed between calculated
mean voided volume and voided volume at strong desire17. Mean voided volume was
half the voided volume at strong desire17. We replaced voided volume at strong desire
in our formula for BOON by 2 times mean voided volume estimated from the frequen-
cy-volume chart. We validated the use of the formula BOON=prostate volume minus 3
times maximum free flow rate minus 0.2 times mean voided volume in a further group
of 95 consecutive men. In table 11.4 the results of this validation are listed.
Discussion
The combination: prostate size (ml) minus 3 times maximum urinary free flow rate
(ml/s) minus 0.1 times effective capacity (ml) was optimal in the classification of unob-
structed, equivocal and obstructed men compared to urodynamic classification.
Extension of this combination with more parameters did not increase the selection
power.
As no correlation exists between symptom score and obstruction grade, including
symptom score does not make sense (appendix). Consequently, in our group the combi-
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Table 11.4 Unobstructed, equivocal and obstructed men according to the provisional
definition of the ICS in relation to BOON with mean voided volume incorporated in stead
of effective capacity.
Number Number of Number of Number of 
of men unobstructed equivocal obstructed 
men men men
All men 95 (100%) 17 (18%) 23 (24%) 55 (58%)
Men with BOON>-40 50 (53%) 1 11 38 
(100%) (2%) (22%) (76%)
Men with BOON>-20 28 (29%) 0 4 24 
(100%) (0%) (14%) (86%)
Men with BOON>-10 17 (18%) 0 3 14 
(100%) (0%) (18%) (82%)
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nation of maximal urinary flow rate with symptom score to discriminate obstructed and
unobstructed men, as proposed by Schacterle et al.3, did not work.
The selecting power of our bladder outlet obstruction number (BOON) is similar to the
power of the clinical prostate score (CLIPS)1. The CLIPS contains comparable parame-
ters as our BOON plus post-void residual volume. Application of the clinical prostate
score thus has the disadvantage that it requires reliable estimation of residual volume.
However, in our group, omission of post-void residual volume score in the CLIPS, did
not decrease its correlation with obstruction grade. In the same way, extension of our
BOON with post-void residual volume did not increase its correlation with obstruction
grade (see table 11.1). The clinical prostate score thus can be simplified and its applica-
bility increased by omission of post-void residual volume. We prefer the application of
BOON above the modified CLIPS because of its simplicity.
In contrast to the claim of Steele et al.5, we could only select 6.5% of our men who had
values above their cut-off points. But even after this selection, still 25% (and not 0%)
of the men were equivocal or unobstructed. Possibly the selection criteria of Steele et
al. differ largely from those of Rosier et al. and of us.
Regardless which method is used and thus which definition is applied for obstruction,
equivocal and nonobstruction, the selecting power of bladder outlet obstruction num-
ber BOON is relatively similar (table 11.2).
Effective capacity was defined as the voided volume at strong desire to void. At home a
lower bladder content may trigger the patient to empty his bladder and only a few
times he will wait until strong desire. This explains why voided volume at strong
desire is twice the mean voided volume calculated from the frequency-volume chart.
Estimation of mean voided volume from frequency-volume charts is easy.
Ultrasonography is accepted as a useful investigation of the prostate and is a reliable
method to estimate prostate size6. Uroflowmetry with measurement of maximum uri-
nary flow rate has become the most frequently used urodynamic examination. This
means that in most urological practises the parameters mean voided volume, prostate
volume and maximum urinary flow rate are easy to access. Using the easily applicable
formula: prostate volume minus 3 times maximum urinary flow rate minus 0.1 times
voided volume at strong desire (or 0.2 times mean voided volume at home), it is possi-
ble to predict the chance to have or not to have bladder outlet obstruction. This chance
can easily be estimated by applying the figures 11.1 and 11.2. BOON may contribute to
the non-invasive selection of men in whom it is unlikely that their LUTS are due to
bladder outlet obstruction and in whom further investigation is indicated. 
174
CHAPTER 11
hoofdstuk 11  24-07-2001  13:58  Pagina 174
Conclusions
Bladder outlet obstruction number (BOON) may be calculated with an easily applicable
formula composed of readily available parameters: prostate size, maximum urinary flow
and voided volume at strong desire. The easy to use formula is BOON=prostate size
(ml) - 3 x maximum urinary flow rate (ml/s) - 0.1 x voided volume (ml) at strong desire.
The voided volume at strong desire is twice the mean voided volume calculated from
frequency-volume charts. Replacement of voided volume at strong desire by twice the
mean voided volume, did not affect the selection power of the formula. Extension of
the formula to more than 3 parameters did not result in a better correlation of the for-
mula with obstruction grade and thus in a better classification of men. The results are
hardly dependent on the method used to quantify the urethral resistance and thus to
classify obstructed, equivocal and non-obstructed men. 
Appendix
Pearson’s correlation coefficient (r) between 2 variables X and Y is defined:
r(X,Y) = Cov(X,Y)/[Var(X)*Var(Y)]1/2 
in which Cov(X,Y) is the covariance of X and Y, and Var(X) and Var(Y) are the variances of X
and Y respectively. For variance and covariance additional laws apply:
Var(X+W) = Var(X) + Var (W) + 2Cov(X,W)
Cov(X+W,Y) = Cov(X,Y) + Cov(W,Y)
Suppose that there is a significant positive correlation with correlation coefficient c1 between
OG (obstruction grade) and a parameter A and also between OG and a parameter B (correla-
tion coefficient c2). Suppose c1≥ c2, thus c2=γc1 with 0<γ≤ 1.
We shall prove that under certain conditions a linear combination of A and B, A+αB with
α>0, results in a correlation with OG with a correlation coefficient higher than c1.
We introduce a new variable β, defined by:
β2 = Var(B)/Var(A)
If B’ = B/β then:
Var(B’) = Var(A)
If:
α‘ = αβ
then:
r(OG,A+αB) = r(OG,A+α‘B’)
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According to the definition:
r(OG,A+α‘B’) =[Cov(OG,A+α‘B’)]/[Var(OG)*Var(A+α‘B’)]1/2 
By applying the additional laws and using var(A)=Var(B’), the right-hand expression in this
equation can be changed into:
[r(OG,A)+α‘r(OG,α‘B’)] / [1+α‘2+2α‘r(A,B’)]1/2 
Substitution of r(OG,A) = c1, r(OG,α‘B’) = r(OG,B) = γc1 and r(A,B’) = r(A,B) results in:
r(OG,A+α‘B’)=[ c1 + γα‘c1]/[1+α‘
2+2α‘r(A,B)]1/2 
Thus the combination A+α‘B’ will result in an improvement of the correlation with OG with a
factor:
[1 + γα‘] / [1 + 2α‘r(A,B) + α‘2]1/2
Minimum and maximum values for r(OG,A+α‘B’) are found for:
δ/δα‘ [r(OG,A+α‘B’)] = 0
or:
α‘ = [γ-r(A,B)] / [1-γr(A,B)]
Because A and B are positively correlated with OG, it is reasonable to assume that the corre-
lation between A and B is positive too, thus r(A,B)≥ 0. The improvement of the correlation is
maximal if r(A,B)=0 and equals: 
[ γ2 + 1 ]1/2 
If γ = 0 no improvement can be obtained. The maximum improvement is about 40% (γ=1).
We may combine a third parameter c3 that correlates with OG (correlation coefficient c3 ≤ c2
≤ c1) with A+α‘B’ and so on. However, the improvement will be limited to only a few parame-
ters due to a decreasing γ and an expected increase of the correlation coefficient between the
combination and the next parameter. This is clearly illustrated in table 11.1 of the Chapter. 
We assume that our calculations also apply to Kendall and Gibbons correlation coefficient.
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Benign prostatic hyperplasia (BPH) affects a considerable number of elderly men. In a
lot of these men, BPH is associated with lower urinary tract symptoms (LUTS).
Depending on the degree of bothersomeness of these LUTS, the patient will seek med-
ical treatment. Due to the ageing population, BPH creates not only a substantial, but
also an increasing demand on the health care system. Investigation of the contribution
of the results of different examination methods to the final diagnosis of men with LUTS
suggestive of BPH is necessary. Patronised by the World Health Organisation (WHO),
the International Scientific Committee of the International Consultation on BPH, from
1991 onwards, formulated recommendations concerning the evaluation of LUTS sug-
gestive of BPH based upon such research. Every two years the recommendations are
adapted to new scientific developments and views.
The investigations, reported in this thesis, focussed on symptoms and diagnostics in
clinical BPH in well-defined groups of men with LUTS suggestive of BPH. We included
only men who fulfilled the criteria of the International Scientific Committee1. We were
somewhat astonished about the number of men who had to be excluded5 because they
were already taking medication active on the lower urinary tract before diagnosis has
been completed. We do not know whether this was due to an increasing preference for
medication over surgery or that it was just to tide over waiting times for health care.
We only included men who were able to produce at least one voiding with a volume of
more than 150 ml. The latter criteria led to an exclusion of about 5%. Except for one
man who had a bladder capacity of 1100 ml, the maximum capacity in the other men
was 900 ml6. Most men (81%) had no residual volume, or had a residual volume lower
than 100 ml6. These data give support to our assumption that our groups included men
who were able to compensate more or less for the impaired outflow conditions due to
BPH and that we excluded men with severe and prolonged obstruction. In a reasonable
number of these excluded men, bladder properties might have been changed resulting
in (partly) decompensated bladders. With our selection procedure aetiology to
patients’ complaints was reduced to a minimum of variables in contrast to
other studies, and thus our groups were well suited for studying symptoms,
bothersomeness and diagnostics and their mutual interactions in BPH. Only
5% of our men were excluded because they did not void more than 150 ml. Thus the
men included in our study form a reasonably representative sample of the pop-
ulation of men who attend a urologic clinic, and for whom there is some suspi-
cion of prostatic obstruction. 
Knowledge about the presence or absence of bladder outlet obstruction is still consid-
ered as decisive in the choice of treatment. The only reliable method (until now) for
directly diagnosing bladder outlet obstruction in BPH is simultaneous measurement of
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the driving pressure and the resulting urinary flow rate. However, pressure-flow stud-
ies are considered too invasive and to cause discomfort to the patient. However, our
experience was that urodynamics was associated with low objective and sub-
jective morbidity, provided that specific precautions were fulfilled1. Taking into
account these precautions, patients who were not able to produce a reliable pressure-
flow registration were exceptional.  We found 53% of our patients to be obstructed,
27% to be equivocal and 20% to be unobstructed6. This distribution emphasises the
need for pressure-flow studies.
There are different methods of analysing pressure-flow studies to define bladder outlet
obstruction. In our group of men, high agreement existed between the different meth-
ods of classification6. Differences between the methods were marginal and are not like-
ly to influence a decision whether or not to perform surgery6. In normal clinical
practice, the high agreement between the methods leaves the urologist free to
choose between the group specific urethral resistance factor URA, the Schäfer
nomogram or the (simple applicable) AG-number in order to evaluate urethral
resistance and thus to classify men as obstructed, equivocal or unobstructed6. 
Despite the strict selection procedures, we reconfirmed the reported absence of a cor-
relation between prostate volume and symptoms or quality of life, and between degree
of bladder outlet obstruction and symptoms or quality of life4. Additionally, the pres-
ence of residual volume and/or an unstable bladder was not reflected in significantly
more symptoms or a lower quality of life4. The subjective interpretation of symptoms
by the patient will surely contribute to the lack of such associations: there was no asso-
ciation between score on incomplete emptying and the actual presence or absence of
residual volume. If there were significant correlations between symptoms and urody-
namic parameters, on average the correlation with the cumulative symptom index and
quality of life remained poor. This can be attributed to the opposite implications of uro-
dynamics on symptoms: a high bladder contractility results in a high score on urgency
but in a low score on weak urinary stream and intermittency. The lack of associa-
tions does not mean that the value of urodynamics is questionable, it just
demonstrates that urodynamics and symptoms and quality of life reflect differ-
ent aspects of BPH. 
Correlations between objective parameters, obtained by urodynamics, are more pro-
nounced7. In contrast to the still generally accepted assumptions (based on digital rec-
tal examinations), obstruction grade increased significantly with increasing
prostate volume, which agrees with recent published findings based on studies per-
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formed with rectal ultrasound. Maximum urinary free flow rate was strongly negatively
correlated with obstruction grade. Patients with significant residual volume have
larger prostates and higher outlet obstruction grades. Surprisingly, no correla-
tion between the severity of residual volume and contractility grade was
found. We found a remarkable reduction of effective bladder capacity (voided
volume at strong desire to void) at increasing degrees of bladder outlet
obstruction7. 
To decide what is pathological in elderly men requires a knowledge of what can be con-
sidered as normal. Therefore, we studied 14 elderly, symptom-free population-based
men8 and found 5 of them to be obstructed. Additionally, 6 of them exhibited an unsta-
ble bladder and 6 had significant residual volume. Nevertheless, mean prostate volume
in these men was found to be 21 ml (in our patients 38 ml) and a mean cumulative
symptom score of 3 was found (in our patients 17). Typical urodynamic findings in
men with LUTS suggestive for BPH are thus also common in healthy elderly
men without LUTS. Effective capacity in the symptom-free group was signifi-
cantly higher than in the men with LUTS. Since normality in urodynamics
may include so many different features, the interpretation of urodynamic eval-
uations should be made with caution. 
Up to now, decision making for treatment has been mainly based on symptoms and the
degree of bladder outlet obstruction. However, what characterises men who seek treat-
ment for BPH is not their obstruction degree or possible risk for upper urinary tract
damage, but rather worry and embarrassment about urinary symptoms. We used vali-
dated methods to quantify these effects of disease5. The symptoms with the highest
prevalence were weak urinary stream, frequency and urgency. Hesitancy had
the lowest prevalence. The symptoms urgency, nocturia and hesitancy were
the most bothersome. The majority of men experienced only a little physical discom-
fort due to their urination problems. Patients were only discouraged from doing things
they would usually do when the symptom index (range 0 to 35) exceeded 20 (which
was the case in 30% of the men). Bother about incomplete emptying and bother
about frequency have a high impact on well-being, in contrast to weak urinary
stream and, surprisingly, hesitancy. Confirming the earlier reported lack of associa-
tion between score on incomplete emptying and the actual presence or absence of
residual volume, bothering about incomplete emptying was also not associated with the
actual residual volume. Obviously, an increase in frequency is interpreted by the
patient as caused by incomplete emptying.
Since bothersomeness and well-being should be regarded as the outstanding parame-
ters to measure outcome after treatment, we strongly recommend the addition of
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questions directed at bothersomeness and health-related quality of life, to the
symptom questions. 
For this purpose validated questionnaires are available5. Bother due to LUTS and
impact on a patient’s quality of life should contribute to treatment decisions.
In a subgroup of the men, it has been demonstrated that reporting on frequency-vol-
ume charts during just 24 hours is reliable and sufficient to gain insight into
the voiding habits during normal daily life of a man with LUTS suggestive of
BPH2. In our group nocturia due to polyuria was an exceptional finding. When data
from frequency-volume charts were associated with symptoms and quality of life, then
high diuria and small voided volumes at night and in daytime contributed to
high symptoms and a low quality of life3. We suppose that frequent voiding of small
volumes interferes with daily social life and therefore with quality of life. Again, a high
negative correlation was found between mean voided volume at night and in daytime
and score on incomplete emptying. Also in this subgroup the latter score was hardly
dependent on the presence or absence of residual volume. This suggests once more
that frequent voiding of small volumes may be (wrongly) interpreted as caused by
inability to empty the bladder completely.
Comparing data from frequency-volume charts with filling cystometric estimated
parameters revealed that cystometric capacity (bladder volume at strong desire to
void) and especially effective capacity (cystometric capacity minus residual vol-
ume=voided volume at strong desire) corresponded significantly to the maxi-
mum voided volume reported on the frequency-volume chart. Effective
capacity was twice as high as the mean voided volume calculated from the
charts9. Effective capacity represents the “strong desire to void” volume, which will
not be frequently used by patients in everyday life. Patients shall void at their “first or
normal desire to void” volume, resulting in a voided volume that is half of that voided
at strong desire. This means that bladder capacities can easily be calculated from data
from frequency-volume charts and residual volume. Interestingly, the presence of
instability was not associated with smaller voided volumes or higher nocturia
or diuria derived from frequency-volume charts9. As has been mentioned earlier,
symptom-free elderly male volunteers also showed detrusor instability8. It seems
that the association of detrusor instability with BPH is non-specific. In con-
trast to some results published by others, decreased bladder compliance was
an exceptional finding in our group9. These findings support the opinion that filling
cystometry is of minor diagnostic importance in BPH, when reliable frequency-volume
charts are available.
Association of data from frequency-volume charts with data obtained by pressure-flow
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studies10 showed a substantial reduction of the reported maximum voided vol-
ume at increasing obstruction grade, due to an increase in residual volume and
a simultaneous decrease in bladder capacity. These effects can lead in themselves
to complaints of frequency, nocturia and small voided volumes and the (wrong) feeling
of an inability to empty the bladder completely. We suppose that the declining vol-
ume of the bladder at the onset and early phase of BPH is the major cause of
bothersomeness and a loss of general well-being. Evidently, the shrinking bladder
leads men to a substantial reduction in fluid intake10. This illustrates that interpreta-
tion of the symptoms should be done carefully taking into account possible
adaptations of the patient’s behaviour with regard to troublesome symptoms
(such as less urgency, frequency and nocturia due to reduction of fluid intake). 
Frequency-volume charts with reporting on fluid intake, deserve more atten-
tion than only to identify patients with nocturnal polyuria or excessive fluid
intake. In our group, patients with nocturnal polyuria and excessive fluid intake were
exceptional. The maximum voided volume in voiding diaries is a reliable reflection of
the effective capacity. Functional bladder capacity (average voided volume derived from
the voiding diary) is only 50% of the effective capacity. Frequency-volume charts allow
for quantification of frequency and nocturia. We strongly recommend the use of fre-
quency-volume charts during one representative 24 h period in the initial eva-
luation of men with LUTS suggestive of BPH.
A shortcoming of our study is that our observations apply to the total group of
studied patients. It is difficult to interpret the results for an individual patient,
because the variability is high. Besides, we performed a cross-section study.
As a consequence, it is difficult to find out the cause and effect relations
between the parameters.
Urodynamic evaluations may improve diagnosis of patients with LUTS, and may guide
selection of patients for specific treatment modalities. Whereas filling cystometry is of
minor diagnostic importance, pressure-flow studies should be done before invasive
treatments are considered.  As has been mentioned above, these investigations can be
done with low subjective and objective morbidity and with reliable results.
Nevertheless we realise that, due to a number of factors, the barrier to perform a pres-
sure-flow study in our clinic may be lower than in other clinics. Therefore, we investi-
gated the possibility of non-invasive assessment of benign prostatic obstruction in
elderly men with LUTS11. Based upon the associations of parameters with obstruction
grade4,7,9,10, we investigated which linear combination of easily available non-invasive
parameters allowed the classification of men as obstructed, equivocal or unobstructed
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in optimal agreement with urodynamic classification. This has led to the development
of the bladder outlet obstruction number BOON, defined as BOON=prostate
volume (Vprostate, in ml) minus 3 times maximum urinary free flow rate
(Qmax, in ml/s) minus 0.1 times voided volume at strong desire (Vstrong, ml),
or BOON=Vprost - 3xQmax - 0.1xVstrong. Extension of this formula to more
than 3 parameters did not result in a better classificiation. Replacement of
voided volume at strong desire by 2 times mean voided volume (Vmean) calcu-
lated from frequency volume charts, thus:
BOON = Vprost - 3xQmax - 0.2xVmean,
did not affect the results. In chapter 11 nomograms are given with which an
urologist can predict what chance a man has with a known BOON to be
obstructed, equivocal or unobstructed.
When the BOON is not conclusive enough, we strongly advise the performing
of pressure-flow studies to be aware of low bladder contractility without obstruction
or other causes for LUTS. It is generally accepted that men with low flow/ low pres-
sure BPH might not realise the same benefit from surgical treatment as do obstructed
patients. By performing urodynamics, patients can be informed before treat-
ment in an optimal manner. 
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De prostaat is een klier ter grootte van een walnoot die zich vlak onder de blaas rond
de plasbuis bevindt. Normaal weegt de prostaat ongeveer 15 gram. Na het dertigste
levensjaar kan de prostaat gaan groeien tot zelfs meer dan 100 gram. Deze meestal
goedaardige vergroting van de prostaat wordt benigne prostaathyperplasie (BPH)
genoemd. BPH kan aanleiding geven tot meerdere klachten, zoals een zwakke urine-
straal, vaak moeten plassen, ‘s nachts vaak het bed uit moeten om te plassen, de urine
moeilijk op kunnen houden en nadruppelen. Ook kan BPH andere aandoeningen ver-
oorzaken, zoals blaasontsteking of het ontstaan van blaasstenen. Deze verschijnselen
kunnen als zeer hinderlijk ervaren worden en een grote invloed hebben op het dage-
lijks leven van de patiënt en diens kwaliteit van leven.
Om de diagnose BPH te kunnen stellen, maakt de uroloog gebruik van verschillende
onderzoeken. Door middel van geluidsgolven (echografisch) onderzoek wordt de groot-
te van de prostaat bepaald. De ernst van verschillende klachten, en de hinder die een
patiënt daarvan ondervindt, worden in kaart gebracht met behulp van vragenlijsten.
Door de patiënt in een aangepast toilet te laten plassen, kunnen de sterkte van de uri-
nestraal en de uitgeplaste hoeveelheid worden gemeten. Daarna kan de in de blaas
achtergebleven hoeveelheid urine worden bepaald. Patiënten vullen bovendien gedu-
rende een aantal dagen een  plasdagboek in. Dit dagboek geeft informatie over tijdstip-
pen en de dan geplaste hoeveelheden overdag en ‘s nachts en over de hoeveelheden
vocht die de patiënt drinkt.
Belangrijk bij BPH is het onderzoek naar het gedrag van de blaas als deze gevuld wordt
en wanneer deze zich ledigt (urodynamisch onderzoek: UDO). Dit onderzoek kan de
oorzaak van de klachten achterhalen. Hiertoe wordt een dun slangetje (een catheter)
door de plasbuis tot in de blaas geschoven. Met deze catheter kan de blaasdruk worden
gemeten en de blaas worden gevuld tot de patiënt goede aandrang heeft. De patiënt
wordt dan gevraagd te plassen. Het slangetje is zo dun dat de patiënt er gemakkelijk
langs kan plassen. De blaasdruk wordt tijdens het plassen gemeten. Omdat de patiënt
in het aangepaste toilet plast, wordt ook de sterkte van de uitgeplaste straal gemeten.
Het UDO geeft onder andere informatie over de blaasinhoud bij aandrang (de blaasca-
paciteit), eventuele ongewenste samentrekkingen van de blaasspier (blaaskrampen),
de knijpkracht van de blaasspier, de hinder die de blaasspier ondervindt bij het plassen
door de vergrote prostaat (de obstructie) en de achtergebleven hoeveelheid urine in de
blaas (het residu). Een zwakke straal bij het plassen kan veroorzaakt worden door een
vergrote prostaat die in de weg zit (obstructie). Het kan echter ook gebeuren dat de
prostaat niet in de weg zit, maar de blaasspier verzwakt is. Urodynamisch onderzoek is
(tot nu toe) de enige methode om een zwakke blaasspier te onderscheiden van obstruc-
tie, als oorzaak van de klachten. 
Internationaal staan onderzoek en behandeling van de aandoening BPH volop in de
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belangstelling. Een internationale commissie van de Wereld Gezondheidsorganisatie
spreekt zich iedere twee jaar onder andere uit over welke van de diagnostische onder-
zoeken belangrijk of minder belangrijk zijn, afhankelijk van de dan geldende weten-
schappelijke inzichten.
BPH kan behandeld worden met medicijnen of met een operatie die vaak via de plas-
buis uitgevoerd kan worden. De kans dat een man in zijn leven voor BPH behandeld
moet worden, wordt geschat op 30%. In Nederland vonden in 1999 ongeveer 10.000
prostaatoperaties plaats. De kosten hiervan waren ruim 32 miljoen Euro. Aangezien de
kans op BPH toeneemt als men ouder wordt, zal het aantal patiënten wereldwijd toene-
men door de vergrijzing. Onderzoek en behandeling van patiënten met BPH zullen
daardoor een toenemende vraag naar de gezondheidszorg veroorzaken. Het goed in
kaart brengen van de klachten en de hinder ervan voor de patiënt en een goede diagno-
se van BPH zijn vereist voor verbeteringen in behandeling van deze veel voorkomende
aandoening.
De doelstellingen van dit proefschrift waren:
1. het bestuderen van verschillende diagnostische onderzoeksmethoden en hun
onderlinge overeenkomsten en verschillen bij mannen met klachten veroorzaakt
door BPH;
2. het onderzoeken van de ernst van de klachten, de hinder die patiënten ervan heb-
ben en de invloed hiervan op hun welzijn;
3. het in maat en getal uitdrukken van de diagnostische bijdrage van de verschillende
(combinaties van) onderzoeksmethoden.
We hebben onderzoek gedaan bij 565 mannen boven de 50 jaar die van 1993 tot 2000 de
polikliniek urologie in het Universitair Medisch Centrum in Utrecht bezochten met
klachten veroorzaakt door BPH. 
De onderzochte patiënten voldeden aan strenge eisen: ze moesten meer dan 150 ml
kunnen plassen bij de meting van de stevigheid van de urinestraal, ze mochten geen
prostaatkanker of neurologische ziektes hebben en ze mochten niet aan hun prostaat
geopereerd zijn. Ook patiënten die medicatie innamen die de urinewegen beïnvloeden,
werden uitgesloten. Met onze strenge eisen hoopten we mannen met ernstige en lang
bestaande obstructie uit te sluiten. Bij een deel van deze mannen zal de blaas immers
niet goed meer werken en zijn er al veranderingen opgetreden in de blaasspier. Onze
onderzochte patiëntengroep zal daardoor een juiste afspiegeling zijn van mannen die
zich bij een urologische kliniek melden met klachten mogelijk veroorzaakt door BPH.
Uitgebreide diagnostiek werd uitgevoerd, waaronder echografie van de prostaat, klach-
tenvragenlijsten, meting van de sterkte van de urinestraal, residu-bepaling en urodyna-
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misch onderzoek. We hebben geprobeerd de onderzoeken zo betrouwbaar mogelijk uit
te voeren. Veel aandacht werd besteed aan de privacy en het comfort van de patiënt tij-
dens de onderzoeken. Daarnaast werd er altijd gecontroleerd of de onderzoeksresulta-
ten wel betrouwbaar waren, bijvoorbeeld door de patiënt te vragen of hij geplast had
zoals thuis. Als dat niet het geval was, werd het onderzoek herhaald. Indien er bijvoor-
beeld na het plassen urine achterbleef in de blaas werd altijd onderzocht of dat elke
keer zo was.
De bestudeerde patiëntengroep bleek gemiddeld 66 jaar oud te zijn. De hoogste leeftijd
was 90 jaar. Het gemiddelde prostaatgewicht was 38 gram (variërend van 10 tot 155
gram). De urinestraalsterkte bedroeg gemiddeld 12 ml per seconde, terwijl een man
zonder BPH gemakkelijk 30 ml per seconde haalt. De gemiddelde blaascapaciteit was
415 ml, terwijl deze normaal ruim 500 ml is.
Urodynamisch onderzoek wordt door veel urologen gezien als tijdrovend, duur en
belastend voor de patiënt. Onze ervaring is echter dat urodynamisch onderzoek niet
belastend hoeft te zijn, mits er voorzorgsmaatregelen getroffen worden die de privacy
en het comfort van de patiënt bevorderen.
De aan- of afwezigheid van obstructie in de plasbuis door de vergrote prostaat is
belangrijk bij de keuze van de behandeling. In onze patiëntengroep bleek 53% van de
patiënten een obstructie te hebben, 20% had geen obstructie en bij 27% was dit twij-
felachtig.
Er zijn verschillende rekenmethoden bedacht door natuurkundigen en urologen om de
gegevens over blaasdruk en de sterkte van de urinestraal (waarmee de mate van
obstructie bepaald wordt) te bekijken. Wij vonden een grote mate van overeenstem-
ming tussen deze methoden. De gevonden kleine verschillen zullen naar verwachting
de beslissing over wel of niet opereren niet beïnvloeden.
Ondanks onze strenge eisen bij de samenstelling van de patiëntengroep vonden wij,
net als in de literatuur, geen verband tussen de grootte van de prostaat en de ernst van
de klachten en de kwaliteit van leven van de patiënt. Ook vonden wij geen verband tus-
sen de mate van obstructie en de ernst van de klachten. Daarnaast bleek ook het
achterblijven van urine in de blaas na het plassen (het residu) of blaaskrampen niet tot
meer klachten of een slechtere kwaliteit van leven te leiden. 
De zwakke verbanden tussen urodynamische bevindingen en de ernst van de klachten,
kan verklaard worden door tegengestelde uitwerkingen die een urodynamische bevin-
ding te weeg kan brengen. Een grote knijpkracht van de blaas kan tot een ernstige
klacht over vaak moeten plassen leiden terwijl er dan geen klacht is over een zwakke
urinestraal. Daarnaast kan de patiënt een verkeerde voorstelling van de werkelijkheid
hebben. Zo bleken patiënten die goed leeg plassen toch net zo vaak het gevoel te heb-
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ben niet goed te kunnen leegplassen als die patiënten die daadwerkelijk niet goed leeg-
plasten. Het ontbreken van verbanden wil niet zeggen dat de waarde van urodynamisch
onderzoek twijfelachtig is. Het toont alleen aan dat urodynamica en het in kaart bren-
gen van klachten elkaar aanvullen in de diagnostiek.
Er zijn wel verbanden gevonden tussen andere gemeten grootheden. Bij een toene-
mend prostaatgewicht neemt ook de mate van obstructie toe. De sterkte van de urine-
straal in de groep patiënten nam af bij een toenemende obstructie. Patiënten met een
aanzienlijk residu bleken grotere prostaten en een grotere obstructie te hebben dan
patiënten die hun blaas helemaal leeg plasten. Daarnaast was het opmerkelijk dat de
blaascapaciteit (sterk) afnam bij toenemende obstructie.
Om te achterhalen of uitkomsten van onderzoeken afwijkend zijn, is het belangrijk te
weten wat de blaasfunctie is van oudere mannen zonder klachten. Veertien gezonde
vrijwilligers hebben we urologisch onderzocht. Het gemiddelde prostaatgewicht was
21 gram. Vijf vrijwilligers bleken een obstructie te hebben. Tevens bleken zes vrijwilli-
gers blaaskrampen te vertonen en hadden zes een aanzienlijk urineresidu. Typische
urodynamische bevindingen bij patiënten met klachten veroorzaakt door BPH blijken
dus ook voor te komen bij gezonde oudere mannen. Urodynamische bevindingen moe-
ten dus behoedzaam worden geïnterpreteerd en altijd worden gecombineerd met de
bevindingen van andere onderzoeken.
Tot nu toe werd de beslissing om een patiënt met BPH te behandelen voornamelijk
gebaseerd op de ernst van de klachten en de mate van obstructie door de prostaat.
Echter, de mannen met BPH komen niet naar de uroloog omdat ze een obstructie ver-
moeden of bang zijn voor risico op schade aan hun urinewegen. Ze komen omdat ze
zich zorgen maken en omdat ze hinder van hun klachten ondervinden. We hebben deze
zorgen en hinder in onze groep onderzocht. De klachten die het meest voorkwamen,
waren een zwakke urinestraal, vaak moeten plassen en loze aandrang. De klachten die
de patiënten het hinderlijkst vonden, waren vaak moeten plassen, waaronder ‘s nachts
en het moeten persen om de urinestraal op gang te brengen.
Ongeveer 30% van de patiënten liet zich door de klachten ervan weerhouden de dingen
te doen die ze gewend waren te doen. De zorgen die patiënten zich maken over het
niet goed leeg kunnen plassen en het vaak moeten plassen hadden een grote invloed op
het welzijn van de patiënten, in tegenstelling tot bijvoorbeeld de zorgen die patiënten
zich maken over een zwakke urinestraal. Wij pleiten voor de toevoeging aan de dia-
gnostiek van vragen over de hinder van en de zorgen over de klachten en de gevolgen
hiervan voor de kwaliteit van leven. 191
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In een subgroep van 160 patiënten toonden we aan dat het invullen van een plasdag-
boek gedurende 24 uur betrouwbaar en toereikend is om inzicht te krijgen in het plas-
gedrag tijdens het dagelijks leven van een man met klachten veroorzaakt door BPH.
Toen de gegevens verkregen van plasdagboeken vergeleken werden met de antwoor-
den op vragen over klachten, bleek dat vooral het overdag vaak moeten plassen en
kleine plasjes overdag en ‘s nachts aanleiding waren tot ernstige klachten.
Het uitgeplaste volume bij sterke aandrang tijdens het UDO bleek overeen te komen
met de grootste geplaste hoeveelheid ingevuld in het plasdagboek. Mensen zullen in
hun dagelijks leven meestal gaan plassen bij eerste of normale aandrang en niet wach-
ten tot ze sterke aandrang hebben. De grootste geplaste hoeveelheid bleek ongeveer
twee keer zo groot te zijn als de gemiddelde geplaste hoeveelheid van het plasdagboek.
Het vaststellen van blaaskrampen tijdens het UDO hield geen verband met kleinere
plashoeveelheden of een groter aantal keren plassen in het plasdagboek. Aangezien
gezonde mannelijke vrijwilligers ook blaaskrampen lieten zien, lijkt het erop dat blaas-
krampen niet kenmerkend zijn voor BPH. Bovenstaande resultaten tonen aan dat uro-
dynamische metingen tijdens het vullen van de blaas bij BPH niet belangrijk zijn voor
de diagnostiek, mits er betrouwbaar ingevulde plasdagboeken beschikbaar zijn.
We veronderstellen dat de afnemende blaasinhoud bij het voortschrijden van de aan-
doening de belangrijkste oorzaak is van de hinder die patiënten gaan ondervinden van
BPH. De krimpende blaas leidt ertoe dat veel patiënten hun vochtinname verminde-
ren. Bij de beoordeling van de klachten dient rekening gehouden te worden met het feit
dat patiënten hun gedrag aangepast kunnen hebben aan hinderlijke klachten. Wij plei-
ten voor het gebruik van plasdagboeken gedurende een normale periode van 24 uur bij
onderzoek van patiënten met klachten veroorzaakt door BPH. Dit is immers de enige
manier om een inzicht te krijgen in het aantal keren dat een patiënt overdag en ‘s
nachts plast en hoeveel de patiënt drinkt.
Een tekortkoming van ons onderzoek is het feit dat bovenstaande resultaten voor de
totale groep patiënten gelden. Het is moeilijk onze resultaten voor een enkele patiënt
weer te geven aangezien er een enorme spreiding is van de onderzochte grootheden
tussen mensen. 
Urodynamisch onderzoek kan de diagnose bij patiënten met urologische klachten ver-
beteren. Urodynamisch onderzoek zal gedaan moeten worden indien een operatie
wordt overwogen. We realiseren ons echter wel dat, om verschillende redenen, urody-
namisch onderzoek in andere klinieken niet zo vanzelfsprekend is als in onze kliniek.
Daarom hebben we onderzocht of het mogelijk was de mate van obstructie in de plas-
buis te voorspellen op basis van gegevens verkregen uit een aantal onderzoeken die
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toch al worden uitgevoerd. Dit heeft geleid tot een eenvoudige formule waarin het
volume van de prostaat, de sterkte van de urinestraal en de grootste uitgeplaste hoe-
veelheid (of twee maal de gemiddeld geplaste hoeveelheid) op het plasdagboek kunnen
worden ingevuld. Met het getal dat daar uitkomt (de BOON) kan de uroloog aan de
hand van twee grafieken (uit hoofdstuk 11) voorspellen of een patiënt wel of niet een
obstructie heeft. Als de BOON niet voldoende uitsluitsel geeft, raden wij met klem aan
wèl urodynamisch onderzoek uit te voeren om op de hoogte te zijn van mogelijke ande-
re oorzaken van de klachten. Door urodynamisch onderzoek uit te voeren, kunnen pati-
ënten goed worden geïnformeerd over hun aandoening en over de verwachtingen na
behandeling van de aandoening.
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Iedereen die op welke manier dan ook heeft bijgedragen aan de tot standko-
ming van dit proefschrift wil ik hartelijk bedanken.
Allereerst en bovenal gaat mijn dank uit naar mijn co-promotor Dr. van
Venrooij. Beste Ger, zonder jouw enorme enthousiasme, betrokkenheid en
goede adviezen was dit proefschrift niet tot stand gekomen. We hebben al-
tijd enorm prettig kunnen samenwerken. Betreft onze samenwerking is het
geheel zeker meer geworden dan de som der delen! De onzekerheden die
“Durven Kiezen” met zich meebracht heeft ons gelukkig niet belemmerd in
onze werkzaamheden. Integendeel, het zette ons aan tot extra inspanning
wat tot een snelle opeenvolging van artikelen heeft geleid. Jouw weten-
schappelijke integriteit is altijd een voorbeeld voor mij geweest. Wanneer
ik ook binnenviel, je nam altijd de tijd om mijn werk te bespreken. Ook wil
ik je heel hartelijk bedanken voor het beschikbaar stellen van je uitvoerige
bestand wat je hebt opgebouwd van de patiënten. Jarenlang urodynamisch
onderzoek is daaraan vooraf gegaan. Het is dan ook een proefschrift om
trots op te zijn.
De urodynamicaverpleegkundigen Ulli, Ria, Angelique en Femmy wil ik
bedanken voor de geweldige zorg waarmee ze de beschreven patiënten
omringd hebben.
Prof. dr. Boon, mijn promotor. Beste Tom, heel hartelijk wil ik je bedanken
voor de mogelijkheid die je me bood om naast mijn werkzaamheden als
onderzoekscoördinator dit proefschrift te kunnen schrijven. Bedankt voor
het in mij gestelde vertrouwen. Je gaf me een grote mate van vrijheid bij
de uitvoering van het onderzoek en het runnen van het “trialbureau”
Urologie. Ik ben er trots op je eerste promovenda te zijn!
Drs. Zeijlemaker, beste Bram, ik ben je dankbaar dat ik via jou aan deze
baan gekomen ben. Ik had direct het gevoel dat ik bij jullie op mijn plek zou
zijn en dat is zeker uitgekomen. Je bent al een paar jaar bij ons weg, maar
ik mis de gezellige uro-landdagen en frequente borrels nog steeds…
Drs. Lock, beste Tycho, bedankt voor de prettige samenwerking betref-
fende de vele trials die we samen uitvoeren. Veel onderzoekspatiënten
geven blijk van hun waardering voor de extra tijd, zorg en aandacht die wij
gezamenlijk aan hen geven. 
Dr. van Moorselaar, beste Jeroen, we hebben nog niet veel samengewerkt
aangezien je interesse vooral uitgaat naar de oncologie. Wetenschappelijk
onderzoek wordt echter altijd door jou gestimuleerd. Ik wil je bedanken
voor je enthousiasme. 
Lieve Ellen en Els, vele leuke, ontspannende gesprekken heb ik met jullie
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gevoerd, vooral tijdens de lunchpauzes die wij vrijwel altijd samen door-
brachten. Ik wil jullie enorm bedanken voor de gezelligheid en praktische
hulp.  
Op de polikliniek kon ik altijd terecht voor organisatorische zaken rondom
de onderzoekspatiënten. Betty, Justine, Anneke, Usha, Carla, Simone,
Angela en de verpleging: bedankt hiervoor!
Leuk vond ik de samenwerking met de (oud)assistenten Urologie. Karel,
Karin, Robert-Jan, Paul, Miel, John, Reinder, Astrid, John, Roshani, Ben
en Laetitia (en natuurlijk de AGNIO’s): bedankt voor de gezellige tijd!
Beste Harm, heel leuk vind ik het dat je de BPHIL-studie voort gaat zetten,
waar ik me al jaren mee bezig houd. Ik verheug me op onze verdere samen-
werking. Ik wens je veel succes toe bij jouw promotie en ben je dankbaar
dat je me als paranimf op 6 september bijstaat!
Altijd gezellig was de samenwerking met het Lasercentrum. Christiaan,
Matthijs en Ruud, bedankt dat jullie altijd voor mij klaar stonden (ik zal
zorgen voor bitterballen op mijn feest!).
Pieter Dik wil ik hartelijk bedanken voor de schitterende tekening op de
achterkant van mijn proefschrift. Deze geeft een perfecte weergave van
Ger en de precieze metingen die aan dit proefschrift vooraf zijn gegaan!
Hedie von Bannisseht van de Audiovisuele Dienst bedank ik hartelijk voor
de prachtige lay-out en cover van mijn proefschrift. De leden van de
beoordelingscommissie wil ik bedanken voor hun bereidheid het manuscript
te beoordelen.
Ik ben mijn schoonouders, Renata en Rolf en mijn vrienden dankbaar die
mijn vorderingen altijd met veel interesse hebben gevolgd. Barbara en
José, als Dr. hebben jullie me goede tips kunnen geven!
Lieve Hans, ik ben heel blij dat je mijn paranimf wilde zijn. Aan jouw heb ik
een geweldige broer en ik wens je alle geluk toe met jouw carrière.
Lieve mam, ik ben je zeer dankbaar voor je onvoorwaardelijke steun.
Intens heb je meegeleefd met de voortgang van dit proefschrift en het is nu
dan ook een beetje jouw feestje! Papa zou zeker trots geweest zijn…
Lieve Marcel, heel erg bedankt voor je liefde en steun. Met veel geduld heb
je mijn, vaak gedetailleerde, verhalen aangehoord over alle ins en outs van
mijn promotie-onderzoek. Als technicus heb je ondertussen al behoorlijk
wat kennis opgedaan van de medische wereld; je was altijd perfect in staat
de juiste “kritische” vragen te stellen over mijn onderzoek. Zelfs in India
dacht je aan mijn promotie, wat mij prachtige stof heeft opgeleverd voor
mijn kleding!
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